13_cis_retinoic_acid
  MOE2008           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   10.6160    5.4820   -0.2300 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9350    3.3080   -0.3420 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1650   -3.7930   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9360   -5.2870   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970   -6.0950   -0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4270   -3.2930    0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2930   -5.6270    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3720   -4.1470    0.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180   -3.1060    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2620   -3.5100   -1.8950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4900   -1.8530    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5940   -3.7230    1.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5660   -1.0700    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5800    0.3580    0.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3000    1.0310    0.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7270    1.0260    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8760    2.4440    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0420    3.0690    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2550    4.4870    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0830    5.3300    0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4270    5.0940    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7040    4.4870   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0  0  0  0
  2 22  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  3  9  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  8 12  1  0  0  0  0
 11 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
13_cis_retinoic_acid

> <PRIMARY_SOM>
7

>  <Citation>
Marill et al.,Biochem. Pharmacol.,63,933,2002

$$$$
1_2_4_trichlorobenzene
  MOE2008           3D

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0020   -0.0040    0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0220    1.7320    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    2.4400    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1490    3.8220    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0570    4.4980    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2480    3.7900    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2290    2.4070    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0800    6.2340    0.0380 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7620    4.6380    0.0550 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  6  9  1  0  0  0  0
M  END
>  <ID>
1_2_4_trichlorobenzene

> <PRIMARY_SOM>
3 4

>  <Citation>
Bogaards, J.J.P.; Omen, B.V.; Wolf, C.R.; Van Bladeren, P.J. Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes. Toxicol. Appl. Pharamcol. 1995, 132, 44–52.

$$$$
1_nitropyrene
  MOE2008           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0390    1.3600   -0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.0010   -0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1410    2.0400    0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2820    2.0300   -0.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1220   -0.6970   -1.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2830   -0.6680   -0.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3610    1.3650    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860    3.3850    0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4220    1.3080   -0.7240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2860    3.3880    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3460   -0.0350   -1.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0330   -2.0400   -1.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4320    0.0210   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3500   -2.0120   -1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1260    4.0670    0.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1980   -2.6940   -1.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5130    4.1530    0.0820 N   0  3  0  0  0  0  0  0  0  0  0  0
   -2.5330    5.2010   -0.5780 O   0  5  0  0  0  0  0  0  0  0  0  0
   -3.4450    3.7150    0.7680 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  2  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  1  0  0  0  0
  6 14  2  0  0  0  0
  7 13  2  0  0  0  0
  8 15  2  0  0  0  0
  9 11  2  0  0  0  0
 10 15  1  0  0  0  0
 10 17  1  0  0  0  0
 12 16  2  0  0  0  0
 14 16  1  0  0  0  0
 17 18  1  0  0  0  0
 17 19  2  0  0  0  0
M  CHG  1  17   1
M  CHG  1  18  -1
M  END
>  <ID>
1_nitropyrene

> <PRIMARY_SOM>
7 8 13 14

> <SECONDARY_SOM>
17

>  <Citation>
Chae, Y.-H.; Thomas, T.; Guengerich, F.P.; Fu, P.P.; El-Bayoumy, K. Comparative Metabolism of 1-, 2-, and 4-Nitropyrene by Human Hepatic and Pulmonary Microsomes. Cancer. Res. 1999, 59, 1473–1480.

$$$$
2-acetylaminofluorene
  MOE2008           3D

 17 19  0  0  0  0  0  0  0  0999 V2000
   -6.8360   -1.5590    1.1320 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3310   -0.7930    2.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4640   -2.7850    1.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8530   -3.2700   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7010   -3.4360    2.2390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7320    0.4240    1.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2280    1.1940    2.8910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3100    0.7760    4.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9020   -0.4280    4.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4130   -1.2100    3.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5390    2.5390    2.7910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2400    2.8310    4.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7020    1.7830    5.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6090    3.9430    4.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4430    3.9940    6.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9010    2.9540    6.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5380    1.8340    6.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  6  1  0  0  0  0
  2 10  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  2  0  0  0  0
  8 13  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  2  0  0  0  0
 13 17  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
2-acetylaminofluorene

> <PRIMARY_SOM>
6

> <SECONDARY_SOM>
1 15

> <TERTIARY_SOM>
17

>  <Citation>
McManus ME. et al.,Cancer Research, 50, 3367-3376, 1990

$$$$
2-acetylbenzothiophene
  MOE2008           3D

 12 13  0  0  0  0  0  0  0  0999 V2000
    1.3680   -0.0260    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -1.0630    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8970   -0.6570    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9960    0.7350    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5590    1.4760    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0860   -1.4150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3260   -0.7760   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980    0.6090   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410    1.3870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -0.1330    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4080   -1.2100    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6040    1.1440    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  5  1  0  0  0  0
  1 10  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  6  2  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
M  END
>  <ID>
2-acetylbenzothiophene

> <PRIMARY_SOM>
5

>  <Citation>
Elizabeth M. Joshi, Brian H. Heasley, Mahendra D. Chordia, and Timothy L. Macdonald, In Vitro Metabolism of 2-Acetylbenzothiophene:  Relevance to Zileuton Hepatotoxicity, Chem. Res. Toxicol., 2004, 17 (2), pp 137–143

>  <DOI>
10.1021/tx0341409

$$$$
2-naphthylamine
  MOE2008           2D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.7860    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0  0  0  0
  2  3  1  0  0  0  0
  2 11  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
M  END
>  <ID>
2-naphthylamine

> <PRIMARY_SOM>
1

>  <Citation>
Butler, M.N.; Iwasaki, M.; Guengerich, F.P.; Kadlubar, F.K. Human Cytochrome P-450PIA (P450IA2), the Phenacetin O-deethylase, Is Primarily Responsible for the Hepatic 3-Demethylation of Caffeine and N-Oxidation of Carcinogenic Arylamines. Proc. Natl Acad. Sci. USA 1989, 86, 7696–7700. 

$$$$
2_nitropyrene
  MOE2008           2D

 19 22  0  0  0  0  0  0  0  0999 V2000
    0.3570    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7870    0.6180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    1.0300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.0310    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    1.7860    1.8560    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.6190    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  2  0  0  0  0
  2  3  2  0  0  0  0
  2 17  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4 15  2  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  2  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  2  0  0  0  0
 17 19  1  0  0  0  0
M  CHG  1  17   1
M  CHG  1  19  -1
M  END
>  <ID>
2_nitropyrene

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
5 6 17

>  <Citation>
Chae, Y.-H.; Thomas, T.; Guengerich, F.P.; Fu, P.P.; El-Bayoumy, K. Comparative Metabolism of 1-, 2-, and 4-Nitropyrene by Human Hepatic and Pulmonary Microsomes. Cancer. Res. 1999, 59, 1473–1480.

$$$$
3-O-methylfluorescein
  MOE2008           3D

 26 30  0  0  1  0  0  0  0  0999 V2000
    0.5560   -0.9440    1.7110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4780    2.2140   -0.6820 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2590   -2.9630    2.5790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0450    1.2880   -0.3330 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8650    4.0800   -0.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3640   -0.3470    0.3960 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7420   -1.4670   -0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.0500    0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980    0.8400    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1180   -2.5640    0.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4170    1.2920   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8220    2.0350   -0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0040   -2.2330    1.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7640   -1.5300   -1.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1400   -0.8080    0.6370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6500    0.7700    0.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5310   -3.7550   -0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7520    1.6620   -0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6700    3.1310   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4760   -0.4340    0.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750   -2.7220   -2.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4970    1.8650    0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7870    0.8040   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5570   -3.8280   -1.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0020    3.0350   -0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1330    0.4510    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  1  0  0  0  0
  1 13  1  0  0  0  0
  2 11  1  0  0  0  0
  2 12  1  0  0  0  0
  3 13  2  0  0  0  0
  4 23  1  0  0  0  0
  4 26  1  0  0  0  0
  5 25  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6  9  1  0  0  0  0
  7 10  2  0  0  0  0
  7 14  1  0  0  0  0
  8 11  2  0  0  0  0
  8 15  1  0  0  0  0
  9 12  2  0  0  0  0
  9 16  1  0  0  0  0
 10 13  1  0  0  0  0
 10 17  1  0  0  0  0
 11 18  1  0  0  0  0
 12 19  1  0  0  0  0
 14 21  2  0  0  0  0
 15 20  2  0  0  0  0
 16 22  2  0  0  0  0
 17 24  2  0  0  0  0
 18 23  2  0  0  0  0
 19 25  2  0  0  0  0
 20 23  1  0  0  0  0
 21 24  1  0  0  0  0
 22 25  1  0  0  0  0
M  END
>  <ID>
3-O-methylfluorescein

> <PRIMARY_SOM>
26

>  <Citation>
Sudsakorn et al., Drug Metab. Dispos., 2007, 35, 841-847

>  <DOI>
10.1124/dmd.106.014472

$$$$
3-cyano-7-ethoxycoumarin
  MOE2008           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3100    0.6530    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    1.3740   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0770    0.6830   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2000    1.4530   -0.3410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710    0.6510   -0.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5570    1.5720   -0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0800   -0.7150   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -1.4240   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7340    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -1.4310    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190   -0.7520    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7390    0.7200    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    1.3540    0.4150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5140    1.3700    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9410   -1.4600    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9280   -2.0590    0.6060 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 15  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
 15 16  3  0  0  0  0
M  END
>  <ID>
3-cyano-7-ethoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Ghosal et al.,Biopharm. Drug Disp.,24,375,2003
Ekins et al.,J. Pharmacol. Exp. Ther.,286,1253,1998

>  <DOI>
10.1002/bdd.374

$$$$
3-cyano-7-methoxycoumarin
  MOE2008           3D

 15 16  0  0  0  0  0  0  0  0999 V2000
    1.3100    0.6530    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    1.3740   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0770    0.6830   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2000    1.4530   -0.3410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710    0.6510   -0.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0800   -0.7150   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -1.4240   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7340    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -1.4310    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190   -0.7520    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7390    0.7200    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    1.3540    0.4150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5140    1.3700    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9410   -1.4600    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9280   -2.0590    0.6060 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 13  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
 14 15  3  0  0  0  0
M  END
>  <ID>
3-cyano-7-methoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Stresser et al.,Drug Metab. Disp.,30,845,2002

>  <DOI>
10.1124/dmd.30.7.845

$$$$
3-ethoxy-4-trifluoromethylcoumarin
  MOE2008           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4650   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5450    1.5830   -0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0970   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0890   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4170    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4690   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 18  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 16 18  1  0  0  0  0
M  END
>  <ID>
3-ethoxy-4-trifluoromethylcoumarin

> <PRIMARY_SOM>
5

>  <Citation>
E. L. Code, C. L. Crespi, B. W. Penman, F. J. Gonzalez, T. K. H. Chang, D. J. Waxman, Drug Metab. Dispos. 1997, 25, 985-993.

$$$$
3-methoxy-4-trifluoromethylcoumarin
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0920    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4660   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4180    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4700   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 17  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 10 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 17  1  0  0  0  0
M  END
>  <ID>
3-methoxy-4-trifluoromethylcoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Stresser et al.,Drug Metab. Disp.,30,845,2002

>  <DOI>
10.1124/dmd.30.7.845

$$$$
3-methylether-estradiol
  MOE2008           3D

 21 24  0  0  1  0  0  0  0  0999 V2000
   -5.1060   -0.2400   -0.5040 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8210    0.3440    0.1670 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7220   -0.7280   -0.1280 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1130    0.6730   -0.4640 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.6390    0.8410   -0.0130 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.1760   -0.4320   -0.3320 C   0  0  3  0  0  0  0  0  0  0  0  0
   -4.1050   -0.4050    0.4980 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.8410   -1.4680    0.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0370    1.7100    0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3760   -1.6220    0.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8920    0.9290    1.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0140    2.0570   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8700   -1.5930   -1.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6820   -0.2450   -0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4080    2.2860   -0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2530    1.0380   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5420   -1.3580   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6480    1.1730    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9300   -1.2110   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4890    0.0580    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7150   -0.7620    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0  0  0  0
  2 20  1  0  0  0  0
  2 21  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3 13  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6 10  1  0  0  0  0
  6 14  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
3-methylether-estradiol

> <PRIMARY_SOM>
21

>  <Citation>
D. M. Stresser, D. Kupfer, Biochem. Pharmacol. 1998, 55, 1861-1871.

>  <DOI>
10.1016/S0006-2952(98)00060-4

$$$$
3-methylindole
  MOE2008           2D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.8640    0.9810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3490    0.3140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8640   -0.3540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800   -0.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350   -0.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3490   -0.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3490    0.7260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350    1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800    0.7260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1190   -1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
3-methylindole

> <PRIMARY_SOM>
2

> <SECONDARY_SOM>
10

>  <Citation>
Thornton-Manning, J.; Appleton, J.L.; Gonzalez, F.J.; Yost, G.S. Metabolism of 3-Methylindole by Vaccinia-Expressed P450 Enzymes: Correlation of 3-Methyleneindolenine Formation and Protein-, Binding. J. Pharmacol. Exp. Ther. 1999, 276, 21–29.

$$$$
4-aminobiphenyl
  MOE2008           2D

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 13  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  7 12  2  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
4-aminobiphenyl

> <PRIMARY_SOM>
13

>  <Citation>
Hammons et al. Carcinogenesis vol.18 no.4 pp.851–854, 1997

>  <DOI>
10.1093/carcin/18.4.851

$$$$
4-chloromethyl-7-ethoxycoumarin
  MOE2008           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3010    0.6480    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1110    1.3590   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    0.6630   -0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2220    1.4250   -0.2790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3910    0.6150   -0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5840    1.5260   -0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910   -0.7310   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1100   -1.4280    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3230   -0.7430    0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6060   -1.4210    0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6680   -2.9040    0.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5540   -3.6600   -1.2370 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7160   -0.6880    0.3540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7200    0.7750    0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7670    1.4060    0.3690 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4900    1.3980    0.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 16  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 13  2  0  0  0  0
 11 12  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
M  END
>  <ID>
4-chloromethyl-7-ethoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Ekins et al.,J. Pharmacol. Exp. Ther.,286,1253,1998

$$$$
4-nitroanisole
  MOE2008           3D

 11 11  0  0  0  0  0  0  0  0999 V2000
   -0.0580    3.4920   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9940    4.1700   -0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0320    3.4740    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.0870    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030    1.3990   -0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1910    0.0510   -0.6710 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2200   -0.7200   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1700    2.1080   -1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8870    5.6220    0.0430 N   0  3  0  0  0  0  0  0  0  0  0  0
   -1.7350    6.1850    0.7500 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0440    6.2020   -0.5330 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  2  3  2  0  0  0  0
  2  9  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  CHG  1   9   1
M  CHG  1  11  -1
M  END
>  <ID>
4-nitroanisole

> <PRIMARY_SOM>
7

>  <Citation>
B.C. Jones et al., Xenobiotica, 1997, 27, 1025-1037

$$$$
4_nitropyrene
  MOE2008           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0260    1.3410   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030   -0.0350    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1700    2.0900   -0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2620    1.9540   -0.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030   -0.7750    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180   -0.6730    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3670    1.4130   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890    3.4500   -0.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4380    1.2060   -0.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3010    3.3040   -0.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4100   -0.1480   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1720   -2.1300    0.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    0.0560    0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2270   -2.0290    0.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1290    4.0520   -0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0370   -2.7540    0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6360    2.1060   -0.0100 N   0  3  0  0  0  0  0  0  0  0  0  0
    4.5350    1.6380   -0.7210 O   0  5  0  0  0  0  0  0  0  0  0  0
    3.7360    3.1040    0.7150 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  2  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  1  0  0  0  0
  6 14  2  0  0  0  0
  7 13  2  0  0  0  0
  7 17  1  0  0  0  0
  8 15  2  0  0  0  0
  9 11  2  0  0  0  0
 10 15  1  0  0  0  0
 12 16  2  0  0  0  0
 14 16  1  0  0  0  0
 17 18  1  0  0  0  0
 17 19  2  0  0  0  0
M  CHG  1  17   1
M  CHG  1  18  -1
M  END
>  <ID>
4_nitropyrene

> <PRIMARY_SOM>
17

> <SECONDARY_SOM>
9 11

>  <Citation>
Chae, Y.-H.; Thomas, T.; Guengerich, F.P.; Fu, P.P.; El-Bayoumy, K. Comparative Metabolism of 1-, 2-, and 4-Nitropyrene by Human Hepatic and Pulmonary Microsomes. Cancer. Res. 1999, 59, 1473–1480.

$$$$
5_methylchrysene
  MOE2008           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4100    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2540    2.1320    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2390    2.1040    0.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2490   -0.6870   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1980   -0.6580    0.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    1.3940    0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080    3.5210   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4180    1.4480   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4580    0.0500   -0.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3200   -1.9950   -0.7970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3840    0.0030    0.3540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    2.0670    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5190    4.1500   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6880   -0.6120   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5320   -2.6010   -0.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7000    3.4220   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7150   -1.9180   -0.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130   -2.1030    0.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  6 19  1  0  0  0  0
  7 12  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 10  1  0  0  0  0
 10 15  1  0  0  0  0
 11 16  2  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 18  1  0  0  0  0
M  END
>  <ID>
5_methylchrysene

> <PRIMARY_SOM>
15 18

> <SECONDARY_SOM>
17 13

> <TERTIARY_SOM>
13

>  <Citation>
Koehl et al.,Cancer Res.,56,316,1996

$$$$
6-aminochrysene
  MOE2008           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
    3.9590   -0.3410    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9710   -1.7600    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7300    0.3610   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1470    0.4000    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7200    1.7790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7470   -2.4650   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1580   -2.5120    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9400    2.4970    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1550    1.7960    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4000    2.4610    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5400   -0.3830   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5430   -1.7730   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7310   -3.8600   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1380   -3.9060    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5190    2.5120   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9080    3.9000    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9220   -4.5790   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5060    3.9040   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7050    4.6010    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  1  0  0  0  0
  3  5  1  0  0  0  0
  3 11  2  0  0  0  0
  4  9  2  0  0  0  0
  5  8  2  0  0  0  0
  5 15  1  0  0  0  0
  6 12  2  0  0  0  0
  6 13  1  0  0  0  0
  7 14  2  0  0  0  0
  8  9  1  0  0  0  0
  8 16  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 19  2  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
6-aminochrysene

> <PRIMARY_SOM>
13 17

> <SECONDARY_SOM>
10

>  <Citation>
Yamazaki et al.,Carcinogenesis,14,1271,1993
Koehl et al.,Cancer Res.,56,316,1996

$$$$
6-nitrochrysene
  MOE2008           2D

 21 24  0  0  0  0  0  0  0  0999 V2000
    1.7860    2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.6500    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.3570   -2.0620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -2.0620    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 18  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 18  1  0  0  0  0
  6  7  1  0  0  0  0
  6 15  2  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  8 19  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  2  0  0  0  0
 19 21  1  0  0  0  0
M  CHG  1  19   1
M  CHG  1  21  -1
M  END
>  <ID>
6-nitrochrysene

> <PRIMARY_SOM>
1 2

>  <Citation>
Chae, Y.H.; Yun, C.H.; Guengerich, F.P.; Kadlubar, F.F.; El-Bayoumy, K. Roles of Human Hepatic and Pulmonary Cytochrome P450 Enzymes in the Metabolism of the Environmental Carcinogen 6-Nitrochrysene. Cancer Res. 1993, 53, 2028–2034. 

$$$$
6_methylchrysene
  MOE2008           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0120    1.4320    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0320    0.0250   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    2.1090    0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.1260   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2590   -0.6530   -0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1830   -0.6670   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    1.3760    0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2790    3.5050    0.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4370    1.4680   -0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    0.0880   -0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3430   -2.0470   -0.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960   -0.0150    0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6350   -0.8460    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6310    2.0590    0.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4850    4.1680    0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6800   -0.5540   -0.5830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5640   -2.6850   -0.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6650    3.4420    0.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7330   -1.9370   -0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 12  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 10  1  0  0  0  0
 10 16  1  0  0  0  0
 11 17  2  0  0  0  0
 12 13  1  0  0  0  0
 14 18  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  2  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
6_methylchrysene

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
16 18

> <TERTIARY_SOM>
11

>  <Citation>
Koehl et al.,Cancer Res.,56,316,1996

$$$$
7-benzyloxy-4-trifluoromethylcoumarin
  MOE2008           3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4660   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5440    1.5820   -0.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7980    0.7630   -1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9750    1.6820   -1.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4180    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4700   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 11  2  0  0  0  0
  1 20  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  1  0  0  0  0
 13 15  1  0  0  0  0
 13 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
7-benzyloxy-4-trifluoromethylcoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Donato et al.,Drug Metab. Disp.32,699,2004

>  <DOI>
10.1124/dmd.32.7.699

$$$$
7-benzyloxyquinoline
  MOE2008           3D

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.1470    0.4260   -0.4390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0110   -0.6010    0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4140    0.9480   -0.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9600    0.9200   -1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2620   -1.1050    0.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0690   -1.0870    1.1860 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5120    0.4550    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240    0.3960   -0.8800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3790   -0.6200    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5750   -1.2020    0.3740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6440   -0.6360   -0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9200   -1.3020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2850   -0.5550    0.9210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6890   -0.7850    1.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8810   -1.4080    1.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3050   -2.5490    0.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5380   -3.0670   -0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3470   -2.4450   -0.6670 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  6 13  2  0  0  0  0
  7 13  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 14  1  0  0  0  0
 12 18  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
7-benzyloxyquinoline

> <PRIMARY_SOM>
11

>  <Citation>
Stresser et al.,Drug Metab. Disp.,30,845,2002

>  <DOI>
10.1124/dmd.30.7.845

$$$$
7-benzyloxyresorufin
  MOE2008           3D

 23 26  0  0  0  0  0  0  0  0999 V2000
    5.1790    1.2130    0.5290 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8540    1.3000    0.0400 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4990    1.0090    0.9630 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -1.3890   -0.6930 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3040    0.5560    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2400   -0.7100   -0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9680    0.5580    0.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9540   -0.7820   -0.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5240    1.2060    0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7010    0.5940   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4250   -1.3130   -0.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6480   -0.6670   -0.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8360    1.1300    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6450   -1.4340   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5350    0.4730    0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5210   -0.8530   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9940    0.5850   -0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2160    1.4010   -0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9130    1.2670    1.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0550    2.0300    1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5020    2.9270    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8080    3.0620   -0.9150 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6660    2.3000   -1.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1  7  1  0  0  0  0
  2 10  1  0  0  0  0
  2 17  1  0  0  0  0
  3 15  2  0  0  0  0
  4  6  1  0  0  0  0
  4  8  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  2  0  0  0  0
 10 12  1  0  0  0  0
 11 12  2  0  0  0  0
 13 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 23  2  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 21 22  2  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
7-benzyloxyresorufin

> <PRIMARY_SOM>
17

>  <Citation>
Niwa et al.,Xenobiotica,33,717,2003

>  <DOI>
10.1080/0049825031000121617

$$$$
7-ethoxycoumarin
  MOE2008           3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    1.3350    0.6350    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1530    1.3550   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0500    0.6620   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1730    1.4310   -0.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3420    0.6270   -0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5300    1.5460   -0.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0530   -0.7360   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400   -1.4460   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410   -0.7550    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5980   -1.4580    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7280   -0.7630    0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7550    0.7030    0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8120    1.3130    0.4350 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360    1.3580    0.1850 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
7-ethoxycoumarin

> <PRIMARY_SOM>
5

> <SECONDARY_SOM>
11

>  <Citation>
K. H. Kim, E. M. Isin, C. H. Yun, D. H. Kim, F. P. Guengerich, FEBS J. 2006, 273, 2223-2231.
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

>  <DOI>
10.111/j.1742-4658.2006.05235.x

$$$$
7-ethoxyresorufin
  MOE2008           2D

 18 20  0  0  0  0  0  0  0  0999 V2000
    5.5300    1.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0600    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5300   -1.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9280    0.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7920    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1  7  1  0  0  0  0
  2 10  1  0  0  0  0
  2 17  1  0  0  0  0
  3 15  2  0  0  0  0
  4  6  1  0  0  0  0
  4  8  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  2  0  0  0  0
 10 12  1  0  0  0  0
 11 12  2  0  0  0  0
 13 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
7-ethoxyresorufin

> <PRIMARY_SOM>
17

>  <Citation>
Qwihee P. Lee, Alan G. Fantel and Mont R. Juchau Biochemical Pharmacology Volume 42, Issue 12, 27 November 1991, Pages 2377-2385 

>  <DOI>
10.1016/0006-2952(91)90244-Y

$$$$
7-hydroxy-delta_8_tetrahydrocannabinol
  MOE2008           3D

 24 26  0  0  1  0  0  0  0  0999 V2000
   -1.7450   -1.9170    0.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9230   -1.1120    0.2230 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.5030   -0.0560   -0.7820 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2010    0.5890   -0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7160    1.7130   -1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4960    2.3110   -0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2710    1.7820    0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8170    0.6470    0.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3950    0.0450    0.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7110   -1.0780    1.2740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6470    0.9280   -1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9690    0.2560   -1.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1550   -1.0400   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0910   -1.9160   -0.3430 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.4150    2.2640   -2.1570 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660    2.3890    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2920    3.1740   -0.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8920    2.2560   -1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5990    3.0740   -2.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1970    2.1570   -3.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0760    1.0920   -1.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470   -2.8090   -0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1520   -2.8040    1.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6560   -2.7510    0.6490 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  1  0  0  0  0
  1 22  1  0  0  0  0
  1 23  1  0  0  0  0
  2  3  1  0  0  0  0
  2 14  1  0  0  0  0
  3  4  1  0  0  0  0
  3 11  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  2  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7 16  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 21  1  0  0  0  0
 13 14  1  0  0  0  0
 14 24  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
7-hydroxy-delta_8_tetrahydrocannabinol

> <PRIMARY_SOM>
14

>  <Citation>
Matsunaga, T.; Kishi, N.; Higuchi, S.; Watanabe, K.; Ohshima, T.; Yamamoto, I. CYP3A4 is a Major Isoform Responsible for Oxidation of 7-Hydroxy-Delta(8)-Tetrahydrocannabinol to 7-Oxo-Delta(8)-Tetrahydrocannabinol in Human Liver Microsomes. Drug Metab. Dispos. 2000, 28, 1291–1296.

$$$$
7-methoxycoumarin
  MOE2008           2D

 13 14  0  0  0  0  0  0  0  0999 V2000
    6.3580   -1.0350    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1280   -1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4640    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4640   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980   -1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3580    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2640    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2640   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1 12  1  0  0  0  0
  2  8  1  0  0  0  0
  2 13  1  0  0  0  0
  3 12  2  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  4 10  1  0  0  0  0
  5  6  1  0  0  0  0
  6  8  2  0  0  0  0
  7  9  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
7-methoxycoumarin

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
11

>  <Citation>
K. H. Kim, E. M. Isin, C. H. Yun, D. H. Kim, F. P. Guengerich, FEBS J. 2006, 273, 2223-2231.

>  <DOI>
10.111/j.1742-4658.2006.05235.x

$$$$
7-methoxyresorufin
  MOE2008           2D

 17 19  0  0  0  0  0  0  0  0999 V2000
    5.5300    1.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0600    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5300   -1.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9280    0.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1  7  1  0  0  0  0
  2 10  1  0  0  0  0
  2 17  1  0  0  0  0
  3 15  2  0  0  0  0
  4  6  1  0  0  0  0
  4  8  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  2  0  0  0  0
 10 12  1  0  0  0  0
 11 12  2  0  0  0  0
 13 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
7-methoxyresorufin

> <PRIMARY_SOM>
17

>  <Citation>
Qwihee P. Lee, Alan G. Fantel and Mont R. Juchau Biochemical Pharmacology Volume 42, Issue 12, 27 November 1991, Pages 2377-2385 

>  <DOI>
10.1016/0006-2952(91)90244-Y

$$$$
7-pentoxyresorufin
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    5.2650    1.2870   -0.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9660    1.2130   -0.3450 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5630    1.2360   -0.2660 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1490   -1.5190    0.3120 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4070    0.5370   -0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3620   -0.8290    0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0580    0.6230   -0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0640   -0.8250    0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6240    1.1950   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8180    0.4910   -0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5620   -1.5240    0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7830   -0.8690    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9110    1.2820   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7570   -1.4820    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6110    0.6200   -0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6170   -0.8130    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1220    0.4000   -0.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3390    1.2660   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5860    0.4360   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8040    1.3010   -0.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0500    0.4700   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1  7  1  0  0  0  0
  2 10  1  0  0  0  0
  2 17  1  0  0  0  0
  3 15  2  0  0  0  0
  4  6  1  0  0  0  0
  4  8  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  2  0  0  0  0
 10 12  1  0  0  0  0
 11 12  2  0  0  0  0
 13 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
7-pentoxyresorufin

> <PRIMARY_SOM>
17

>  <Citation>
Qwihee P. Lee, Alan G. Fantel and Mont R. Juchau Biochemical Pharmacology Volume 42, Issue 12, 27 November 1991, Pages 2377-2385 

>  <DOI>
10.1016/0006-2952(91)90244-Y

$$$$
7MBAC
  MOE2008           2D

 19 22  0  0  0  0  0  0  0  0999 V2000
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3 18  2  0  0  0  0
  4  5  1  0  0  0  0
  4 15  2  0  0  0  0
  5  6  1  0  0  0  0
  5 14  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 13 19  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
7MBAC

> <PRIMARY_SOM>
10 11

> <SECONDARY_SOM>
1 2 17 18 19

>  <Citation>
Roberts-Thompson, S.J.; McManus, M.E.; Tukey, R.H.; Gonzales, F.J.; Holder, G.M.
Metabolism of Polycyclic Aza-aromatic Carcinogens Catalyzed by Four Expressed Human
Cytochromes P450. Cancer Res. 1995, 55, 1052–1059. 

$$$$
9_cis_retinal
  MOE2008           3D

 21 21  0  0  0  0  0  0  0  0999 V2000
   12.4990    1.0310    1.0610 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8230   -1.7510    0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3690   -3.1400   -0.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5050   -4.1340   -0.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1130   -1.3120   -0.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6130   -3.6580   -1.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9010   -2.1920   -1.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6680   -0.8150   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0300   -1.7590    1.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3810    0.1120   -0.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350   -1.8110   -1.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5710    0.6880   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8160    2.1040   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6550    3.0250   -0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0310    2.6280    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2560    1.9020    0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4190    2.5280    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6980    1.8960    0.6630 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7500    0.4060    0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7670    2.6730    0.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1380    2.1950    1.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 21  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  1  0  0  0  0
  2  8  1  0  0  0  0
  2  9  1  0  0  0  0
  3  4  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  2  0  0  0  0
  5 10  1  0  0  0  0
  6  7  1  0  0  0  0
  7 11  1  0  0  0  0
 10 12  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
9_cis_retinal

> <PRIMARY_SOM>
21

>  <Citation>
Zhang et al.,Drug Metab. Dispos.,28,292,2000

$$$$
AMMC
  MOE2008           3D

 22 23  0  0  0  0  0  0  0  0999 V2000
    1.2550    0.6470   -0.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710    1.3510   -0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1430    0.7520   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2610    1.5030   -0.4840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4440    0.7980   -0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550   -0.5400    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -1.2310    0.4720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2630   -0.6410    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5380   -1.3210    0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5100   -2.7090    0.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6750   -0.6910    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0160   -1.3320    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8780   -0.5930    1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2660   -1.1700    1.2510 N   0  3  0  0  0  0  0  0  0  0  0  0
    7.9520   -1.2620   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9940    0.1000   -0.7490 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2950   -2.4960    1.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7040   -3.5890    1.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0600   -0.2420    2.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790    0.6770   -0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7370    1.2400   -0.7950 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    1.2960   -0.7200 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 22  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 20  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 17  1  0  0  0  0
 14 19  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 20 21  2  0  0  0  0
 20 22  1  0  0  0  0
M  CHG  1  14   1
M  END
>  <ID>
AMMC

> <PRIMARY_SOM>
5

>  <Citation>
Chauret et al.,Drug Metab. Disp.,29,1196,2001

$$$$
BFC
  MOE2008           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.1100    1.2610   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0110   -0.1270   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0270    2.0910   -0.0250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3510    1.8940    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3440   -0.7250   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1580   -0.8880    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3040    1.5500   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5080    1.1200    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    0.0910   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090   -0.2710    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3110    2.2480   -0.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5040   -2.2080   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8080   -2.5900   -0.0520 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9560   -2.7790    1.0730 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9170   -2.7810   -1.1100 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6900    1.8070    0.0580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8030    0.9170    0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0630    1.7130    0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6730    2.0820   -1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8500    2.8260   -1.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4190    3.2030    0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8120    2.8360    1.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6350    2.0910    1.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 12  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  2  0  0  0  0
  8 10  1  0  0  0  0
  8 16  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 12 15  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 23  2  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 21 22  2  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
BFC

> <PRIMARY_SOM>
17

>  <Citation>
Renwick et al.,Xenobiotica,30,955,2000

$$$$
BMAMC
  MOE2008           3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -0.0780    1.4220   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0270    0.0360   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    2.1910   -0.3790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2850    2.1100   -0.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2740   -0.6170   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310   -0.6660   -0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    1.5840   -0.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4800    1.3960   -0.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    0.1290   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4500    0.0070   -0.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3870    2.2260   -0.4650 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3970   -2.0990    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3590   -2.6270    1.3790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0190   -2.8000    1.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1030   -3.3390    3.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6140   -4.6600    3.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4900   -5.1360    4.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250    2.1360   -0.4890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7820    1.3100   -0.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 12  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  2  0  0  0  0
  8 10  1  0  0  0  0
  8 18  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
BMAMC

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
14

>  <Citation>
J. Venhorst, R. C. A. Onderwater, J. H. N. Meerman, J. N. M. Commandeur, N. P. E. Vermeulen, Drug Metab. Dispos. 2000, 28, 1524-1532.

$$$$
Bropirimine
  MOE2008           2D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290    0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    1.8560    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    1.0310    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 15  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  2  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  2  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
Bropirimine

> <PRIMARY_SOM>
10 11 12

>  <Citation>
Wynalda, M.A.; Hauer, M.J.; Wienkers, L.C. Human Biotransformation of Bropirimine: Characterization of the Major Bropirimine Oxidative Metabolites Formed In Vitro. Drug Metab. Dispos. 1998, 26, 1048–1051.

$$$$
CARBAMAZEPINE
  MOE2008           3D

 18 20  0  0  0  0  0  0  0  0999 V2000
   -0.0160    1.3460    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1410    2.0430    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.0020    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5380   -0.6750    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5860   -0.7260   -1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9940    1.9420    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4440    2.9240   -1.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2160    3.3490    0.0260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2340    1.3780    0.0200 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5960   -2.1490    0.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0400    0.0180    2.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5470   -2.0400   -1.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2760    2.6700    0.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6690    1.1490    2.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5810    3.5840   -1.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0860   -2.7920   -0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5530    3.4430   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  2  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  7 15  1  0  0  0  0
  8 16  2  0  0  0  0
 11 17  2  0  0  0  0
 12 15  2  0  0  0  0
 13 17  1  0  0  0  0
 14 18  2  0  0  0  0
 16 18  1  0  0  0  0
M  END
>  <ID>
CARBAMAZEPINE

> <PRIMARY_SOM>
13 16

> <SECONDARY_SOM>
17 18

>  <Citation>
Robin E. Pearce, Gangadhara R. Vakkalagadda and J. Steven Leeder, Drug Metab. Dispos., 30:1170–1179, 2002

$$$$
CMV423
  MOE2008           3D

 19 21  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3910    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450   -0.6580   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3060   -0.0320   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3720    1.3500   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000    2.0840    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3000    2.1260    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3910    1.8440   -0.7640 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3800    2.7220   -0.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9310    3.5780    0.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6010    3.1890    0.8110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5550    3.9320    1.9810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.7360    2.7270   -1.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5000    0.7730   -1.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6500    1.8760   -2.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9810    0.5390   -2.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6860    4.6870    1.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3620    4.4910    2.1010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6270    5.9190    0.5660 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  7 11  2  0  0  0  0
  8  9  1  0  0  0  0
  8 14  1  0  0  0  0
  9 10  2  0  0  0  0
  9 13  1  0  0  0  0
 10 11  1  0  0  0  0
 10 17  1  0  0  0  0
 11 12  1  0  0  0  0
 13 15  1  0  0  0  0
 14 16  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  2  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
CMV423

> <PRIMARY_SOM>
13

>  <Citation>
Bournique et al.,Br. J. Clin. Pharm.,52,53,2001

>  <DOI>
10.1046/j.0306-5251.2001.01413.x

$$$$
CP_125_611
  MOE2008           3D

 26 28  0  0  1  0  0  0  0  0999 V2000
    0.8370    0.6700   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4420    1.2230   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2500    1.1140   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6340    1.6900   -0.0550 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.7660    0.4380    1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5120   -0.1160    1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3130    0.0020   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7090    3.2000   -0.3090 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.0000    4.0160    0.6700 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6120    4.1550    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1560    5.0480    1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1430    3.6880   -0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0570    2.8440   -1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8980    1.3690   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5250    0.9120   -0.9120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9930    4.5450    2.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    3.1990    2.3250 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    5.3950    3.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5700    6.7730    2.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7380    7.2990    1.8660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750    8.6620    1.8000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1970    9.1930    0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720    8.8030    1.0190 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.1960    8.8320   -0.4300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1570   10.5420    0.8830 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0390    6.4310    1.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  8  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 16  1  0  0  0  0
 11 26  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  2  0  0  0  0
 18 19  1  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 20 26  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 22 24  1  0  0  0  0
 22 25  1  0  0  0  0
M  END
>  <ID>
CP_125_611

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
17

>  <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

>  <DOI>
10.2133/dmpk.22.336

$$$$
CP_677_623
  MOE2008           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -1.8080    3.8640    0.5460 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4930    4.1910    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2830    5.0800    0.9350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2670    4.5630    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4880    3.2130    1.7300 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4910    2.8110    2.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9700    5.4250    2.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    6.7920    2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250    7.3130    1.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5390    8.6650    1.8480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4560    9.2040    0.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6730    8.6930    1.2710 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1560    8.9780   -0.3070 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5090   10.5410    1.1800 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    6.4530    0.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3 15  2  0  0  0  0
  4  5  1  0  0  0  0
  4  7  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
  9 15  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
M  END
>  <ID>
CP_677_623

> <PRIMARY_SOM>
6

>  <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

>  <DOI>
10.2133/dmpk.22.336

$$$$
DBAJAC
  MOE2008           2D

 22 26  0  0  0  0  0  0  0  0999 V2000
    1.4290    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 18  2  0  0  0  0
  2  3  1  0  0  0  0
  2 15  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 22  2  0  0  0  0
 11 12  1  0  0  0  0
 11 19  2  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
DBAJAC

> <PRIMARY_SOM>
3 4 8 9 15 16 21 22

> <SECONDARY_SOM>
6 13 17 18 19 20

>  <Citation>
Roberts-Thompson, S.J.; McManus, M.E.; Tukey, R.H.; Gonzales, F.J.; Holder, G.M.
Metabolism of Polycyclic Aza-aromatic Carcinogens Catalyzed by Four Expressed Human
Cytochromes P450. Cancer Res. 1995, 55, 1052–1059. 

$$$$
DDTC_Me
  MOE2008           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410    2.2100    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.8580   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1190    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    1.4960    0.0210 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.8800    0.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    4.1710    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  1  0  0  0  0
  2  5  1  0  0  0  0
  3  4  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
DDTC_Me

> <PRIMARY_SOM>
6 7

> <SECONDARY_SOM>
8

>  <Citation>
Madan et al.,Alcohol. Clin. Exp. Res.,22,1212,1998

>  <DOI>
10.111/j.1530-0277.1998.tb03901.x

$$$$
DMBA
  MOE2008           2D

 20 23  0  0  0  0  0  0  0  0999 V2000
    1.0720    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 18  2  0  0  0  0
  2  3  1  0  0  0  0
  2 15  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  2  0  0  0  0
  6  7  2  0  0  0  0
  6 20  1  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 13 19  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
DMBA

> <PRIMARY_SOM>
8 9

> <SECONDARY_SOM>
3 4 19 20

> <TERTIARY_SOM>
15 16 17

>  <Citation>
Shou, M.; Korzekwa, K.R.; Krausz, K.W.; Buters, J.T.; Grogan, J.; Goldfarb, I.; Ardwick, J.P.H.; Gonzalez, F.J.; Gelboin, H.V. Specificity of cDNA-Expressed Human and Rodent Cytochrome P450s in the Oxidative Metabolism of the Potent Carcinogen 7,12-Dimethylbenz[a]anthracene. Mol. Carcinog. 1996, 17, 241–249. 

>  <DOI>
10.1002/(SICI)1098-2744(199612)17:4<241::AID-MC8>3.0.CO;2-G

$$$$
DMXAA
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -0.3550   -0.2020    0.2630 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5960    3.7040   -0.4820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9050   -3.2550   -0.2190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1860   -1.5800   -1.7380 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9530    0.1760    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3380    1.4910   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3350    0.7580    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0730    2.1030   -0.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300   -0.8260    0.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6580    0.3400    0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3120    2.5330   -0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2770   -0.4930   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6760    1.8250   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6440    0.8290   -0.3080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1070    3.0360   -0.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9970   -1.0910    0.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6940    1.2750    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5360   -2.2420    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4200    2.6180    0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3540   -1.5250    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0310   -1.9540   -0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1  7  1  0  0  0  0
  2 11  2  0  0  0  0
  3 21  1  0  0  0  0
  4 21  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 11  1  0  0  0  0
  6 13  1  0  0  0  0
  7  8  2  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  8 15  1  0  0  0  0
  9 12  2  0  0  0  0
  9 18  1  0  0  0  0
 10 16  1  0  0  0  0
 10 17  2  0  0  0  0
 12 14  1  0  0  0  0
 12 20  1  0  0  0  0
 13 14  2  0  0  0  0
 15 19  2  0  0  0  0
 16 21  1  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
DMXAA

> <PRIMARY_SOM>
20

>  <Citation>
S. F. Zhou, J. W. Paxton, M. D. Tingle, P. Kestell, Drug Metab. Dispos. 2000, 28, 1449-1456.

$$$$
EMAMC
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0790    1.4210   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0290    0.0350   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    2.1890   -0.3750 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2840    2.1100   -0.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2700   -0.6180   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2350   -0.6650   -0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    1.5810   -0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4800    1.3980   -0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3700    0.1260   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4520    0.0090   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3890    2.2210   -0.4500 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3910   -2.1000    0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3450   -2.6240    1.4000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0330   -2.7980    1.8150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0420   -3.3310    3.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6230    2.1390   -0.5110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7820    1.3130   -0.4730 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 12  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  2  0  0  0  0
  8 10  1  0  0  0  0
  8 16  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
EMAMC

> <PRIMARY_SOM>
17

> <SECONDARY_SOM>
14

>  <Citation>
J. Venhorst, R. C. A. Onderwater, J. H. N. Meerman, J. N. M. Commandeur, N. P. E. Vermeulen, Drug Metab. Dispos. 2000, 28, 1524-1532.

$$$$
FLU-1
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.1410    1.5410   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6190    1.7140   -0.4590 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.1160    0.0520   -0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.3140   -0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3570    4.2450    0.2480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    2.2130   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    3.7010   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3580    2.1900   -1.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9030    0.7820    0.3010 O   0  5  0  0  0  0  0  0  0  0  0  0
   -1.1220    3.6010    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090   -0.4180   -0.8400 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9720   -0.3770   -1.4370 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.4400   -0.6190    0.6650 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0590    4.3410    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  1  6  1  0  0  0  0
  2  4  1  0  0  0  0
  2  8  2  0  0  0  0
  2  9  1  0  0  0  0
  3 11  1  0  0  0  0
  3 12  1  0  0  0  0
  3 13  1  0  0  0  0
  4  7  1  0  0  0  0
  5 10  1  0  0  0  0
  6 10  2  0  0  0  0
  7 14  2  0  0  0  0
 10 14  1  0  0  0  0
M  CHG  1   2   1
M  CHG  1   9  -1
M  END
>  <ID>
FLU-1

> <PRIMARY_SOM>
5

>  <Citation>
Goda et al.,Drug Metab. Disp.,34,828,2006

>  <DOI>
10.1124/dmd.105.008623

$$$$
GTS-21
  MOE2008           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -1.3480    0.4550    2.0780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2390   -0.9250   -0.3110 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3280    1.8680    0.0210 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5370   -2.8250    0.2630 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5010    2.1630    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2930    3.2700   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0930    0.8430    0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7250    3.1610    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5810    0.8150   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3490   -0.2160   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2690   -0.4780   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1010   -0.3620   -0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9310   -0.0350    0.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6760   -0.9230   -1.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3790   -0.5250   -1.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9000   -1.6410    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3130   -0.2400    0.8350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0520   -1.1250   -1.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8790   -0.7750   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0610   -1.7220   -1.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6010   -2.8340   -0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3120    0.7330    3.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7060   -1.4870   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0  0  0  0
  1 22  1  0  0  0  0
  2 19  1  0  0  0  0
  2 23  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 16  2  0  0  0  0
  4 21  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  2  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 15  2  0  0  0  0
 11 16  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
 13 17  1  0  0  0  0
 14 18  2  0  0  0  0
 15 20  1  0  0  0  0
 17 19  2  0  0  0  0
 18 19  1  0  0  0  0
 20 21  2  0  0  0  0
M  END
>  <ID>
GTS-21

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
22

>  <Citation>
R. Azuma, M. Komuro, B. H. Korsch, J. C. Andre, O. Onnagawa, S. R. Black, J. M. Mathews, Xenobiotica 1999, 29, 747-762.

>  <DOI>
10.1080/004982599238362 

$$$$
Genistein
  MOE2008           2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.3570    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2150    1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2150   -1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  1  0  0  0  0
  2 12  1  0  0  0  0
  3  4  2  0  0  0  0
  3  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 10  2  0  0  0  0
  6  7  2  0  0  0  0
  6 19  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  8 18  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 20  1  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
Genistein

> <PRIMARY_SOM>
14 16

> <SECONDARY_SOM>
7 9

>  <Citation>
Roberts-Kirchhoff, E.S.; Crowley, J.R.; Hollenberg, P.F.; Kim, H. Metabolism of Genistein by Rat and Human Cytochrome P450s. Chem. Res. Toxicol. 1999, 12, 610–616.

>  <DOI>
10.1021/tx9802320

$$$$
IQ
  MOE2008           2D

 15 17  0  0  0  0  0  0  0  0999 V2000
   -1.4240   -1.6290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1390   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1390   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4240    0.0210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7100   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    0.0210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040   -1.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7100   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9960    0.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1760    0.8280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3320    0.1610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1390   -0.0110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4090    1.6290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 10  1  0  0  0  0
  6  7  2  0  0  0  0
  6 12  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
 11 15  1  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
IQ

> <PRIMARY_SOM>
15

>  <Citation>
Hammons et al. Carcinogenesis vol.18 no.4 pp.851–854, 1997

>  <DOI>
10.1093/carcin/18.4.851

$$$$
KR_31543
  MOE2008           3D

 33 36  0  0  1  0  0  0  0  0999 V2000
    1.0150    1.1300   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2220    1.7620    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3090    1.0890    0.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5460    1.7390    0.8530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1570   -0.2340    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0750   -0.8700    0.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1590   -0.1840    0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390   -0.8740    0.3750 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5270   -0.0540    0.2840 C   0  0  3  0  0  0  0  0  0  0  0  0
    4.6600   -1.0050   -0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8100    0.6000    1.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9170   -0.4100    2.6570 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3930    0.1030    3.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9870    1.3930    1.6100 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8750    2.4350    2.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3710    0.9490   -0.8510 C   0  0  3  0  0  0  0  0  0  0  0  0
    4.5380    1.7130   -1.0970 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1730    1.8490   -0.6210 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.8230    2.6560   -1.7830 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.4620    2.1370   -3.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8320    4.1040   -1.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    4.7500   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3980    0.7570   -3.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0320    0.2260   -4.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190    1.0870   -5.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2660    0.4480   -7.0470 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7700    2.4620   -5.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1380    2.9710   -4.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    4.5820    0.6260 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8540    5.2830    1.0850 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4040    5.8260   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5740    6.6630    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8060    5.5510   -1.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  1 18  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
  9 16  1  0  0  0  0
 11 12  1  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 23  1  0  0  0  0
 20 28  2  0  0  0  0
 21 22  1  0  0  0  0
 22 29  1  0  0  0  0
 22 33  2  0  0  0  0
 23 24  2  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 25 27  2  0  0  0  0
 27 28  1  0  0  0  0
 29 30  2  0  0  0  0
 30 31  1  0  0  0  0
 31 32  1  0  0  0  0
 31 33  1  0  0  0  0
M  END
>  <ID>
KR_31543

> <PRIMARY_SOM>
18

>  <Citation>
Ji et al,Arch. Pharm. Res.,27,239,2004

$$$$
MAMC
  MOE2008           3D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450    2.0910    0.0020 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340    2.0670    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2930   -0.6960   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000   -0.7210    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3310    1.4630   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4140    1.3420    0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    0.0560   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3890   -0.0520    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3530    2.1250   -0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3640   -2.2010   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2800   -2.7030    1.3550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6050    1.9940    0.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6240    0.9920    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 12  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  2  0  0  0  0
  8 10  1  0  0  0  0
  8 14  1  0  0  0  0
 12 13  1  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
MAMC

> <PRIMARY_SOM>
15

>  <Citation>
J. Venhorst, R. C. A. Onderwater, J. H. N. Meerman, J. N. M. Commandeur, N. P. E. Vermeulen, Drug Metab. Dispos. 2000, 28, 1524-1532.

$$$$
MBDB
  MOE2008           3D

 15 16  0  0  1  0  0  0  0  0999 V2000
    3.6900    1.4860   -0.3990 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3880   -0.5360    0.7140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2280   -0.7890    0.6660 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9130    0.1540   -0.3960 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.8110   -0.3000   -1.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6550    1.5460    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5640   -0.3930   -0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4440    0.6850   -0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8210    2.0830    0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9790   -1.5740   -0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7100    0.5470   -0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070   -0.6060    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2650   -1.6900    0.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6470   -2.0520    0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7440    0.7980    0.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0  0  0  0
  1 15  1  0  0  0  0
  2 12  1  0  0  0  0
  2 15  1  0  0  0  0
  3  4  1  0  0  0  0
  3 14  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  9  1  0  0  0  0
  7  8  2  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
 10 13  2  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
MBDB

> <PRIMARY_SOM>
14 15

>  <Citation>
Maurer et al.,Toxicol. Lett.,112'96113,133,2000

$$$$
MDMA
  MOE2008           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
   -0.1980    0.9860    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1170   -0.2320   -0.4890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9720    1.5920    0.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5450    1.6170    0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1290   -0.8050   -0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2220    0.9960    0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6740    2.6530    1.4460 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.2650   -0.2080   -0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8970    3.5000    1.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8140    1.9920    2.7370 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7820    2.9920    3.7910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3910   -1.9790   -1.2730 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8220   -2.0540   -1.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850   -0.9320   -0.4110 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5 12  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 14  1  0  0  0  0
 10 11  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
MDMA

> <PRIMARY_SOM>
11 13

>  <Citation>
Maurer et al.,Toxicol. Lett.,112'96113,133,2000

$$$$
MEXILETINE
  MOE2008           3D

 13 13  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760    2.0910    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0480    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920   -0.7760    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4130   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    3.5980    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5560    2.2420    1.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0300   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8890    2.9890    1.4710 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.7930    4.2920    0.6750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9560    2.1500    0.9100 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  2  0  0  0  0
  7 10  1  0  0  0  0
  9 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
MEXILETINE

> <PRIMARY_SOM>
6 8

> <SECONDARY_SOM>
10

> <TERTIARY_SOM>
13

>  <Citation>
M. Nakajima, K. Kobayashi, N. Shimada, S. Tokudome, T. Yamamoto, Y. Kuroiwa, Br. J. Clin. Pharmacol. 1998, 46, 55-62.
L. LABBE, Z. ABOLFATHI, E . LESSARD, H. PAKDEL, P. BEAUNE and J. TURGEON, xenobiotica, 2003, vol. 33, no. 1, 13–25 

>  <DOI>
10.1046/j.1365-2125.1998.00048.x
10.1080/0049825021000017948

$$$$
MMAMC
  MOE2008           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -0.0490    1.3470   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0050   -0.0450    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1270    2.1180   -0.0910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570    2.0400   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3070   -0.7020    0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000   -0.7460    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740    1.5100   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4510    1.3260    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    0.0490   -0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4190   -0.0680    0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4090    2.1560   -0.2810 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4300   -2.1880    0.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4590   -2.7940    1.3760 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060   -2.9960    1.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5970    2.0710    0.0150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7540    1.2440    0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 12  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  2  0  0  0  0
  8 10  1  0  0  0  0
  8 15  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
MMAMC

> <PRIMARY_SOM>
16

> <SECONDARY_SOM>
14

>  <Citation>
J. Venhorst, R. C. A. Onderwater, J. H. N. Meerman, J. N. M. Commandeur, N. P. E. Vermeulen, Drug Metab. Dispos. 2000, 28, 1524-1532.

$$$$
MPBP
  MOE2008           3D

 17 18  0  0  1  0  0  0  0  0999 V2000
    0.6300    0.6530    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8220    0.9230    0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9070    0.4360    0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6150    1.7930    2.0820 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.4170    0.9410    3.2480 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7150    2.8380    2.1450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970    3.8750    3.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5990    1.2280    0.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7130    0.9660   -0.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5980    0.1340   -1.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7900   -0.1450   -2.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3680   -0.4390   -1.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7480   -0.1800   -1.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7410    1.6620    4.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0910    0.7500    5.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890    0.7250    5.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6890    0.4390    3.7950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  1  0  0  0  0
  1 13  2  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5 14  1  0  0  0  0
  5 17  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  2  0  0  0  0
 12 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
MPBP

> <PRIMARY_SOM>
11

>  <Citation>
Peters et al.,Drug Metab. Disp.,36,163,2008

>  <DOI>
10.1124/dmd.107.017293 

$$$$
MeIQx
  MOE2008           2D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -1.0670   -1.6290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7820   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7820   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670    0.0210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3530   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3620    0.0210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0760   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0760   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3620   -1.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3530   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3540    0.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5330    0.8280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6890    0.1610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4960    0.0210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4960   -0.0110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7660    1.6290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 14  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 10  1  0  0  0  0
  6  7  2  0  0  0  0
  6 12  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
 11 16  1  0  0  0  0
 13 15  1  0  0  0  0
M  END
>  <ID>
MeIQx

> <PRIMARY_SOM>
16

>  <Citation>
Hammons et al. Carcinogenesis vol.18 no.4 pp.851–854, 1997

>  <DOI>
10.1093/carcin/18.4.851

$$$$
N7-methylcyclohexylline
  MOE2008           2D

 21 23  0  0  0  0  0  0  0  0999 V2000
    1.1660    1.4920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6510    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1660    0.1580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3820    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470    1.2380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3820    1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    2.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470   -1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4760   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4760   -1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4760    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4210    2.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  1  0  0  0  0
  1 21  1  0  0  0  0
  2  3  2  0  0  0  0
  2 19  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6  7  1  0  0  0  0
  6 10  2  0  0  0  0
  7  8  1  0  0  0  0
  7 20  1  0  0  0  0
  8  9  1  0  0  0  0
  8 11  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 18  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
N7-methylcyclohexylline

> <PRIMARY_SOM>
13 14 15 16 17 18

> <SECONDARY_SOM>
19 21

>  <Citation>
Jagdish K. Racha, Allan E. Rettie, and Kent L. Kunze, Biochemistry 1998, 37, 7407-7419

>  <DOI>
10.1021/bi973011m

$$$$
N7-methylfurafylline
  MOE2008           2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.1050    1.3700    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1050    0.0350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3200    0.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940   -0.1230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090    0.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090    1.1150    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940    1.5270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3200    1.1150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8230   -0.1230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940    2.3520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4150    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8230    1.5270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940   -0.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8630   -1.0250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090   -1.3600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1950   -2.1810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0020   -2.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4150   -1.6380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3600    2.1540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  1  0  0  0  0
  1 20  1  0  0  0  0
  2  3  2  0  0  0  0
  2 12  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  1  0  0  0  0
  5 14  1  0  0  0  0
  6  7  1  0  0  0  0
  6 10  2  0  0  0  0
  7  8  1  0  0  0  0
  7 13  1  0  0  0  0
  8  9  1  0  0  0  0
  8 11  2  0  0  0  0
 14 16  1  0  0  0  0
 15 16  1  0  0  0  0
 15 19  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
M  END
>  <ID>
N7-methylfurafylline

> <PRIMARY_SOM>
17 18 19

> <SECONDARY_SOM>
12

>  <Citation>
Jagdish K. Racha, Allan E. Rettie, and Kent L. Kunze, Biochemistry 1998, 37, 7407-7419

>  <DOI>
10.1021/bi973011m

$$$$
NDEA
  MOE2008           3D

  7  6  0  0  0  0  0  0  0  0999 V2000
   -1.4200    2.1290    0.5220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3850    1.7790    1.2100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3770    3.4350    0.4020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0280    3.8820    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4090    3.6260   -1.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2950    3.9590   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7110    4.0650   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
NDEA

> <PRIMARY_SOM>
4 6

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NDMA
  MOE2008           3D

  5  4  0  0  0  0  0  0  0  0999 V2000
   -1.3690    2.2250    0.6680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.6420    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    3.4600    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    4.0510   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    4.2100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
M  END
>  <ID>
NDMA

> <PRIMARY_SOM>
4 5

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NMBA
  MOE2008           3D

  8  7  0  0  1  0  0  0  0  0999 V2000
   -1.4650    2.1740    0.6830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6120    1.8440    1.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3880    3.4570    0.4440 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0270    3.8870    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2740    3.9110   -0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4850    3.5250   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9000    4.0240   -1.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4100    3.6640   -2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
NMBA

> <PRIMARY_SOM>
4

> <SECONDARY_SOM>
5

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NNK
  MOE2008           3D

 15 15  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450   -0.6570   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3060   -0.0310   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740    1.3520   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2030    2.0870    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.1250    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2980    3.3380    0.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5960    1.3670    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7630    2.3580    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0850    1.5880    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2020    2.5370    0.0450 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6820    3.0880    1.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7620    2.8860   -1.0630 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6900    3.6740   -1.0540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  2  0  0  0  0
M  END
>  <ID>
NNK

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
13

>  <Citation>
Smith, T.J.; Guo, Z.Y.; Guengerich, F.P.; Yung, C.S. Metabolism of 4-Methylnitrosamino-1(3-pyridyl)1-butanone (NNK) by Human Cytochrome P4501A2 and Its Inhibition by Phenethyl Isothiocyanate. Carcinogenesis 1996, 17, 809–813.

$$$$
NN_dimethyl_M_toluamide
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.1290    1.5810    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030    1.2190    2.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1550    0.6120    2.9330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1900    0.3630    2.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    0.7200    0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180    1.3260    0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3690    2.2250    0.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.6420    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    3.4600    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    4.0510   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    4.2100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    4.8880    1.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2880    4.8280    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2940    0.2200    4.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 14  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
NN_dimethyl_M_toluamide

> <PRIMARY_SOM>
14

>  <Citation>
Usmani et al.,Drug Metab. Disp.,30,289,2002

>  <DOI>
10.1124/dmd.30.3.289

$$$$
N_desacetyl_indiplon
  MOE2008           3D

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.2250    0.2970    0.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -0.2360    1.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1530   -1.5360    0.8860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2510   -2.1190    0.1360 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.0340   -0.5980    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4060   -0.3790   -0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8090   -0.8920   -1.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2140    0.2190    0.5970 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0840   -1.3630   -1.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1740   -1.7480   -3.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9430   -1.5070   -3.5490 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0870   -0.9570   -2.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4910   -1.7250   -4.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3370   -2.3350   -5.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360   -1.3810   -5.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4330   -0.7800   -4.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8120   -0.5750   -2.8870 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1240   -3.4550   -5.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9340   -4.0550   -6.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6900   -5.1790   -6.2240 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5030   -5.7300   -7.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9430   -3.5030   -7.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1670   -2.3880   -8.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3680   -1.8090   -7.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  2  0  0  0  0
  7  9  1  0  0  0  0
  7 12  2  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 17  1  0  0  0  0
 13 14  1  0  0  0  0
 13 15  2  0  0  0  0
 14 18  1  0  0  0  0
 14 24  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 18 19  2  0  0  0  0
 19 20  1  0  0  0  0
 19 22  1  0  0  0  0
 20 21  1  0  0  0  0
 22 23  2  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
N_desacetyl_indiplon

> <PRIMARY_SOM>
21

>  <Citation>
Madan et al.,Xenobiotica,37,736,2007

>  <DOI>
10.1080/00498250701433054

$$$$
N_nitrosodiamylamine
  MOE2008           3D

 13 12  0  0  0  0  0  0  0  0999 V2000
   -0.0150    1.2860    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -0.6270    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430    2.0350    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.0010    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6950    2.2890    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7460    2.2580   -1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0100    3.0720    1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0810    3.0050   -1.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4620    3.3250    2.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5330    3.2620   -2.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7760    4.1080    2.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8680    4.0080   -2.8380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  3  2  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
N_nitrosodiamylamine

> <PRIMARY_SOM>
10 11

> <SECONDARY_SOM>
8 9

> <TERTIARY_SOM>
6 7 12 13

>  <Citation>
Bellec et al.,Mutation Res.,377,199,1997

>  <DOI>
10.1016/S0027-5107(97)00073-0

$$$$
O6-benzylguanine
  MOE2008           2D

 18 20  0  0  0  0  0  0  0  0999 V2000
    1.2220   -1.1890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7060   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2220   -2.5240    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4370   -2.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780   -2.6810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920   -2.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7060   -2.6810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920   -1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780   -0.2060    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4370   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7060    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7060    2.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920    2.6810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780    2.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4 11  2  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 18  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
O6-benzylguanine

> <PRIMARY_SOM>
2

>  <Citation>
Roy, S.K.; Korzekwa, K.R.; Gonzalez, F.J.; Moschel, R.C.; Dolan, M.E. Human Liver Oxidative Metabolism of O6-Benzylguanine. Biochem. Pharmacol. 1995, 50, 1385–1389.

>  <DOI>
10.1016/0006-2952(95)02019-5 

$$$$
PMAMC
  MOE2008           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.0780    1.4220   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0270    0.0360   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    2.1910   -0.3790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2850    2.1100   -0.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2740   -0.6160   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310   -0.6660   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    1.5840   -0.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4800    1.3960   -0.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    0.1290   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4500    0.0070   -0.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3880    2.2260   -0.4660 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3970   -2.0990    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3590   -2.6270    1.3790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0180   -2.8000    1.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1030   -3.3400    3.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6140   -4.6600    3.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250    2.1360   -0.4890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7820    1.3100   -0.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 12  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  2  0  0  0  0
  8 10  1  0  0  0  0
  8 17  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
PMAMC

> <PRIMARY_SOM>
18

> <SECONDARY_SOM>
14

>  <Citation>
J. Venhorst, R. C. A. Onderwater, J. H. N. Meerman, J. N. M. Commandeur, N. P. E. Vermeulen, Drug Metab. Dispos. 2000, 28, 1524-1532.

$$$$
PhIP
  MOE2008           2D

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.7390   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7390   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0240    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6900   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6900   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0240   -1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0080   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5240   -1.2860    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5240    0.0490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4040    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8330    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8330    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4040    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7780    0.8330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8330   -0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  1  8  1  0  0  0  0
  2  3  1  0  0  0  0
  2  9  1  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4 10  1  0  0  0  0
  5  6  2  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  7 17  1  0  0  0  0
  9 16  1  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
PhIP

> <PRIMARY_SOM>
17

> <SECONDARY_SOM>
13

>  <Citation>
Crofts, F.G.; Sutter, T.R.; Strickland, P.T. Metabolism of 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine by Human Cytochrome P4501A1 and P4501B1. Carcinogenesis 1998, 19, 1969–1973.

>  <DOI>
10.1093/carcin/19.11.1969

$$$$
RHP+
  MOE2008           2D

 25 27  0  0  1  0  0  0  0  0999 V2000
    0.7140    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.4120    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -0.4120    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1430    0.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5720   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2870   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2870   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5720   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0010   -2.0620    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5720    2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2870    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2870    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5720    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0010    2.0620    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 19  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 18  1  0  0  0  0
 16 17  1  0  0  0  0
 19 20  1  0  0  0  0
 19 24  2  0  0  0  0
 20 21  2  0  0  0  0
 21 22  1  0  0  0  0
 22 23  2  0  0  0  0
 22 25  1  0  0  0  0
 23 24  1  0  0  0  0
M  CHG  1   6   1
M  END
>  <ID>
RHP+

> <PRIMARY_SOM>
10

>  <Citation>
Fang et al.,Drug Metab. Disp.,29,1638,2001

$$$$
TFMPP
  MOE2008           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.1200    0.6730    0.5590 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1570    1.3320    0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8980    0.8330   -0.9410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9890   -0.6110   -0.9250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1780   -1.2640   -1.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2530   -1.3250   -0.7130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9740   -0.7810    0.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710   -0.5640   -1.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5840   -1.2210   -1.5480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6260   -2.6100   -1.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4590   -3.3440   -1.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4910   -4.8380   -1.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3840   -5.4060   -1.8740 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5520   -5.3700   -1.9880 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5670   -5.3310   -0.0500 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2560   -2.6620   -1.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  8  1  0  0  0  0
  5 16  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 12 15  1  0  0  0  0
M  END
>  <ID>
TFMPP

> <PRIMARY_SOM>
9 10

>  <Citation>
Staack et al.,Biochem. Pharma.,67,235,2004

>  <DOI>
10.1016/j.bcp.2003.08.029

$$$$
abbott-66193
  MOE2008           3D

 15 16  0  0  1  0  0  0  0  0999 V2000
   -0.0240    1.6300    0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    0.1680    0.1310 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.0030    2.4640    0.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4580    2.6620    0.7340 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0280   -0.5500    0.8580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2000    0.0110   -1.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7330    3.8520    1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6370    4.1860    1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200   -0.2120    0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6530    4.8930    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670    5.4580    1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2740   -0.7700    1.4550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6270    0.5960   -0.1730 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    6.1430    1.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1380    6.4450    1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  1  0  0  0  0
  7  8  2  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
  9 13  2  0  0  0  0
 10 14  2  0  0  0  0
 11 15  2  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
abbott-66193

> <PRIMARY_SOM>
10 11 14 15

>  <Citation>
J. M. Machinist, M. D. Mayer, M. S. Shet, J. L. Ferrero, A. D. Rodrigues, Drug Metab. Dispos. 1995, 23, 1163-1174.

$$$$
abt_438
  MOE2008           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6790   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0280   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770    1.4110   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710    2.0860    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3320    2.1140    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7640    2.3510    1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7620    1.3160    2.5010 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7490    2.3520    3.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9870    3.4140    3.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4880    3.4050    2.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3720    2.1320    5.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8830    1.9520    6.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5240    1.7260    7.5730 C   0  0  3  0  0  0  0  0  0  0  0  0
   -4.2220    2.9060    8.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0010    0.4930    8.1660 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7400   -0.1900    9.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8410    0.2180    9.3790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2600   -1.3240    9.6090 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 12  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
 13 14  3  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
abt_438

> <PRIMARY_SOM>
7

>  <Citation>
Machinist et al.,Drug Metab. Disp.,26,970,1998

$$$$
abt_761
  MOE2008           3D

 21 22  0  0  1  0  0  0  0  0999 V2000
   -0.1040    1.2970    0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0510   -0.0830    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3070   -0.6640    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4110    0.1350   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2590    1.5130   -0.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0030    2.0930   -0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4520    1.9200    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7600    2.3130    1.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7580    1.3120    2.5780 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6430    2.3780    3.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8700    3.4740    3.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3660    3.4390    2.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2780    2.1490    5.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8090    1.9580    6.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600    1.7290    7.5130 C   0  0  3  0  0  0  0  0  0  0  0  0
   -4.3350    2.9420    8.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0200    0.5360    8.2000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6670    0.2090    8.0530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170   -0.2210    9.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0050    0.0430    9.2060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1960   -1.3040    9.5950 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 12  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
 13 14  3  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  1  0  0  0  0
 17 18  1  0  0  0  0
 17 19  1  0  0  0  0
 19 20  2  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
abt_761

> <PRIMARY_SOM>
7

>  <Citation>
Machinist et al.,Drug Metab. Disp.,26,970,1998

$$$$
acenocoumarol
  MOE2008           3D

 26 28  0  0  1  0  0  0  0  0999 V2000
   -0.8310   -1.1120   -0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3890   -1.4210    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7150   -0.8230    1.5110 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.8400   -0.3330    2.9400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9080   -1.6020    1.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4030   -1.6360   -0.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6950   -2.2680    2.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0740   -2.4750    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5400   -2.7990    1.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3630   -3.0230    0.0320 N   0  3  0  0  0  0  0  0  0  0  0  0
    2.9350   -3.7630    0.8440 O   0  5  0  0  0  0  0  0  0  0  0  0
    2.8100   -2.7160   -1.0810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9790    0.8760    3.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2770    0.9380    4.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8930    1.7870    2.3480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2890   -2.8170    1.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3980   -3.5260    1.3500 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1460   -3.0960    0.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6640   -3.1860    2.7900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7960   -1.9390   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6360   -1.1930    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3260   -0.0550   -0.7000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5720   -1.5510   -1.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6740   -2.3130   -1.9240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0080   -3.4700   -1.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2420   -3.8690   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4 13  1  0  0  0  0
  5 16  1  0  0  0  0
  5 21  2  0  0  0  0
  6  8  2  0  0  0  0
  7  9  2  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  2  0  0  0  0
 13 14  1  0  0  0  0
 13 15  2  0  0  0  0
 16 17  1  0  0  0  0
 16 19  2  0  0  0  0
 17 18  1  0  0  0  0
 18 20  1  0  0  0  0
 18 26  2  0  0  0  0
 20 21  1  0  0  0  0
 20 23  2  0  0  0  0
 21 22  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  2  0  0  0  0
 25 26  1  0  0  0  0
M  CHG  1  10   1
M  CHG  1  11  -1
M  END
>  <ID>
acenocoumarol

> <PRIMARY_SOM>
24

>  <Citation>
H. H. Thijssen, J. P. Flinois, P. H. Beaune, Drug Metab. Dispos. 2000, 28, 1284-1290

$$$$
acetaminophen
  MOE2008           3D

 11 11  0  0  0  0  0  0  0  0999 V2000
    2.4050   -3.6550   -0.0050 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2420    2.2160   -0.0110 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9270    1.8530   -0.0200 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8460    0.4550   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5710   -0.1110   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9720   -0.3690   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4180   -1.4950   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8280   -1.7540   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5510   -2.3000   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0810    2.6090   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7400    4.0660   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0  0  0  0
  2 10  2  0  0  0  0
  3  4  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  2  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  7  9  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
M  END
>  <ID>
acetaminophen

> <PRIMARY_SOM>
1 3

>  <Citation>
Patten et al.,Chem. Res. Toxicol.,6,511,1993

>  <DOI>
10.1021/tx0034a019

$$$$
acetanilide
  MOE2008           2D

 10 10  0  0  0  0  0  0  0  0999 V2000
    4.5980    0.7500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    0.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -0.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -1.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -1.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -2.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    1.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    2.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  2  0  0  0  0
  2  3  1  0  0  0  0
  2  9  1  0  0  0  0
  3  4  2  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  2  0  0  0  0
  6  8  2  0  0  0  0
  7  8  1  0  0  0  0
  9 10  1  0  0  0  0
M  END
>  <ID>
acetanilide

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
4 5

>  <Citation>
G. Liu, H. V. Gelboin, M. J. Myers, Arch. Biochem. Biophys. 1991, 284, 400-406.

>  <DOI>
10.1016/0003-9861(91)90315-A

$$$$
aflatoxin_b1
  MOE2008           3D

 23 27  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3860    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2040   -0.6810   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4070    0.0130   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4210    1.3960   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070    2.0940    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    3.5010    0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0740    4.1330    0.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2890    3.3080    0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0440   -0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2320    4.5270   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5420    5.8930    0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0780    5.5710    0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -0.9870    0.0490 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5000   -2.3480    0.4360 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.9510   -2.1740   -0.0480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880   -0.6960    1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5620   -1.4860    2.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5390   -2.2880    1.8730 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8110    6.3780    0.5410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2940    3.7290    1.0310 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5960    2.0690   -0.1410 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6320    1.0880   -0.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 10  1  0  0  0  0
  2  3  2  0  0  0  0
  2 14  1  0  0  0  0
  3  4  1  0  0  0  0
  3 16  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 22  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  1  0  0  0  0
  9 10  1  0  0  0  0
  9 21  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 20  2  0  0  0  0
 14 15  1  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 15 19  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
aflatoxin_b1

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
17 18 23

> <TERTIARY_SOM>
11

>  <Citation>
X. Y. He, L. L. Tang, S. L. Wang, Q. S. Cai, J. S. Wang, J. Y. Hong, Int. J. Cancer 2006, 118, 2665-2671

>  <DOI>
10.1002/ijc.21665

$$$$
albendazole
  MOE2008           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.0160    1.3040    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2610    1.7870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1600    2.0840    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2880   -0.4440   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0600    3.4280    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1130    0.6930   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8660   -1.7150   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0350    3.9560    0.0220 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4920    0.5510   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2440   -1.8420   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1720    4.1860    0.0350 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9770   -3.4440   -0.0570 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.0540   -0.7080   -0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7320   -2.9870   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0640    5.6340    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5890   -4.2540   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0700   -3.8690   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  7  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  2  0  0  0  0
  5  8  1  0  0  0  0
  6  9  2  0  0  0  0
  6 12  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  2  0  0  0  0
 10 14  2  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 12 16  1  0  0  0  0
 13 15  1  0  0  0  0
 15 17  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
albendazole

> <PRIMARY_SOM>
13

>  <Citation>
Rawden et al.,Br. J. Clin. Pharm.,49,313,2000

$$$$
all_trans_retinal
  MOE2008           3D

 21 21  0  0  0  0  0  0  0  0999 V2000
   -0.5970    2.1490   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5530    0.7000   -0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2910    2.8540   -1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2560    2.8410    0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5710   -0.1380   -0.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2520   -6.2510   -1.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6130   -7.6700   -1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6980   -3.7120   -0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0340   -5.7750   -1.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5010   -1.5730   -0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8460   -4.3490   -1.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6100   -2.2820   -0.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8620   -8.6110   -1.1330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3340    4.3490   -1.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5090    4.3110    0.2950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0820    2.2340   -2.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4460    2.7510    1.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6240    2.1990    0.7470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7370    5.0270   -0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8520   -6.6330   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1870   -2.2040   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  3 14  1  0  0  0  0
  3 16  1  0  0  0  0
  4 15  1  0  0  0  0
  4 17  1  0  0  0  0
  4 18  1  0  0  0  0
  5 10  1  0  0  0  0
  6  7  1  0  0  0  0
  6  9  2  0  0  0  0
  7 13  2  0  0  0  0
  8 11  2  0  0  0  0
  8 12  1  0  0  0  0
  9 11  1  0  0  0  0
  9 20  1  0  0  0  0
 10 12  2  0  0  0  0
 10 21  1  0  0  0  0
 14 19  1  0  0  0  0
 15 19  1  0  0  0  0
M  END
>  <ID>
all_trans_retinal

> <PRIMARY_SOM>
7

>  <Citation>
Zhang et al.,Drug Metab. Dispos.,28,292,2000
Chen et al.,Drug Metab. Disp.,28,315,2000

$$$$
all_trans_retinol
  MOE2008           3D

 21 21  0  0  0  0  0  0  0  0999 V2000
   -2.4230   -2.1670    0.8290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5910   -1.3550    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8950   -2.0620    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0360   -1.0460    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6360    0.0600   -0.9710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4870    0.8640   -0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0150    1.6870    0.8180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9050    1.8040   -1.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4110   -0.0620    0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0880    0.5000    0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9900   -0.0500   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2950    0.4020    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3970   -0.1490   -0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4490    1.4960    1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6800    0.3290   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7780   -0.2080   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1130    0.2050   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1930   -0.3680   -0.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2700    1.2770    0.8290 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5650   -0.0290   -0.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2670   -1.2340    0.0810 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  9  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
all_trans_retinol

> <PRIMARY_SOM>
20

>  <Citation>
Chen et al.,Drug Metab. Disp.,28,315,2000

$$$$
almotriptan
  MOE2008           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    1.8260   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2360    2.0820    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3230   -0.3920   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2010   -0.7020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1320    0.7110   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8930    3.2450    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060    1.3770    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3930   -0.0110    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9600    3.7610    1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7220    2.1120    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4550    5.1440    1.4420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2740    2.4160   -1.6360 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.2670    5.6570    2.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9040    5.0740    1.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7080    3.2180   -1.4300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4620    3.3860   -2.2840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6740    1.2140   -2.2800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8680    4.6750   -1.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0370    2.5880   -1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3700    4.9580   -1.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9020    3.6120   -0.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5  7  1  0  0  0  0
  6 10  2  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 13 16  1  0  0  0  0
 14 17  1  0  0  0  0
 14 18  2  0  0  0  0
 14 19  2  0  0  0  0
 17 20  1  0  0  0  0
 17 21  1  0  0  0  0
 20 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
almotriptan

> <PRIMARY_SOM>
21 20

>  <Citation>
Salva et al.,Drug Metab. Disp.,31,404,2003

>  <DOI>
10.1124/dmd.31.4.404

$$$$
ametryne
  MOE2008           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0540   -1.5120   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1190   -0.7170   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9630    0.6030   -0.0800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2590    1.1280   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3240    0.3330   -0.0230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1680   -0.9870   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2730   -1.8130    0.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6190   -1.2340    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6560   -2.3580    0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870   -1.2620   -0.0810 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5600   -0.3870   -0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0010   -0.0580    1.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7000   -1.0950   -0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4660    2.8780   -0.0840 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2730    2.9810   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
ametryne

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
8 11

> <TERTIARY_SOM>
12 13

>  <Citation>
Lang et al.,Chem. Res. Tox.,10,1037,1997

$$$$
aminopyrine
  MOE2008           3D

 16 17  0  0  1  0  0  0  0  0999 V2000
    1.2340    0.6640   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0720    1.3640    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1000    0.6680    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1030   -0.7260    0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0540   -1.4490    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150   -2.8580    0.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180   -0.7300   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0970   -3.6770    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410   -3.3550    0.6360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270   -5.1190    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300   -6.2220    0.3620 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8290   -6.1260    0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350   -7.5700    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750   -5.0000   -0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -3.6910   -0.1960 N   0  0  3  0  0  0  0  0  0  0  0  0
    2.4120   -3.2500   -0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6 15  1  0  0  0  0
  8  9  2  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 14  2  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
aminopyrine

> <PRIMARY_SOM>
12 13

>  <Citation>
Niwa et al.,Xenobiotica,29,187,1999

>  <DOI>
10.1080/004982599238731

$$$$
amiodarone
  MOE2008           3D

 31 33  0  0  0  0  0  0  0  0999 V2000
   -6.5630    1.6000    1.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4340    1.7120    2.8180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4150    1.0520    3.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5170    0.2730    2.7910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6380    0.1520    1.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6710    0.8140    0.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5540    0.5170   -0.5810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8830   -0.5730    0.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5180   -0.2980   -0.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1050   -0.8230   -2.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8270   -2.1440   -2.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4080   -2.6770   -3.8040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1300   -3.9980   -4.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7020   -1.4260    0.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3480   -0.8510    0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2260   -1.6330    0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0360   -1.0920    0.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1950    0.2310    0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0820    1.0130   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1830    0.4770    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8400   -2.6080    0.8160 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7180   -2.2640    1.0540 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.3290    3.0050   -0.6610 I   0  0  0  0  0  0  0  0  0  0  0  0
    2.4400    0.7600    0.1160 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8990    0.4710   -1.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2910    1.0740   -1.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2380    0.4360   -0.4820 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5310   -0.8950   -1.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5170   -1.6190   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4860    1.2080   -0.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3160    2.5290    0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  7  9  1  0  0  0  0
  8  9  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 14 15  1  0  0  0  0
 14 21  2  0  0  0  0
 15 16  1  0  0  0  0
 15 20  2  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 17 22  1  0  0  0  0
 18 19  2  0  0  0  0
 18 24  1  0  0  0  0
 19 20  1  0  0  0  0
 19 23  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
 27 28  1  0  0  0  0
 27 30  1  0  0  0  0
 28 29  1  0  0  0  0
 30 31  1  0  0  0  0
M  END
>  <ID>
amiodarone

> <PRIMARY_SOM>
30 28

>  <Citation>
Ohyama et al.,Drug Metab. Dispos., 28:1303–1310, 2000

$$$$
amitriptyline
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0810    1.5320   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0940   -0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410    2.2850    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1220    2.1320   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7000   -0.4150   -1.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7770   -0.7760    0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360    2.0220   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3650    3.2740    1.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4640    3.5550    0.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5310    0.4770   -2.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6080   -1.7700   -1.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8610   -2.1290    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7370    0.9930   -1.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6880    2.7600   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5130    4.0030    1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1970    4.1140   -0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1690   -2.6260   -1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6820    3.7450    0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5560    5.5090   -0.7940 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1630    5.9650   -2.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5830    5.5890    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 16  1  0  0  0  0
 10 13  1  0  0  0  0
 11 17  2  0  0  0  0
 12 17  1  0  0  0  0
 14 18  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
amitriptyline

> <PRIMARY_SOM>
20 21

>  <Citation>
K. Venkatakrishnan, L. L. von Moltke, D. J. Greenblatt, J. Pharmacol. Exp. Ther. 2001, 297, 326-337.

$$$$
antipyrine
  MOE2008           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
   -0.5220    2.9500    0.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2640    0.5920   -0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370   -0.4150   -0.1310 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4770    0.1550    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    0.4060    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9410    1.8060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3900    1.4870    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9690   -1.7690   -0.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7370   -0.6370    0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9960    1.4380   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7270   -0.7690    0.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3860    1.2840   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1170   -0.9260    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9470    0.0990    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  4  1  0  0  0  0
  3  8  1  0  0  0  0
  4  7  2  0  0  0  0
  4  9  1  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6  7  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
antipyrine

> <PRIMARY_SOM>
9

> <SECONDARY_SOM>
7

> <TERTIARY_SOM>
8

>  <Citation>
G. Engel, U. Hofmann, H. Heidemann, J. Cosme, M. Eichelbaum, Clin. Pharmacol. Ther. 1996, 59, 613-623.

$$$$
aprepitant
  MOE2008           3D

 37 40  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3690    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7850   -2.3030   -0.0020 N   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6510   -4.5920   -0.0920 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.2570    1.8110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320   -0.4050   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690   -5.7820   -4.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6800   -9.6640   -4.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9900   -3.1080   -0.2390 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.0600    0.7260   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4060   -6.5560   -4.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1010   -8.4140   -4.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6010   -4.9320   -1.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0080   -6.8330   -2.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2110   -0.8980    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8750   -7.7040   -4.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5440   -7.9770   -2.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9670   -6.1230   -3.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2270   -4.8600    1.2440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4910   -6.3560   -0.9900 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.5040   -2.8460   -1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6170    2.9740    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -6.2670   -4.6270 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2850   -5.9330   -6.3630 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -4.4280   -4.6480 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7940   -9.3300   -5.5200 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.2840  -10.2810   -5.5460 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690  -10.5420   -3.7240 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8630   -2.7400   -1.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6140   -2.7060   -2.6810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3290   -2.6170    1.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4460   -2.3640   -4.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0310   -4.1130    1.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0840   -2.4650   -3.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3360   -2.4990   -3.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9060   -2.1280   -5.4340 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.5060   -6.7830    0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0  0  0  0
  1  5  1  0  0  0  0
  2  9  1  0  0  0  0
  2 15  1  0  0  0  0
  2 31  1  0  0  0  0
  3  6  2  0  0  0  0
  3 15  1  0  0  0  0
  4  9  1  0  0  0  0
  4 13  1  0  0  0  0
  4 19  1  0  0  0  0
  5 10  1  0  0  0  0
  5 22  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 23  1  0  0  0  0
  7 24  1  0  0  0  0
  7 25  1  0  0  0  0
  8 12  1  0  0  0  0
  8 26  1  0  0  0  0
  8 27  1  0  0  0  0
  8 28  1  0  0  0  0
  9 21  1  0  0  0  0
 11 16  2  0  0  0  0
 11 18  1  0  0  0  0
 12 16  1  0  0  0  0
 12 17  2  0  0  0  0
 13 20  1  0  0  0  0
 14 17  1  0  0  0  0
 14 18  2  0  0  0  0
 14 20  1  0  0  0  0
 19 33  1  0  0  0  0
 20 37  1  0  0  0  0
 21 29  2  0  0  0  0
 21 30  1  0  0  0  0
 29 35  1  0  0  0  0
 30 34  2  0  0  0  0
 31 33  1  0  0  0  0
 32 34  1  0  0  0  0
 32 35  2  0  0  0  0
 32 36  1  0  0  0  0
M  END
>  <ID>
aprepitant

> <PRIMARY_SOM>
4 31 33

> <SECONDARY_SOM>
20

>  <Citation>
Sanchez et al.,Drug Metab. Disp.,32,1287,2004

>  <DOI>
10.1124/dmd.104.000216

$$$$
arachidonic_acid
  MOE2008           3D

 22 21  0  0  0  0  0  0  0  0999 V2000
   10.1270    3.3080   -2.6290 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8510    4.8200   -0.9420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8710    1.5580    1.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7460    0.7020    1.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6580    0.8720    0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0100    1.4510    3.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8160    0.4310   -0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1120    0.5960    3.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4170    1.7080   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4690    0.6900    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7050   -0.8280   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010   -1.9960   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6380    2.7370   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2360   -0.3180    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470   -2.3160   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2990   -2.6660   -1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2270   -1.6330    1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4220   -2.2230   -0.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6240   -2.7690   -1.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5070   -3.3210    0.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1780   -3.2830    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5920    3.7460   -1.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0  0  0  0
  2 22  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 11  2  0  0  0  0
  9 10  1  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
 12 16  1  0  0  0  0
 13 22  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 15 20  1  0  0  0  0
 16 19  2  0  0  0  0
 18 19  1  0  0  0  0
 18 21  1  0  0  0  0
 20 21  2  0  0  0  0
M  END
>  <ID>
arachidonic_acid

> <PRIMARY_SOM>
7 11 16 19

> <SECONDARY_SOM>
4 6 8 20 21

> <TERTIARY_SOM>
12 15 18

>  <Citation>
Rifkind et al.,Arch. Biochem. Biophys.,320,380,1995
Bylund et al.,J. Pharma. Exp. Thera.,284,51,1998

>  <DOI>
10.1016/0003-9861(95)90023-3

$$$$
atomoxetine
  MOE2008           3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -0.1900    1.2080    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3720   -0.1630    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7070   -1.0030    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9680   -0.4740    0.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500    0.8970    0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0710    1.7370    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3650    2.1240    0.0110 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2050    3.3050    0.7980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6370    3.0040    2.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9860    1.7000    2.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4190    1.3940    3.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5040    2.3870    4.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1580    3.6880    4.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7240    3.9980    3.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3460    5.4160    2.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4410    2.5040   -1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7030    3.3320   -1.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7760    3.6970   -3.1410 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0030    4.4850   -3.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
atomoxetine

> <PRIMARY_SOM>
12

> <SECONDARY_SOM>
19

>  <Citation>
Ring et al.,30,319,2002

>  <DOI>
10.1124/dmd.30.3.319

$$$$
atrazine
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.2530   -1.3280    0.0220 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8930   -0.6570    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8830    0.6740    0.0820 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2670    1.3280    0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4100    0.6630    0.0280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4060   -0.6680    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5990   -1.3610   -0.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8700   -0.6330   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0290   -1.6300   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930   -1.3390    0.0770 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3560   -0.5980    0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4110   -1.4290    0.8510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8290   -0.3160   -1.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2760    3.0640    0.0950 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
atrazine

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
11

>  <Citation>
Lang et al.,Chem. Res. Tox.,10,1037,1997

$$$$
azelastine
  MOE2008           3D

 27 30  0  0  1  0  0  0  0  0999 V2000
   -3.4850    0.0180    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9280    1.3150   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7720    2.4230   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8700   -0.1420    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1270    2.2430   -0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6780    0.9710   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4710    1.4520   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5700   -1.1260    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7190    0.3960    0.0380 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2410   -0.8960    0.1230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0030   -2.2620    0.1920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430    2.8200   -0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6580    2.6860   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3650    2.5430   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3270    2.7120    1.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7420    2.4210   -1.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4110    2.4410   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7030    2.5890    1.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1400    2.2880    0.0060 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3200   -2.0310    0.2200 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.5740   -2.0620   -0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0190   -3.4710   -1.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4270   -4.3400   -0.2980 N   0  0  3  0  0  0  0  0  0  0  0  0
    2.2100   -3.5610    0.6300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660   -3.1270    1.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5620   -1.8800    1.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3260   -5.3590   -0.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  4  1  0  0  0  0
  1  8  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  1  0  0  0  0
  3  5  2  0  0  0  0
  4  6  2  0  0  0  0
  5  6  1  0  0  0  0
  7  9  2  0  0  0  0
  7 12  1  0  0  0  0
  8 10  1  0  0  0  0
  8 11  2  0  0  0  0
  9 10  1  0  0  0  0
 10 20  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 13 15  1  0  0  0  0
 14 16  1  0  0  0  0
 15 18  2  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 17 19  1  0  0  0  0
 20 21  1  0  0  0  0
 20 26  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 23 27  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
M  END
>  <ID>
azelastine

> <PRIMARY_SOM>
27

>  <Citation>
Nakajima et al., Drug Metab. Dispos.,1999, 27, 1381-1391 

$$$$
benzo_a_pyrene
  MOE2008           3D

 20 24  0  0  0  0  0  0  0  0999 V2000
    3.8520   -0.2940   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8800   -1.7060   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6180    0.3960   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0690    0.4180   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6180    1.8130   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6750   -2.4370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1150   -2.3900   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8500    2.5080   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0550    1.8100   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360   -0.3640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820   -0.2710   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4600   -1.7590    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3050   -1.6650   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7130   -3.8310    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1310   -3.7840   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360    2.5710   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8740    3.9020   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9350   -4.5020    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4670    3.9640   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6870    4.6290   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  1  0  0  0  0
  3  5  1  0  0  0  0
  3 10  2  0  0  0  0
  4  9  2  0  0  0  0
  4 11  1  0  0  0  0
  5  8  2  0  0  0  0
  5 16  1  0  0  0  0
  6 12  2  0  0  0  0
  6 14  1  0  0  0  0
  7 13  1  0  0  0  0
  7 15  2  0  0  0  0
  8  9  1  0  0  0  0
  8 17  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  2  0  0  0  0
 14 18  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  2  0  0  0  0
 17 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
benzo_a_pyrene

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
9 11 12 13 14 16 17 19 20

>  <Citation>
Bauer et al.,Chem. Res. Toxicol.,8,136,1995

$$$$
benzo_a_pyrene-7_8-diol
  MOE2008           3D

 22 26  0  0  0  0  0  0  0  0999 V2000
   -1.4160    0.2380   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3820   -1.1790   -0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1460   -1.8370   -0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0520   -1.1300   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700   -1.8090   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4740   -1.1060   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4750    0.2880    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6750    0.9980    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6670    2.3920    0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4590    3.0880    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2480    2.3970    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0370    3.0820    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1660    2.3770    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2040    0.9720   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0270    0.2780   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2500    0.9880    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5890   -1.8940   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8090   -1.2300   -0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8600    0.1540   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6700    0.8750   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5760   -3.2610   -0.0930 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9810   -1.9270   -0.0900 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 20  2  0  0  0  0
  2  3  1  0  0  0  0
  2 17  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  2  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 17 21  1  0  0  0  0
 18 19  2  0  0  0  0
 18 22  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
benzo_a_pyrene-7_8-diol

> <PRIMARY_SOM>
19 20

>  <Citation>
Kim, J.H.; Stansbury, K.H.; Walker, N.J.; Trush, M.A.; Strickland, P.T.; Sutter, T.R. Metabolism of Benzo[a]Pyrene and Benzo[a]Pyrene-7, 8-Diol by Human Cytochrome P450 1B1. Carcinogenesis 1998, 19, 1847–1853.

>  <DOI>
10.1093/carcin/19.10.1847

$$$$
biochanin_A
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0020    1.3150    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0980    0.0190   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1970    1.9620    0.5200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1400    2.0230    0.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1480   -0.6850   -0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3650   -0.5580   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3360    1.3020    0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3850    1.4260    0.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    0.0640   -0.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5120    0.1390    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1160   -1.8370   -0.9380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5430   -1.8180   -0.7760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5010    2.1150    0.9530 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.4680   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9220    0.1370   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1810   -0.3610   -0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2920   -1.4810   -1.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1380   -2.0960   -1.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8830   -1.5910   -1.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5630   -1.9000   -1.6870 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5560   -3.0500   -2.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 11  2  0  0  0  0
  6 10  2  0  0  0  0
  6 12  1  0  0  0  0
  7  9  2  0  0  0  0
  8 10  1  0  0  0  0
  8 13  1  0  0  0  0
  9 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 19  2  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 17 20  1  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
biochanin_A

> <PRIMARY_SOM>
21

>  <Citation>
Tollesen et al.,J. Agric. Food Chem.,50,4783,2002

>  <DOI>
10.1021/jf025549r

$$$$
bortezomib
  MOE2008           3D

 28 29  0  0  1  0  0  0  0  0999 V2000
   -0.0160    1.3440    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9150   -3.0770   -0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2420    2.0930    0.0010 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.0050   -2.2120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6250   -4.5300   -0.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5100    2.6820    1.4320 B   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2930   -0.7750    0.0100 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.4670   -4.9820   -0.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9740   -2.6660   -0.9220 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0600   -0.5960   -0.0110 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1490    3.2360   -1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0880   -0.4230    1.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3030   -6.7220   -1.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5780    3.5820    2.0150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6830    2.3160    2.1430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5670   -5.4280   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4340   -1.0990    1.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    4.0190   -1.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2120   -6.2750   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -7.1650   -0.5430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5930   -2.3640    1.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5110   -0.4500    0.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5900    3.1180   -1.5290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3270    5.2340   -1.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7460   -1.0700    0.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8280   -2.9840    1.7040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9040   -2.3380    1.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  2  8  1  0  0  0  0
  2 11  2  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  3 10  2  0  0  0  0
  4  7  1  0  0  0  0
  4 12  1  0  0  0  0
  5  8  1  0  0  0  0
  6  9  2  0  0  0  0
  6 17  1  0  0  0  0
  7 15  1  0  0  0  0
  7 16  1  0  0  0  0
  8 13  1  0  0  0  0
  9 20  1  0  0  0  0
 12 19  1  0  0  0  0
 13 18  1  0  0  0  0
 14 17  2  0  0  0  0
 14 21  1  0  0  0  0
 18 22  2  0  0  0  0
 18 23  1  0  0  0  0
 19 24  1  0  0  0  0
 19 25  1  0  0  0  0
 20 21  2  0  0  0  0
 22 27  1  0  0  0  0
 23 26  2  0  0  0  0
 26 28  1  0  0  0  0
 27 28  2  0  0  0  0
M  END
>  <ID>
bortezomib

> <PRIMARY_SOM>
4

>  <Citation>
Pekol et al.,Drug Metab. Disp.,33,771,2005

$$$$
bpr0l075
  MOE2008           3D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -8.0490   -0.3380   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1490   -1.3680    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7990   -1.3240   -0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3480   -0.1890   -0.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2240    0.8470   -1.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5690    0.7870   -0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0180   -0.1880   -1.2970 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6600    1.0070   -1.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3290   -0.7270    0.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1580   -1.9850    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8540   -2.3470    0.7180 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6130   -0.0400    0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6530    1.4360    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6790   -0.6470    0.2820 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6570    2.0770   -0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.7380    3.4700   -0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7760    4.2280    0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7920    3.5750    1.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7420    2.1800    1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.7540    3.9760   -1.2130 O   0  0  0  0  0  0  0  0  0  0  0  0
  -13.3550    5.0970   -0.5750 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.8540    5.5970    0.1810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6060    6.1070   -0.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9180    4.3430    1.7370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9950    3.5490    2.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  2 11  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  9 10  2  0  0  0  0
  9 12  1  0  0  0  0
 10 11  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  2  0  0  0  0
 13 15  1  0  0  0  0
 13 19  2  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 16 20  1  0  0  0  0
 17 18  2  0  0  0  0
 17 22  1  0  0  0  0
 18 19  1  0  0  0  0
 18 24  1  0  0  0  0
 20 21  1  0  0  0  0
 22 23  1  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
bpr0l075

> <PRIMARY_SOM>
3 5

> <SECONDARY_SOM>
8

>  <Citation>
Yao et al.,Drug Metab. Disp.,35,1042,2007

>  <DOI>
10.1124/dmd.106.014597

$$$$
bromodichloromethane
  MOE2008           2D

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.6190    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.6190    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.6190    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
M  END
>  <ID>
bromodichloromethane

> <PRIMARY_SOM>
1 4

>  <Citation>
John W. Allis and Guangyu Zhao, Chemico-Biological Interactions 140 (2002) 137–153

$$$$
bufuralol
  MOE2008           3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.4010    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1860    2.0950    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3090    1.7840    0.0300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4070   -0.4150    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170   -0.6880   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3780    1.4020   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1890    3.6020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1260    0.7150    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3900    0.0150   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0770    4.1050    1.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6310    0.7800    0.0560 C   0  0  3  0  0  0  0  0  0  0  0  0
   -4.1100    1.0450    1.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0740    1.8360   -0.7990 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5780    0.9900    1.5270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9700    1.2520    2.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4650    2.6330    3.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4950    1.2080    3.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3580    0.1860    3.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 16 19  1  0  0  0  0
M  END
>  <ID>
bufuralol

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
6 7

>  <Citation>
H. Yamazaki, Z. Y. Guo, M. Persmark, M. Mimura, K. Inoue, F. P. Guengerich, T. Shimada, Mol. Pharmacol. 1994, 46, 568-577.

$$$$
caffeine
  MOE2008           3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    3.5950    2.6770   -0.0050 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3470   -1.3750    0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6480   -1.4160    0.0060 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1170    1.0210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    0.6490   -0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0820   -1.1970    0.0060 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8040    0.6730    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8150   -0.6930    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6100    1.4500   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4170   -0.7600    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8580   -0.1290    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6730   -2.8560    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6620    2.3560   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1980    1.3350   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  2  0  0  0  0
  2 10  2  0  0  0  0
  3  8  1  0  0  0  0
  3 10  1  0  0  0  0
  3 12  1  0  0  0  0
  4  7  1  0  0  0  0
  4 11  1  0  0  0  0
  4 13  1  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 14  1  0  0  0  0
  6  8  1  0  0  0  0
  6 11  2  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
M  END
>  <ID>
caffeine

> <PRIMARY_SOM>
12

> <SECONDARY_SOM>
14

> <TERTIARY_SOM>
13

>  <Citation>
Lang, D.H.; Rettie, A.E. In Vitro Evaluation of Potential In Vivo Probes for Human Flavin-
Containing Monooxygenase (FMO): Metabolism of Benzydamine and Caffeine by FMO
and P450 Isoforms. Br. J. Clin. Pharmacol. 2000, 50, 311–314.

$$$$
capsaicin
  MOE2008           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690    2.0890    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    2.1120    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110   -0.6800   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3790    1.4200   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7530    2.3420    1.4040 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    0.0350   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320   -2.0400   -0.0200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9090    2.9870    1.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5940   -0.6250   -0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1300   -2.4740   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3410    3.2240    3.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6020    3.3760    0.7430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6770    3.9690    3.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1160    4.2090    4.5400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4520    4.9540    4.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8840    5.1910    5.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1560    6.4060    6.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5880    6.6430    7.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5940    7.5840    8.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9810    7.2760    7.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
 10 13  1  0  0  0  0
 10 14  2  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 20 22  1  0  0  0  0
M  END
>  <ID>
capsaicin

> <PRIMARY_SOM>
2 3 6 12

>  <Citation>
Reilly et al.,Chem. Res. Toxicol.,16,336,2003

>  <DOI>
10.1021/tx025599q

$$$$
carbaryl
  MOE2008           3D

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0060    1.3790    0.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0010   -0.0010   -0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2280    2.0940    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1750    2.0600    0.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1620   -0.7040    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1680   -0.6260   -0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4090    1.4140   -0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360    3.4700    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1300    3.3930    0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1420   -2.0460   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3660    0.0810   -0.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730    4.0950    0.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2980   -2.7320   -0.1950 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0810   -2.6390   -0.1140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2760   -4.1920   -0.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  3  7  1  0  0  0  0
  3  8  2  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  1  0  0  0  0
  7 11  2  0  0  0  0
  8 12  1  0  0  0  0
  9 12  2  0  0  0  0
 10 13  1  0  0  0  0
 10 14  2  0  0  0  0
 13 15  1  0  0  0  0
M  END
>  <ID>
carbaryl

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
8

> <TERTIARY_SOM>
7

>  <Citation>
Tang et al,Chem. Biol. Inter.,141,229,2002

>  <DOI>
10.1016/S0009-2797(02)00074-1

$$$$
carbofuran
  MOE2008           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -0.0300    1.3910   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200    0.0040   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1890    2.0740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3020    1.8760   -0.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4660   -0.4510   -0.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690   -0.6940   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2050    3.4340    0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.3700    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1990    0.8470   -0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730   -0.0130    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0140    4.1060    1.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5510    0.9540    0.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3780    0.9160   -1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9200    5.4510    1.1420 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9260    3.5010    2.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7120    6.1820    2.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  2  0  0  0  0
  4  9  1  0  0  0  0
  5  9  1  0  0  0  0
  6 10  2  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 12  1  0  0  0  0
  9 13  1  0  0  0  0
 11 14  1  0  0  0  0
 11 15  2  0  0  0  0
 14 16  1  0  0  0  0
M  END
>  <ID>
carbofuran

> <PRIMARY_SOM>
5

>  <Citation>
Usmani et al.,Chem. Biol. Inter.,150,221,2004

>  <DOI>
10.1016/j.cbi.2004.09.015

$$$$
carvedilol
  MOE2008           3D

 30 33  0  0  1  0  0  0  0  0999 V2000
   -3.7140   -1.3820    0.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0840   -1.3100    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650   -2.7190    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6960   -0.4240    0.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5460   -2.6120   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0030   -0.2410    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4900   -3.4630   -0.1440 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0480   -3.1650    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3810   -0.8760    0.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9430    0.8830    0.7060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8950   -2.9010   -0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3500   -0.5160   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -2.2250    0.4360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8560    1.8220    0.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7990   -1.8350   -0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3800    2.3260   -0.5270 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0850    3.1520   -0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    3.1290   -1.0990 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9390    2.2590    0.1690 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2850    2.8460    0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2650    1.6950    0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6160    2.0490    0.1430 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7310    1.2810    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8870   -0.1450   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8810    2.0790    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1770   -0.6550   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8930   -1.0840   -0.0710 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1620    1.5450   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3170    0.1590   -0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0060   -2.5390   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5  7  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  8 13  2  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 15  2  0  0  0  0
 12 15  1  0  0  0  0
 14 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  2  0  0  0  0
 23 25  1  0  0  0  0
 24 26  1  0  0  0  0
 24 27  1  0  0  0  0
 25 28  2  0  0  0  0
 26 29  2  0  0  0  0
 27 30  1  0  0  0  0
 28 29  1  0  0  0  0
M  END
>  <ID>
carvedilol

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
30

>  <Citation>
Oldham and Clarke,Drug Metab. Disp.,25,970,1997

$$$$
celecoxib
  MOE2008           3D

 26 28  0  0  0  0  0  0  0  0999 V2000
    3.4160   -4.6090   -0.2690 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1990    4.5310   -1.0150 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970    5.6480    0.3330 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.0260    4.2600    1.1450 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500   -4.9250   -0.9000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6670   -5.0860   -0.8240 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7440    1.3390   -0.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5730    2.0390   -0.0210 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3400   -5.0130    1.3880 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8440    2.1920    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6920   -0.0790   -0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2510    1.8260   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3240    3.4690    0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9250    3.3300    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8520   -0.8530   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450   -0.7080   -0.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5230   -2.8520   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9970    1.8230    1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8820    1.5320   -1.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7730   -2.2440   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3550   -2.0980   -0.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9800    1.2200   -0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3560    1.5180    1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2420    1.2260   -1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9180    4.4330    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4340    0.9020   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  2  0  0  0  0
  1  6  2  0  0  0  0
  1  9  1  0  0  0  0
  1 17  1  0  0  0  0
  2 25  1  0  0  0  0
  3 25  1  0  0  0  0
  4 25  1  0  0  0  0
  7  8  1  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 14  2  0  0  0  0
 10 12  1  0  0  0  0
 10 13  2  0  0  0  0
 11 15  2  0  0  0  0
 11 16  1  0  0  0  0
 12 18  2  0  0  0  0
 12 19  1  0  0  0  0
 13 14  1  0  0  0  0
 14 25  1  0  0  0  0
 15 20  1  0  0  0  0
 16 21  2  0  0  0  0
 17 20  2  0  0  0  0
 17 21  1  0  0  0  0
 18 23  1  0  0  0  0
 19 24  2  0  0  0  0
 22 23  2  0  0  0  0
 22 24  1  0  0  0  0
 22 26  1  0  0  0  0
M  END
>  <ID>
celecoxib

> <PRIMARY_SOM>
26

>  <Citation>
Tang et al.,J. Pharmacol. Exp. Ther.,293,453,2000

$$$$
chlorpromazine
  MOE2008           3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    9.2890    0.0450    0.1860 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.7020   -4.2120    0.6280 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.3510   -1.2390   -0.3250 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    3.3000    1.1460 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1790    0.1510   -0.7280 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8570    1.0080    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6660    2.4360    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6520   -1.6350    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970   -2.0440   -0.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9350   -2.9400    0.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2290   -3.3890    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7240   -0.7300   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9620   -1.5230   -0.7590 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2430   -3.3030    0.8170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0610   -4.1620    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2770    4.6550    0.6310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0350    2.9650    1.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0190   -1.1010    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8020   -2.2930   -0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2870   -2.3890    0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8520   -3.6200   -0.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0  0  0  0
  2 10  1  0  0  0  0
  2 11  1  0  0  0  0
  3  5  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  7  1  0  0  0  0
  4 16  1  0  0  0  0
  4 17  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8 10  2  0  0  0  0
  8 12  1  0  0  0  0
  9 11  2  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 15  1  0  0  0  0
 12 18  2  0  0  0  0
 13 19  2  0  0  0  0
 14 20  2  0  0  0  0
 15 21  2  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
chlorpromazine

> <PRIMARY_SOM>
21

>  <Citation>
Yoshii et al,Life Sci.,67,175,2000

>  <DOI>
10.1016/S0024-3205(00)00613-5

$$$$
chlorpropamide
  MOE2008           3D

 17 17  0  0  0  0  0  0  0  0999 V2000
   -0.0220    1.7580    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1660    2.4650    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2280    2.4320    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0240   -0.5080    1.5800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2600   -0.4040   -0.5140 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2650   -0.3700   -0.5380 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1480    3.8470    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2480    3.8140    0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0300   -0.2570    2.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0590    4.5230    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0120   -0.6670    3.6650 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9970    0.3390    1.9470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0830    6.2580    0.0350 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.1580   -0.3940    4.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8830   -0.9610    5.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0800   -0.6760    6.8420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  1  0  0  0  0
  8 11  2  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 10 13  2  0  0  0  0
 11 14  1  0  0  0  0
 12 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
chlorpropamide

> <PRIMARY_SOM>
4 3

>  <Citation>
Shon et al.,Brit. J. Clin. Pharma.,59,552,2005

>  <DOI>
10.1111/j.1365-2125.2005.02364.x

$$$$
chlorpyrifos
  MOE2008           3D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.1140    1.5240    0.0170 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1110   -0.0700    0.0480 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6920    1.8420   -0.0310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5980    2.1420   -1.2880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270    2.2860    1.5480 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2010   -0.4860    1.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2140    1.1690   -1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350    3.5590   -1.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7860   -0.5280    2.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4410   -0.8520    1.5800 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7330    1.3420   -1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1590    4.2220   -2.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4550   -0.9550    3.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4130   -0.0510    1.9050 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.7880   -1.2630    2.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8590   -1.3260    3.8080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4320   -1.7320    3.0910 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3280   -1.8680    5.3880 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
  9 14  1  0  0  0  0
 10 15  2  0  0  0  0
 13 16  2  0  0  0  0
 15 16  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
M  END
>  <ID>
chlorpyrifos

> <PRIMARY_SOM>
1 5

>  <Citation>
Tang et al.,Drug Metab. Disp.,29,1201,2001

$$$$
chlorzoxazone
  MOE2008           3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.3330    0.6250    0.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2120    1.4210    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0080    0.7740   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5940   -1.3800   -0.3940 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0710   -0.6280   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710   -1.4210   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530   -0.7460    0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5300   -1.2400    0.3190 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3560   -0.1320    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5690   -0.1620    0.6630 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250    1.0690    0.4690 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  END
>  <ID>
chlorzoxazone

> <PRIMARY_SOM>
3

>  <Citation>
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

$$$$
cilostazol
  MOE2008           3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -0.0150    1.2860    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2260   -0.4020   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0090    0.6210   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2650    1.7000   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4660    8.4510   -8.1650 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3480    8.0580   -6.8260 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2150    9.5180   -8.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6640    8.9520   -5.8120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060    2.1400    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5480    8.5680   -4.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2940    9.8550   -9.6620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9160    6.7770   -6.5110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310   10.3430   -6.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9530   10.3010   -7.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1160    7.2880   -4.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    6.3930   -5.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7500    3.1270    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0020    6.9090   -2.8760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0470    1.8580   -1.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0340    1.8450    1.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5430    5.5560   -2.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9000    3.6170   -1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3920    5.0660   -1.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2770    2.7370    1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2900    2.7500   -1.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1180    2.4550    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0  0  0  0
  1  5  1  0  0  0  0
  1 10  1  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5 18  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  2  0  0  0  0
  7 13  1  0  0  0  0
  8 12  2  0  0  0  0
  8 15  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
 10 20  1  0  0  0  0
 10 21  1  0  0  0  0
 11 16  2  0  0  0  0
 13 17  2  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 19  1  0  0  0  0
 18 23  1  0  0  0  0
 19 22  1  0  0  0  0
 20 26  1  0  0  0  0
 21 25  1  0  0  0  0
 22 24  1  0  0  0  0
 23 24  1  0  0  0  0
 25 27  1  0  0  0  0
 26 27  1  0  0  0  0
M  END
>  <ID>
cilostazol

> <PRIMARY_SOM>
14

>  <Citation>
R. Abbas, C. P. Chow, N. J. Browder, D. Thacker, S. L. Bramer, C. J. Fu, W. Forbes, M. Odomi, D. A. Flockhart, Hum. Exp. Toxicol. 2000, 19, 178-184.

$$$$
cinnarizine
  MOE2008           3D

 28 31  0  0  0  0  0  0  0  0999 V2000
    1.1320    0.9920   -0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0250    1.8260    0.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3470    1.5790    1.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2650    2.4540    2.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3200    1.7240    3.0750 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5230   -0.1590    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3250   -0.9210   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5710   -0.5360   -2.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0320    0.6090   -2.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8800    1.3700   -1.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7670    1.0570    4.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8250    0.5130    5.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8390    1.4760    5.6370 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2170    2.4860    6.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4580    1.9350    7.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1060    3.6420    6.8780 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3760    2.1230    4.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3430    2.6820    3.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070    2.2600    7.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    1.7720    8.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9870    0.9560    9.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3340    0.6270    9.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0670    1.1160    8.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6910    4.9370    6.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4860    6.0320    6.8910 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7000    5.8380    7.5440 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1210    4.5510    7.8670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3260    3.4560    7.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5 11  1  0  0  0  0
  5 18  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 17  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 15 19  1  0  0  0  0
 15 23  2  0  0  0  0
 16 24  1  0  0  0  0
 16 28  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 21 22  2  0  0  0  0
 22 23  1  0  0  0  0
 24 25  2  0  0  0  0
 25 26  1  0  0  0  0
 26 27  2  0  0  0  0
 27 28  1  0  0  0  0
M  END
>  <ID>
cinnarizine

> <PRIMARY_SOM>
4 14

>  <Citation>
S. Kariya, S. Isozaki, K. Uchino, T. Suzuki, S. Narimatsu, Biol. Pharm. Bull. 1996, 19, 1511-1514.

$$$$
clobazam
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -0.3440    1.2520    0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5340    2.3210    0.5630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6610    1.4170    0.9300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9330   -0.6520   -0.8140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1460   -0.6410    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8610    2.2590    0.1480 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0890    3.5420    1.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900    2.6280    1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7930   -1.5980   -0.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0070   -0.3460   -2.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2360   -0.0070    1.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3140   -1.7530   -0.2150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6940    1.2440    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3860    3.4120   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    3.6940    1.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7300    2.8140    1.9690 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7150   -2.2350   -1.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9310   -0.9870   -2.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8430    1.3260   -0.0180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7820   -1.9320   -2.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  7 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 16  1  0  0  0  0
  9 17  1  0  0  0  0
 10 18  1  0  0  0  0
 11 19  2  0  0  0  0
 12 14  1  0  0  0  0
 14 20  2  0  0  0  0
 18 21  2  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
clobazam

> <PRIMARY_SOM>
15

>  <Citation>
Giraud et al.,Drug Metab. Disp.,32,1279,2004

$$$$
clomipramine
  MOE2008           3D

 22 24  0  0  1  0  0  0  0  0999 V2000
    1.5210    3.6320   -0.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6940    4.2260    0.8260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3060    3.5670    1.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    2.3030    1.9000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5880    1.7120    0.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9500    2.3720   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7130    1.7340   -1.8280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7550    1.6480   -2.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5520    0.7240   -1.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8330    0.4300   -1.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6750   -0.4200   -1.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2560   -1.0080    0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0010   -0.7200    0.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1500    0.1580   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0760    0.4260    0.5240 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8520   -0.6910    1.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7030   -1.3090   -0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5480   -2.4470    0.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3640   -3.0410   -0.5320 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3240   -2.0110   -0.9510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1460   -4.1200    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3020   -2.0960    0.9570 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 22  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
clomipramine

> <PRIMARY_SOM>
21 20

> <SECONDARY_SOM>
2

>  <Citation>
Nielsen et al.,J. Pharm. Exp. Ther.,277,1659,1996

$$$$
clopidogrel
  MOE2008           3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    1.0800    0.5470    1.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5140    0.7390    2.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1410   -0.4490    3.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4570   -1.7960    2.1930 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000   -0.7920    0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6670   -1.3110   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8940   -0.1450   -1.2510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5030    1.0160   -0.5910 N   0  0  3  0  0  0  0  0  0  0  0  0
    2.8700    2.0010   -1.6110 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.9520    2.9550   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5730    1.6000    0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2270    2.8690   -1.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6060    1.6760   -2.9660 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.2350    3.7580   -1.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9790    4.7450   -0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7170    4.8440    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7120    3.9550   -0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    2.6380   -2.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8490    3.3520   -1.8210 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7480    2.2880   -3.6510 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6710    2.8660   -4.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 18  1  0  0  0  0
 10 12  1  0  0  0  0
 10 17  2  0  0  0  0
 12 13  1  0  0  0  0
 12 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
clopidogrel

> <PRIMARY_SOM>
3

>  <Citation>
Dansette et al.,Chem. Res. Toxicol.,22,369,2009

>  <DOI>
10.1021/tx8004828

$$$$
clotiazepam
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.2680    0.9740    1.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6310    1.9650    2.8520 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0120    1.4890    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0050    2.9330   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3550    0.6300   -0.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3970   -0.7450   -0.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1040   -1.2620    0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2240   -0.4040    1.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2750    3.6420    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4150    4.9500    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4530    5.9010    0.8000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7120    7.0260    1.6700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8390    5.8120    0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7740    6.5090    0.6910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0120    4.8820   -0.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980    3.4920   -0.4500 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5600    3.0550   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6080    3.8920    0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0590    3.6220    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5510    3.8140   -1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0540    5.3920    0.6900 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  8  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  2  0  0  0  0
  4  9  1  0  0  0  0
  4 16  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  9 10  2  0  0  0  0
  9 17  1  0  0  0  0
 10 11  1  0  0  0  0
 10 21  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 13 14  2  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 18 21  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
clotiazepam

> <PRIMARY_SOM>
12 19

>  <Citation>
Mandrioli et al.,Curr. Drug Metab.,9,827,2008
Niwa et al.,Biol. Pharm. Bull.,28,1711,2005

$$$$
clozapine
  MOE2008           3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -1.5480   -0.4800   -0.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680   -1.2720    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8910   -0.9720    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2150    0.1130   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2140    0.9140   -1.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8860    0.6330   -0.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8880    1.4970   -1.4680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    2.1480   -0.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0210    3.5320   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7710    4.1750    0.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5200    3.4400    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4970    2.0600    1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7150    1.3990    0.3440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7480   -0.0690    0.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2520   -0.8370    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9650   -0.6770    0.4640 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0760   -2.1420    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2120   -2.5950   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4510   -1.8980   -0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2630   -0.4760   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970    0.1160    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4970   -2.3930   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1510   -1.9620    0.7300 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 15  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 23  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  2  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 21  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 22  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
clozapine

> <PRIMARY_SOM>
22

> <SECONDARY_SOM>
19

>  <Citation>
Tugnait et al.,Chemico-Bio. Inter.,118,171,1999
Fang et al.,Naunyn-Schm. Arch. Pharma.,358,592,1998
	

>  <DOI>
10.1016/S009-2797(99)00006-X
10.1007/PL00005298

$$$$
coumarin
  MOE2008           3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.2980    0.6720    0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140    1.4020    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0950    0.7190   -0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -0.6730   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.3910   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980   -0.7140   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5580   -1.4270   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6970   -0.7450    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7300    0.7170    0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7950    1.3150    0.2970 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5080    1.3820    0.1950 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  END
>  <ID>
coumarin

> <PRIMARY_SOM>
7 8

>  <Citation>
Lewis et al.,Toxic.,20,256,2006

>  <DOI>
10.1016/.tiv.2005.08.001

$$$$
curcumin
  MOE2008           3D

 27 28  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3910    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5980    2.8730   -0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8260    1.9950   -0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8340    1.4890   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8480    2.8860   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6540    2.1560   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8590    1.5020   -0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0460    2.2040   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4950    2.4520   -0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3580    1.4630   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1680    2.0980    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2950    3.3270   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2370    2.4090   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3890    1.4110   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2620    3.6440   -0.0590 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0350    3.4190   -0.0380 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8110    0.5910   -0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2120   -0.6860   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5080    1.0350   -0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4000    0.0100   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0550    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6280    3.7610   -0.1290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1660   -0.6970    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1420    1.0580   -0.1420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8970    3.4500    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0470    5.0670   -0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0  0  0  0
  1 12  2  0  0  0  0
  1 22  1  0  0  0  0
  2  8  1  0  0  0  0
  2 13  2  0  0  0  0
  2 23  1  0  0  0  0
  3  5  2  0  0  0  0
  3 10  1  0  0  0  0
  4  6  2  0  0  0  0
  4  9  1  0  0  0  0
  5 14  1  0  0  0  0
  6 15  1  0  0  0  0
  7 19  2  0  0  0  0
  7 24  1  0  0  0  0
  8 18  2  0  0  0  0
  8 25  1  0  0  0  0
  9 11  1  0  0  0  0
  9 17  2  0  0  0  0
 10 11  1  0  0  0  0
 10 16  2  0  0  0  0
 12 15  1  0  0  0  0
 13 14  1  0  0  0  0
 14 20  2  0  0  0  0
 15 21  2  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
 22 26  1  0  0  0  0
 23 27  1  0  0  0  0
M  END
>  <ID>
curcumin

> <PRIMARY_SOM>
27 26

>  <Citation>
Sakano and Kawanishi,Arch. Biochem. Biophys.,405,223,2002

>  <DOI>
10.1016/S0003-9861(02)00302-8

$$$$
cyamemazine
  MOE2008           3D

 23 25  0  0  1  0  0  0  0  0999 V2000
   -3.3570    0.0250   10.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8590   -0.1810   10.5240 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.1610    0.6370    9.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3990    0.1090    8.1170 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.3150    0.8260    7.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8930    2.0180    7.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7980    2.7530    7.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1480    2.3060    5.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5880    1.1320    5.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6770    0.3920    6.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0430   -1.0890    5.2830 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8840   -1.6690    6.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6870   -1.0450    7.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2630   -1.6140    8.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9850   -2.7550    8.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7760   -3.3610    7.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1560   -2.8170    6.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9330   -3.2960    9.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7020   -3.7330    9.9360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2780    0.1980   11.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8250   -0.5700   12.9760 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4030   -1.9540   12.8410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2150   -0.0600   14.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2 20  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4 13  1  0  0  0  0
  5  6  1  0  0  0  0
  5 10  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 18  1  0  0  0  0
 16 17  1  0  0  0  0
 18 19  3  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 23  1  0  0  0  0
M  END
>  <ID>
cyamemazine

> <PRIMARY_SOM>
11 22 23

>  <Citation>
Arbus et al., European Journal of Pharmaceutical Sciences, 2007, 32, 357-366

>  <DOI>
10.1016/j.ejps.2007.09.003

$$$$
cyclobenzaprine
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    3.1200   -2.6170   -1.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260   -2.0650   -0.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8600   -2.1010   -0.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0830   -1.0150    0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6980   -1.0290   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -0.4930    0.5840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3590   -0.4270    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1800    1.0080   -0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6630    0.5680    1.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8710    1.6170    1.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9580    1.9800    0.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7530    1.3910   -1.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8230    3.3230    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6660   -1.1610    0.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8880    2.7230   -1.5160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0940    3.6820   -0.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0200   -0.5280    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0480   -1.2490   -0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3680   -0.6320    0.0680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3030   -1.3670   -0.7950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7700   -0.9050    1.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  2  4  2  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  6  2  0  0  0  0
  5  7  1  0  0  0  0
  6  9  1  0  0  0  0
  7  8  1  0  0  0  0
  7 14  2  0  0  0  0
  8 11  2  0  0  0  0
  8 12  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 13  1  0  0  0  0
 12 15  2  0  0  0  0
 13 16  2  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
cyclobenzaprine

> <PRIMARY_SOM>
21 20

>  <Citation>
Wang et al.,Drug Metab. Disp.,24,786,1996

$$$$
cyclohexylline
  MOE2008           2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.1660    1.4920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6510    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1660    0.1580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3820    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470    1.2380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3820    1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    2.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470   -1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4760   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4760   -1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4760    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  2 19  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6  7  1  0  0  0  0
  6 10  2  0  0  0  0
  7  8  1  0  0  0  0
  7 20  1  0  0  0  0
  8  9  1  0  0  0  0
  8 11  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 18  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
cyclohexylline

> <PRIMARY_SOM>
19

>  <Citation>
Jagdish K. Racha, Allan E. Rettie, and Kent L. Kunze, Biochemistry 1998, 37, 7407-7419

>  <DOI>
10.1021/bi973011m

$$$$
cyclophosphamide
  MOE2008           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
   -0.7780    0.0140   -0.1410 P   0  0  3  0  0  0  0  0  0  0  0  0
   -1.5870   -1.4430   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8170   -0.0400    0.3800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5790    1.0700    0.7120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7800    0.4520   -1.6500 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4060    1.2460   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5660   -1.1520   -0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6400    2.7520   -0.2330 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.4840   -1.8010    2.2750 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.9730   -1.2560   -0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6630   -0.1860    0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9450    1.1760    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6810   -2.3340    0.7690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8940    1.2600    0.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2 10  1  0  0  0  0
  3  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4 12  1  0  0  0  0
  6 14  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
  9 13  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
cyclophosphamide

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
7 6

>  <Citation>
Roy et al.,Drug Metab. Disp.,27,655,1999
Bohnenstengel et al.,Eur. J. Clin. Pharmacol.,51,297,1996

$$$$
dacarbazine
  MOE2008           2D

 13 13  0  0  0  0  0  0  0  0999 V2000
    1.4610   -1.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8740   -0.6440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3220   -0.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540   -1.1870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4930    0.7760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9100    1.3590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2900    0.9890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1470    0.0460    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8610   -0.3670    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5760    0.0460    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5760    0.8710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2900   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
dacarbazine

> <PRIMARY_SOM>
12 13

>  <Citation>
J. M. Reid, M. J. Kuffel, J. K. Miller, R. Rios, M. M. Ames, Clin. Cancer Res. 1999, 5, 2192-2197.

$$$$
ddb
  MOE2008           3D

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.7390   -0.0180   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4610    0.8220   -1.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8510    0.7830   -1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5250   -0.0920   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8210   -0.9290    0.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4250   -0.8980    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7390    0.0180   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4610   -0.8220   -1.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8510   -0.7830   -1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5250    0.0920   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8210    0.9290    0.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4250    0.8980    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0510    1.7520   -2.1240 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2070    2.5700   -2.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140    1.6900   -2.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0510   -1.7520   -2.1240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2070   -2.5710   -2.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3150   -1.6900   -2.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8850   -0.1230   -0.3620 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2770   -1.1040    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8850    0.1230   -0.3620 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2770    1.1040    0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6730   -1.7830    1.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6730    1.7840    1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5420   -1.7580    1.4070 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5420    1.7580    1.4070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    2.6230    2.2250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5920    3.4970    3.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3330   -2.6230    2.2260 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5920   -3.4970    3.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  2 13  1  0  0  0  0
  3  4  1  0  0  0  0
  3 15  1  0  0  0  0
  4  5  2  0  0  0  0
  4 19  1  0  0  0  0
  5  6  1  0  0  0  0
  6 23  1  0  0  0  0
  7  8  1  0  0  0  0
  7 12  2  0  0  0  0
  8  9  2  0  0  0  0
  8 16  1  0  0  0  0
  9 10  1  0  0  0  0
  9 18  1  0  0  0  0
 10 11  2  0  0  0  0
 10 21  1  0  0  0  0
 11 12  1  0  0  0  0
 12 24  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
 21 22  1  0  0  0  0
 23 25  2  0  0  0  0
 23 29  1  0  0  0  0
 24 26  2  0  0  0  0
 24 27  1  0  0  0  0
 27 28  1  0  0  0  0
 29 30  1  0  0  0  0
M  END
>  <ID>
ddb

> <PRIMARY_SOM>
26 28

>  <Citation>
Baek et al.,Drug Metab. Disp.,29,381,2001

$$$$
dehydropranidipine
  MOE2008           3D

 33 35  0  0  0  0  0  0  0  0999 V2000
    0.1370    1.6790    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5850    0.3310    0.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0420    2.7590   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2130    1.9540   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2500   -0.2090    1.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3700   -0.4350   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5860    4.0180   -0.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    2.5980    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5940    3.2480   -0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2480    0.9180   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6800   -1.4810    2.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8050   -1.7040   -0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    4.2720   -0.7220 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5100    5.1860   -0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5710    2.2420    1.5530 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3660    2.7790   -0.5460 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0140    3.5880   -0.9420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9810   -0.0160   -1.1590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030    0.9600    0.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4600   -2.2190    1.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3420   -1.9970    3.3060 N   0  3  0  0  0  0  0  0  0  0  0  0
    3.9170    1.9240    1.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9700   -1.0400   -1.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4170   -1.3280    4.2430 O   0  5  0  0  0  0  0  0  0  0  0  0
    0.7290   -3.2390    3.7650 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8670    0.8710    2.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4560   -0.3150    2.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4030   -1.3700    3.7870 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0330   -2.5790    3.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7430   -1.2260    5.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0050   -3.6310    4.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7130   -2.2750    5.9240 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3450   -3.4780    5.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 13  1  0  0  0  0
  9 17  1  0  0  0  0
 10 18  1  0  0  0  0
 10 19  2  0  0  0  0
 11 20  2  0  0  0  0
 11 21  1  0  0  0  0
 12 20  1  0  0  0  0
 15 22  1  0  0  0  0
 18 23  1  0  0  0  0
 21 24  1  0  0  0  0
 21 25  2  0  0  0  0
 22 26  1  0  0  0  0
 26 27  2  0  0  0  0
 27 28  1  0  0  0  0
 28 29  2  0  0  0  0
 28 30  1  0  0  0  0
 29 31  1  0  0  0  0
 30 32  2  0  0  0  0
 31 33  2  0  0  0  0
 32 33  1  0  0  0  0
M  CHG  1  21   1
M  CHG  1  24  -1
M  END
>  <ID>
dehydropranidipine

> <PRIMARY_SOM>
22

>  <Citation>
Kudo et al.,Drug Metab. Disp.,27,303,1999

$$$$
delta3_carene
  MOE2008           3D

 10 11  0  0  1  0  0  0  0  0999 V2000
    0.1120    1.2960   -0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2050   -0.0380   -0.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980   -0.8210    0.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3010   -0.0560    0.9880 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.2040    1.4460    1.0530 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.1120    2.1460    0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0090    2.0060   -1.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3640    0.7960    0.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4410    0.8650   -1.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6850    0.8530    1.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  1  7  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
M  END
>  <ID>
delta3_carene

> <PRIMARY_SOM>
1 2

>  <Citation>
Duisken et al.,Curr. Drug. Metab.,6,593,2005

>  <DOI>
10.2174/138920005774832614

$$$$
dexfenfluramine
  MOE2008           3D

 16 16  0  0  1  0  0  0  0  0999 V2000
    8.5610    0.1550    0.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1050    0.6400   -0.5540 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.6020   -0.0310    1.4540 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.8290    1.1770    1.1220 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.6220   -2.1950    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1320   -2.1730   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4500   -1.0520    0.7240 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.4890   -1.3250    2.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710   -0.9750    0.2640 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360    0.1920    0.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0100    0.2500    0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820   -3.4120   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3700   -1.0380    0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6720   -3.4750   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7630   -1.0900    0.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4080   -2.3160    0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1 15  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  2  0  0  0  0
  5 13  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  2  0  0  0  0
 14 16  2  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
dexfenfluramine

> <PRIMARY_SOM>
10

>  <Citation>
Haritos et al.,Pharmaco.,8,423,1998

$$$$
diMMAMC
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.7080    0.5750   -0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.8170   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4810    1.3260   -0.1220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9040    1.2870   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6080   -1.5040   -0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8920   -1.5020    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7190    0.6970   -0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1080    0.5910    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7180   -0.7650   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0990   -0.8040    0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7680    1.3290   -0.2230 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5920   -2.9990   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8740   -3.6780   -0.0350 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2410    1.3550    0.0910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4100    0.5470    0.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6240   -5.0540   -0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3500   -3.7160    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 12  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  2  0  0  0  0
  8 10  1  0  0  0  0
  8 14  1  0  0  0  0
 12 13  1  0  0  0  0
 13 16  1  0  0  0  0
 13 17  1  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
diMMAMC

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
17 16

>  <Citation>
J. Venhorst, R. C. A. Onderwater, J. H. N. Meerman, J. N. M. Commandeur, N. P. E. Vermeulen, Drug Metab. Dispos. 2000, 28, 1524-1532.

$$$$
diazinon
  MOE2008           3D

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.1120    1.8800    0.2270 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6470    0.6190    0.8930 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4640    1.2210   -0.3820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7740    2.1030   -1.1160 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3540    3.4620    1.3280 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1590   -0.0970    1.9520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080    0.0920   -1.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2940    3.0640   -2.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9650   -1.0970    2.3550 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0590    0.1820    2.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6810   -0.3870   -1.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    3.0950   -3.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5240   -1.8370    3.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3790   -2.9580    3.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7070   -2.4430    4.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5890   -3.9920    2.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4160   -0.6350    3.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7160   -0.4040    4.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6460   -1.6480    4.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
 10 17  2  0  0  0  0
 13 14  1  0  0  0  0
 13 19  2  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 17 18  1  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
diazinon

> <PRIMARY_SOM>
1 5

>  <Citation>
Mutch et al.,Toxicology,224,22,2006

>  <DOI>
10.1016/j.tox.2006.04.024

$$$$
dibenzo_a_h_anthracene
  MOE2008           3D

 22 26  0  0  0  0  0  0  0  0999 V2000
    2.4280    1.4740    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6500    0.7620    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6510   -0.6300    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520   -1.3350    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360   -0.6560    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -1.3850    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070   -0.7540    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4280   -1.4730    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6500   -0.7610   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6510    0.6310   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4520    1.3350   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    0.6570   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0470    1.3850   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070    0.7550    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8650    1.4450    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8930    2.8370    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7020    3.5540    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4850    2.8770    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8650   -1.4450   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8930   -2.8370   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7020   -3.5540    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4850   -2.8770    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 18  2  0  0  0  0
  2  3  1  0  0  0  0
  2 15  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  8  9  1  0  0  0  0
  8 22  2  0  0  0  0
  9 10  1  0  0  0  0
  9 19  2  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
dibenzo_a_h_anthracene

> <PRIMARY_SOM>
17 18 21 22

> <SECONDARY_SOM>
15 16 19 20

>  <Citation>
Shou, M.G.; Krausz, K.W.; Gonzalez, F.J.; Gelboin, H.V. Metabolic Activation of the Potent Carcinogen Dibenzo[a,h]Anthracene by cDNA-Expresed Human Cytochromes P450. Arch. Biochem. Biophys. 1996, 328, 201–207.

>  <DOI>
10.1006/abbi.1996.0161 

$$$$
dibenzo_a_l_pyrene
  MOE2008           3D

 24 29  0  0  0  0  0  0  0  0999 V2000
   -1.8990   -1.1580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8310   -2.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6090   -3.2180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680   -2.4910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7680   -3.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9800   -2.5170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9990   -1.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260   -0.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2750    0.9130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0900    1.6400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8300    1.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6280    1.7450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6200    1.0720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6880   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5450   -1.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.3940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9830   -3.3580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2430   -2.7730    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3520   -1.3910    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1960   -0.6100    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    1.8830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7320    3.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5070    3.9150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540    3.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 20  2  0  0  0  0
  2  3  1  0  0  0  0
  2 17  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  2  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 12 24  2  0  0  0  0
 13 14  1  0  0  0  0
 13 21  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 19 20  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  2  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
dibenzo_a_l_pyrene

> <PRIMARY_SOM>
8 17 18

> <SECONDARY_SOM>
5 6 19 20

>  <Citation>
Shou, M.; Krausz, K.W.; Gonzalez, F.J.; Gelboin, H.V. Metabolic Activation of the Potent Carcinogen Dibenzo[a,l ]pyrene by Human Recombinant Cytochromes P450, Lung and Liver Microsomes. Carcinogenesis 1996, 17, 2429–2433.

>  <DOI>
10.1093/carcin/17.11.2429

$$$$
diphenhydramine
  MOE2008           3D

 19 20  0  0  0  0  0  0  0  0999 V2000
    1.3570    0.6030   -0.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6490    0.9250    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6430    1.6800   -0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2240   -0.2260    0.8720 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4890    0.0400    2.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2200    0.2240    3.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5810   -1.0160    3.4760 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1160   -1.7400    2.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4010   -0.6540    4.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2150    1.3290   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0060    1.0520   -0.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    0.0480   -1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.6810   -1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2610   -0.4050   -1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3960    1.0590   -1.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3110    1.7920   -2.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4780    3.1530   -2.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7310    3.7800   -1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8160    3.0450   -0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  1  0  0  0  0
  1 14  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3 15  1  0  0  0  0
  3 19  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7  9  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
diphenhydramine

> <PRIMARY_SOM>
8 9

>  <Citation>
Tomoko Akutsu, Kaoru Kobayashi, Koichi Sakurada, Hiroshi Ikegaya, Tomomi Furihata, and Kan Chiba, Identification of Human Cytochrome P450 Isozymes Involved in Diphenhydramine N-Demethylation, DRUG METABOLISM AND DISPOSITION, 35:72–78, 2007

>  <DOI>
10.1124/dmd.106.012088

$$$$
diuron
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.8090   -2.6710   -0.0070 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4870   -4.5490    0.0090 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.1380    1.7270    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6970    3.5060   -0.0110 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8440    1.3530   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7950   -0.0450   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9820    2.1470   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5340   -0.6380   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9330   -0.8470    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    4.0370   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7780    4.4530   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4070   -2.0260   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8110   -2.2340    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -2.8280    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0  0  0  0
  2 14  1  0  0  0  0
  3  7  2  0  0  0  0
  4  7  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  6  9  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
diuron

> <PRIMARY_SOM>
10 11

>  <Citation>
Abass et al.,Drug Metab. Disp.,35,1634,2007

>  <DOI>
10.1124/dmd.107.016295

$$$$
domperidone
  MOE2008           3D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -0.1950    1.4340   -0.2610 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0700    0.0850    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8550    2.3930   -0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4820    1.6600   -0.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660   -0.5470   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9910   -0.5980    0.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3220    3.0320   -1.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4990    3.4390    0.9760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1530    0.3960   -0.7970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9400    2.7190   -1.2070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720   -1.8920   -0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8090   -1.9660    0.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4280    4.0300   -1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6400    4.4190    1.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4050   -2.5960    0.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0530    5.0410   -0.0920 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5730   -4.2810    0.7980 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.2350    5.8540    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9740    7.0210    1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2710    7.7710    1.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1230    8.8710    2.1850 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7490    8.9400    3.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3340   10.0270    1.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3610   10.1310    4.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6050    8.0520    4.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4900   10.8220    3.1750 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6590   10.3080    1.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8050   10.5040    5.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0690    8.4110    5.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6750    9.6180    5.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  2  0  0  0  0
  5  9  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 11 15  2  0  0  0  0
 12 15  1  0  0  0  0
 13 16  1  0  0  0  0
 14 16  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 24  2  0  0  0  0
 22 25  1  0  0  0  0
 23 26  1  0  0  0  0
 23 27  2  0  0  0  0
 24 26  1  0  0  0  0
 24 28  1  0  0  0  0
 25 29  2  0  0  0  0
 28 30  2  0  0  0  0
 29 30  1  0  0  0  0
M  END
>  <ID>
domperidone

> <PRIMARY_SOM>
30

>  <Citation>
Ward et al.,Br. J. Clin. Pharm.,58,277,2004

>  <DOI>
10.111/j.1365-2125.2004.02156.x

$$$$
doxepin
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.1050    1.5550    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0160    0.0620    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3570    2.3360    0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690    2.2060   -0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0390   -0.7910    0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2270   -0.5390   -0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3820    1.9120    1.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5600    3.5380   -0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3810    3.6550   -0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3920   -0.2940    0.7730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8680   -2.1810    0.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3970   -1.9220   -0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3020    0.7290    1.7600 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5260    2.6850    1.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7080    4.3080   -0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0740    4.0530   -1.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -2.7460   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6880    3.8840    0.5990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3970    5.4710   -1.3660 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9570    5.7620   -2.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4500    5.7220   -0.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 16  1  0  0  0  0
 10 13  1  0  0  0  0
 11 17  2  0  0  0  0
 12 17  1  0  0  0  0
 14 18  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
doxepin

> <PRIMARY_SOM>
21 20

>  <Citation>
Hartter et al.,Pharma. Res.,19,1034,2002

>  <DOI>
10.1023/A:1016478708902

$$$$
dy_9760e
  MOE2008           3D

 35 39  0  0  0  0  0  0  0  0999 V2000
   -0.0480    1.4150    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0290    0.0230    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760   -0.6480    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3820    0.0600    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3810    1.4360    0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1630    2.1310    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0550    2.3480   -0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8280    3.5070    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4690    3.6190   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4920    2.0630   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0090    1.9840    1.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5350    1.1880    2.3610 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2180    1.3880    3.4550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1580    2.3270    3.2120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0250    2.7050    1.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8090    4.6510    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1600    5.0180   -1.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1160    6.1330   -1.4360 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3630    5.6210   -0.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7870    4.3480   -1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0680    4.6590   -2.9960 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8210    5.1710   -3.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3970    6.4440   -2.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3360    3.4440   -3.6300 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5660    3.2330   -4.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8300    2.0270   -4.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8700    1.0300   -4.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6450    1.2380   -4.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3750    2.4400   -3.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3670    1.7630   -5.6240 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.6110    4.3190   -4.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5620   -0.6150    0.1010 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1920   -2.0080    0.0900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1720   -2.4360    0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6000    0.3680    0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 33  1  0  0  0  0
  4  5  2  0  0  0  0
  4 32  1  0  0  0  0
  5  6  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8  9  2  0  0  0  0
  8 16  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 15  2  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 23  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 24  1  0  0  0  0
 22 23  1  0  0  0  0
 24 25  1  0  0  0  0
 24 29  2  0  0  0  0
 25 26  2  0  0  0  0
 25 31  1  0  0  0  0
 26 27  1  0  0  0  0
 26 30  1  0  0  0  0
 27 28  2  0  0  0  0
 28 29  1  0  0  0  0
 32 35  1  0  0  0  0
 33 34  1  0  0  0  0
M  END
>  <ID>
dy_9760e

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
13

> <TERTIARY_SOM>
27

>  <Citation>
Tachibana et al.,Drug Metab. Disp.,33,1628,2005

>  <DOI>
10.1124/dmd.105.004903

$$$$
efavirenz
  MOE2008           3D

 21 23  0  0  1  0  0  0  0  0999 V2000
   -1.8520   -4.1700   -0.4700 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6250   -0.2560   -2.3270 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430    1.3560   -2.2090 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    1.7930   -1.9570 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0150    1.9860    0.3760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180    3.6190    1.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2210    1.5290    1.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.7470    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -0.3270    0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5280   -1.7350    0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840    0.6660   -0.2070 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5030   -0.2520    0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9490   -0.2940    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4630    0.1600    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190    0.1810    0.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3160    0.8970   -1.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8810   -1.6530   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030   -0.6710    0.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1970    2.4430    0.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9570   -2.5080   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1180   -2.0170    0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 20  1  0  0  0  0
  2 16  1  0  0  0  0
  3 16  1  0  0  0  0
  4 16  1  0  0  0  0
  5 11  1  0  0  0  0
  5 19  1  0  0  0  0
  6 19  2  0  0  0  0
  7 15  1  0  0  0  0
  7 19  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 11 16  1  0  0  0  0
 12 14  3  0  0  0  0
 13 15  2  0  0  0  0
 13 17  1  0  0  0  0
 15 18  1  0  0  0  0
 17 20  2  0  0  0  0
 18 21  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
efavirenz

> <PRIMARY_SOM>
18

>  <Citation>
Ward et al., J. Pharm. Exp. Ther., 2003, 306, 287-300

>  <DOI>
10.1124/jpet.103.049601

$$$$
eletriptan
  MOE2008           3D

 27 30  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.5080    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.2890    1.9660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0740    2.4000    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6690   -0.5540    1.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4950   -0.3700   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2040    0.9130   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5250    3.3430    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8320    3.7610    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7480   -2.0790    1.1740 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.4690    4.2290    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9840    4.7320    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6620   -2.4850    0.0850 N   0  0  3  0  0  0  0  0  0  0  0  0
   -1.3820   -2.6620    2.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3550    5.0540    1.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4030   -3.6840    0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8170   -2.8950   -1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9390   -4.0170    1.9500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7410    6.2230    1.5290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0250    6.4730    3.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3460    7.5130    1.0840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9490    5.6120    1.0960 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650    7.4860    3.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9120    5.6590    3.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5870    7.6820    5.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1350    5.8550    5.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4700    6.8650    5.9500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  1  0  0  0  0
  6  7  1  0  0  0  0
  8 11  2  0  0  0  0
  9 11  1  0  0  0  0
  9 12  1  0  0  0  0
 10 13  1  0  0  0  0
 10 14  1  0  0  0  0
 12 15  1  0  0  0  0
 13 16  1  0  0  0  0
 13 17  1  0  0  0  0
 14 18  1  0  0  0  0
 15 19  1  0  0  0  0
 16 18  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 19 22  2  0  0  0  0
 20 23  2  0  0  0  0
 20 24  1  0  0  0  0
 23 25  1  0  0  0  0
 24 26  2  0  0  0  0
 25 27  2  0  0  0  0
 26 27  1  0  0  0  0
M  END
>  <ID>
eletriptan

> <PRIMARY_SOM>
17

>  <Citation>
Evans et al.,Drug Metab. Dispos.,31,861,2003

>  <DOI>
10.1124/dmd.31.7.861

$$$$
ellipticine
  MOE2008           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4090    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3940    1.8430   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2130    2.1020    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1840   -0.7140    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3240   -0.4180   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1720    0.6770   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0090    3.0920   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4210    1.3930    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.6080    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4020   -0.0290    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1630   -2.2200    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5590    0.7840   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850    3.1780   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6640    2.0490    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6370   -0.7080    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1560    2.0260   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7730    1.3480    0.0340 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7850    0.0210    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6  7  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 11  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 19  2  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
ellipticine

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
12

> <TERTIARY_SOM>
13

>  <Citation>
M. Stiborova et al., Cancer Research, 2004, 64, 8374-8380

$$$$
estradiol
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   10.3770    3.0490   -0.3030 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -2.8320    0.5680 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5030    1.5170    0.0820 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4850    0.0120    0.1280 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.2390   -0.7070    0.4930 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.0790   -0.1380   -0.3080 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.8620    1.7620   -0.5710 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.3360    2.0280   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8500   -0.5390   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0140    1.3800   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7010    0.6920    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3070   -2.2050    0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4110    2.0860    1.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7840   -0.8400   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0450   -2.8500    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7810   -2.1450    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5660   -0.2330   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5710   -2.8090    0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3590   -0.8960   -0.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -2.1780    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0  0  0  0
  2 20  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3 13  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6 10  1  0  0  0  0
  6 14  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
estradiol

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
18

> <TERTIARY_SOM>
11 15

>  <Citation>
Lee et al.,Endocrinology,144,3382,2003

>  <DOI>
10.1210/en.2003-0192

$$$$
estrone
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   10.3430    2.8640   -0.8390 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2420   -2.8500    0.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470    1.6130    0.0460 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4750    0.1110    0.1180 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.2310   -0.5980    0.5090 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.1380   -0.1490   -0.4530 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.9000    1.8650   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4060    2.0270   -0.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8390   -0.4260   -0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0590    1.3520   -0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7380    0.7270    0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3360   -2.1040    0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1540    2.2190    1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8350   -0.8490   -0.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0420   -2.7180    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8060   -2.0900    0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6420   -0.3100   -0.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5930   -2.7560    0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4320   -0.9770   -0.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4230   -2.1930    0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  2  0  0  0  0
  2 20  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3 13  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6 10  1  0  0  0  0
  6 14  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
estrone

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
18

>  <Citation>
Lee et al.,Endocrinology,114,3382,2003

>  <DOI>
10.1210/en.2003-0192

$$$$
ethanol
  MOE2008           3D

  3  2  0  0  0  0  0  0  0  0999 V2000
    2.7320    0.2590   -0.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2400    0.2630   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6970   -0.0840    1.0520 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
M  END
>  <ID>
ethanol

> <PRIMARY_SOM>
2

>  <Citation>
Salmela et al.,Alcohol Clin. Exp. Res.,22,2125,1998

$$$$
ethinylestradiol
  MOE2008           3D

 22 25  0  0  1  0  0  0  0  0999 V2000
   12.3930    0.2340   -2.5470 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1210    0.2370   -2.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8840   -0.2530   -0.7800 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5840   -0.2510   -0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3650   -0.8060    1.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0140   -0.4570    1.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9250   -0.6780    0.6700 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.5490   -0.4310    1.2170 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.0680   -1.1790    2.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6920   -0.5240    2.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1690   -0.7030    1.0450 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.4450   -1.9240    0.9950 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2760    0.4100    0.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5400    1.3190    0.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4660   -0.7650    0.1890 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.6130    0.2270   -0.9530 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0180    0.2330   -1.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1320    0.2650   -0.5080 C   0  0  2  0  0  0  0  0  0  0  0  0
    8.5230    0.2320   -1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7940    0.7290   -2.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0910    0.7310   -2.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6750   -2.1660   -0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2 21  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4 19  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 18  1  0  0  0  0
  8  9  1  0  0  0  0
  8 15  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 15  1  0  0  0  0
 13 14  3  0  0  0  0
 15 16  1  0  0  0  0
 15 22  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
ethinylestradiol

> <PRIMARY_SOM>
21

>  <Citation>
Wang et al., Drug Metab. Dispos. 2004, 32, 1209-1212

>  <DOI>
10.1124/dmd.104.000182

$$$$
etoposide
  MOE2008           3D

 42 48  0  0  1  0  0  0  0  0999 V2000
    0.7860    1.3680    0.9400 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.1160    0.0280    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0770    1.9800    1.4420 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.1640    1.1670    2.0930 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2980   -0.6390    0.5480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1480   -0.5020   -0.5480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7160    0.9200    2.3960 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.9520    3.1680    2.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1000    0.0080    2.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0930    2.1440    2.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3650   -0.1070    1.4880 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.5730   -1.8640   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4120   -1.7200   -1.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6900    1.8450    3.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9170    3.0860    3.2940 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1310    4.0490    2.2510 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9730   -0.1820    3.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9680    1.9620    3.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8970   -1.1780    2.2710 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6180   -2.3960   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3360   -2.4530   -2.0080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9110    0.7950    4.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9100   -1.3230    4.6420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8800    2.9240    3.7620 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3200   -1.1080    2.1540 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.6210   -3.5460   -1.6230 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2450   -3.7740   -1.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7690    0.6130    5.2540 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400   -2.1170    4.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6910    3.9830    2.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7850    0.1050    2.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9460   -2.3130    2.8580 C   0  0  3  0  0  0  0  0  0  0  0  0
    7.1750    0.2100    2.4520 C   0  0  3  0  0  0  0  0  0  0  0  0
    7.4720   -2.2460    2.7170 C   0  0  3  0  0  0  0  0  0  0  0  0
    5.5930   -2.2920    4.2430 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9410   -0.8760    3.2160 C   0  0  3  0  0  0  0  0  0  0  0  0
    7.7110    1.5780    2.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0740   -3.2770    3.5030 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3380   -0.7130    2.9780 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1260    1.6030    2.6730 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6950    0.5750    3.4790 C   0  0  3  0  0  0  0  0  0  0  0  0
    9.1830    0.7180    4.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 11  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 17  1  0  0  0  0
 10 18  2  0  0  0  0
 11 19  1  0  0  0  0
 12 20  2  0  0  0  0
 13 20  1  0  0  0  0
 13 21  1  0  0  0  0
 14 15  1  0  0  0  0
 17 22  2  0  0  0  0
 17 23  1  0  0  0  0
 18 22  1  0  0  0  0
 18 24  1  0  0  0  0
 19 25  1  0  0  0  0
 20 26  1  0  0  0  0
 21 27  1  0  0  0  0
 22 28  1  0  0  0  0
 23 29  1  0  0  0  0
 24 30  1  0  0  0  0
 25 31  1  0  0  0  0
 25 32  1  0  0  0  0
 26 27  1  0  0  0  0
 31 33  1  0  0  0  0
 32 34  1  0  0  0  0
 32 35  1  0  0  0  0
 33 36  1  0  0  0  0
 33 37  1  0  0  0  0
 34 36  1  0  0  0  0
 34 38  1  0  0  0  0
 36 39  1  0  0  0  0
 37 40  1  0  0  0  0
 39 41  1  0  0  0  0
 40 41  1  0  0  0  0
 41 42  1  0  0  0  0
M  END
>  <ID>
etoposide

> <PRIMARY_SOM>
30 29

>  <Citation>
Kawashiro, T.; Yamashita, K.; Zhao, X.J.; Koyama, E.; Tani, M.; Chiba, K.; Ishizaki, T. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Liver Microsomes. J. Pharmacol. Exp. Ther. 1998, 286, 1294–1300.

$$$$
eugenol
  MOE2008           3D

 12 12  0  0  0  0  0  0  0  0999 V2000
   -0.0380    1.3680    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150   -0.0260    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    2.0820    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0810    0.1110 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410   -0.6930   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3900    1.4320    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1560    3.4460    0.0850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3410    1.2250    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4280    0.0410   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2830   -2.1840   -0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2260   -2.7420   -1.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1880   -3.5230   -1.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  5 10  1  0  0  0  0
  6  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
M  END
>  <ID>
eugenol

> <PRIMARY_SOM>
8

>  <Citation>
Sakano et al.,Mutation Res.,565,35,2004

>  <DOI>
10.1016/j.mrgentox.2004.08.009

$$$$
eupatilin
  MOE2008           3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    1.2530    0.5380    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800    1.3020    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3240    2.6110    0.6240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8240    3.4440    0.5940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1530    0.6790    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3110    1.4060    0.1580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4640    0.6130   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1700   -0.6850   -0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0070   -1.4270   -0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430   -0.8260   -0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000   -1.5870   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4920   -2.8910   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7610   -3.6290   -0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7640   -4.8230   -0.7810 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9880   -2.8610   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8560   -1.5040    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6480   -0.8560    0.1060 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2640   -3.4330   -0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4300   -4.7610   -0.5460 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4050   -2.6590   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6140   -3.3020   -0.0350 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5670   -2.5390   -0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2430   -1.3100    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3050   -0.5160    0.6240 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9800   -0.7290    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  2  0  0  0  0
  3  4  1  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 11 17  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 18  2  0  0  0  0
 16 17  1  0  0  0  0
 16 25  2  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 20 21  1  0  0  0  0
 20 23  2  0  0  0  0
 21 22  1  0  0  0  0
 23 24  1  0  0  0  0
 23 25  1  0  0  0  0
M  END
>  <ID>
eupatilin

> <PRIMARY_SOM>
7

>  <Citation>
H. S. LEE, H. Y. JI, E. J. PARK, & S. Y. KIM, Xenobiotica, August 2007; 37(8): 803–817

>  <DOI>
10.1080/00498250701534877

$$$$
fenproporex
  MOE2008           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690    2.2100    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2250    2.1780    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.1500    3.5920    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2440    3.5600    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310   -0.1540    2.1120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1690   -2.0450    1.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0560    4.2670    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9420   -0.1080    3.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2130    0.2720    4.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9230    0.3170    5.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    0.3530    6.8710 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  7  2  0  0  0  0
  5  8  1  0  0  0  0
  5  9  1  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  3  0  0  0  0
M  END
>  <ID>
fenproporex

> <PRIMARY_SOM>
11

>  <Citation>
Kraemer et al.,Biochem Pharm.,68,947,2004

>  <DOI>
10.1016/j.bcp.2004.05.009

$$$$
flunitrazepam
  MOE2008           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -1.6350   -1.0740    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340   -1.6420   -1.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7690   -2.8630   -1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7050   -3.5150   -0.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1100   -2.9490    0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5760   -1.7290    0.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0760    0.2440    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9190    1.1410    0.7990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3590    2.4140    1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9290    3.1980    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2820    2.7990   -0.5340 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3990    0.4450    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920    1.6160   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3810    1.6130   -0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1790    0.5170   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -0.6080    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1990   -0.6590    0.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850   -1.7650    0.7750 N   0  3  0  0  0  0  0  0  0  0  0  0
   -2.9600   -1.2200    1.9890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5750    4.1670   -0.3870 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8720    3.6890   -1.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6090   -1.6800    0.6050 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7990   -2.7650    1.2110 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6 19  1  0  0  0  0
  7  8  2  0  0  0  0
  7 12  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 20  2  0  0  0  0
 11 13  1  0  0  0  0
 11 21  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 22  2  0  0  0  0
 18 23  1  0  0  0  0
M  CHG  1  18   1
M  CHG  1  23  -1
M  END
>  <ID>
flunitrazepam

> <PRIMARY_SOM>
21

>  <Citation>
Hesse et al.,Drug Metab. Disp.,29,133,2001

$$$$
fluoxetine
  MOE2008           3D

 22 23  0  0  1  0  0  0  0  0999 V2000
   -0.2060    1.3430    0.2870 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.2290   -0.0220   -0.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420    1.8010    0.3590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0990    2.3110   -0.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4810   -1.1230    0.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0090   -0.2240   -1.6910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4980    2.1370    1.6380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3470    3.3170   -1.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5000   -2.4100   -0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0100   -1.5100   -2.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6480    2.0430    2.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    2.6010    1.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3240    4.1690   -1.9560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2650   -2.6020   -1.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    2.4070    4.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2510    2.9650    3.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5900    5.0980   -2.7960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4080    2.8630    4.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8860    3.2740    5.5400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2270    3.1010    5.7110 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.6440    4.5890    5.8010 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2960    2.5780    6.5510 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  1  0  0  0  0
  6 10  2  0  0  0  0
  7 11  2  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 14  2  0  0  0  0
 10 14  1  0  0  0  0
 11 15  1  0  0  0  0
 12 16  2  0  0  0  0
 13 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 19 22  1  0  0  0  0
M  END
>  <ID>
fluoxetine

> <PRIMARY_SOM>
17

>  <Citation>
Mandrioli et al.,Curr. Drug Metab.,7,127,2006

>  <DOI>
10.2174/138920006775541561

$$$$
flutamide
  MOE2008           3D

 19 19  0  0  0  0  0  0  0  0999 V2000
   -4.6060    1.0480    0.8830 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4390    2.8400    0.5470 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3030    1.7930   -1.1450 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3990    1.9390   -0.2850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5350   -1.0480   -1.0260 O   0  5  0  0  0  0  0  0  0  0  0  0
   -3.7630   -2.3590    0.5660 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1780    1.4490   -0.1840 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6730   -1.4010   -0.2120 N   0  3  0  0  0  0  0  0  0  0  0  0
    2.8270   -0.3800   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.6950   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5060    1.0910   -0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4420    0.7620   -0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990    1.4070   -0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1990   -0.6820   -0.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7900   -0.7710    1.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4430   -0.6350   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0380   -0.6920   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570   -1.3650   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6830    1.5960    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 19  1  0  0  0  0
  2 19  1  0  0  0  0
  3 19  1  0  0  0  0
  4 11  2  0  0  0  0
  5  8  1  0  0  0  0
  6  8  2  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 16  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
  9 15  1  0  0  0  0
 10 13  1  0  0  0  0
 10 17  2  0  0  0  0
 12 13  2  0  0  0  0
 12 16  1  0  0  0  0
 12 19  1  0  0  0  0
 16 18  2  0  0  0  0
 17 18  1  0  0  0  0
M  CHG  1   5  -1
M  CHG  1   8   1
M  END
>  <ID>
flutamide

> <PRIMARY_SOM>
9

>  <Citation>
M. S. Shet, M. Mcphaul, C. W. Fisher, N. R. Stallings, R. W. Estabrook, Drug Metab. Dispos. 1997, 25, 1298-1303.

$$$$
fluvoxamine
  MOE2008           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
    5.1090   -5.1020    2.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4400   -5.2850    1.3820 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3610   -4.8200    0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2530   -3.3090    0.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4560   -2.5040    0.9280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7050   -2.8610    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0430   -1.7440   -0.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6350   -0.6480   -0.4340 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9180   -0.6740    0.9360 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5830    0.5450    1.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7270    0.6870    2.7380 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7400   -0.2220    3.2470 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6680   -1.9360   -2.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9090   -0.9160   -3.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5610   -1.0880   -4.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9670   -2.2770   -4.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7370   -3.2970   -3.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0840   -3.1290   -2.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6120   -2.4550   -6.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7090   -2.6380   -7.1450 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.8050   -3.5270   -6.5900 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.9550   -1.3800   -6.8770 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7 13  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 13 14  1  0  0  0  0
 13 18  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 16 19  1  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 19 22  1  0  0  0  0
M  END
>  <ID>
fluvoxamine

> <PRIMARY_SOM>
10 11

>  <Citation>
Spigset et al., Pharmacokinetics and disposition, 2001, 57, 653-658

>  <DOI>
10.1007/s002280100373

$$$$
formononetin
  MOE2008           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0180    1.2780    0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0750    0.0550   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    1.8840    0.7740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1360    1.9340    0.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1540   -0.6250   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3200   -0.5270   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3560    1.2390    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3710    1.3470    0.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4410    0.0630   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4780    0.1250    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0810   -1.7050   -1.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5050    1.9850    1.0920 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7690   -0.4620   -0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9390    0.2020   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2000   -0.2870   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3150   -1.4580   -1.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1630   -2.1330   -1.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9070   -1.6360   -1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5870   -1.8650   -1.6370 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5840   -3.0690   -2.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 11  2  0  0  0  0
  6 10  2  0  0  0  0
  7  9  2  0  0  0  0
  8 10  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 18  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 16 19  1  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
formononetin

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
20

> <TERTIARY_SOM>
4 15 17

>  <Citation>
Tollesen et al.,J. Agric. Food Chem.,50,4783,2002

>  <DOI>
10.1021/jf025549r

$$$$
foxy
  MOE2008           3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.1240    1.4920    0.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -0.0260    0.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5650    1.9310    0.2950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3370   -0.4730    0.2090 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5120    1.9500   -0.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2210    2.3850    1.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7240    2.4330   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    1.6070   -2.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5130    2.6880    1.0420 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8290    2.5640   -1.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5320    1.7450   -2.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7310    2.2230   -2.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950   -1.9240   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1910   -0.0780    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3550   -0.0360    2.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7820    1.3070    1.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9910   -2.6520    1.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8200   -2.3250   -0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4530    1.4120   -4.3020 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6360    1.5790   -5.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  2  0  0  0  0
  4 13  1  0  0  0  0
  4 14  1  0  0  0  0
  5  7  2  0  0  0  0
  5  8  1  0  0  0  0
  6  9  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  2  0  0  0  0
 10 12  2  0  0  0  0
 11 12  1  0  0  0  0
 11 19  1  0  0  0  0
 13 17  1  0  0  0  0
 13 18  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
foxy

> <PRIMARY_SOM>
13 14

>  <Citation>
Narimatsu et al.,Biochem. Pharmacol.,71,1377,2006

>  <DOI>
10.1016/j.bcp.2006.01.015

$$$$
furafylline
  MOE2008           2D

 19 21  0  0  0  0  0  0  0  0999 V2000
    1.1050    1.3700    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1050    0.0350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3200    0.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940   -0.1230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090    0.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090    1.1150    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940    1.5270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3200    1.1150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8230   -0.1230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940    2.3520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4150    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8230    1.5270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940   -0.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8630   -1.0250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090   -1.3600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1950   -2.1810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0020   -2.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4150   -1.6380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  2 12  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  1  0  0  0  0
  5 14  1  0  0  0  0
  6  7  1  0  0  0  0
  6 10  2  0  0  0  0
  7  8  1  0  0  0  0
  7 13  1  0  0  0  0
  8  9  1  0  0  0  0
  8 11  2  0  0  0  0
 14 16  1  0  0  0  0
 15 16  1  0  0  0  0
 15 19  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
M  END
>  <ID>
furafylline

> <PRIMARY_SOM>
12

>  <Citation>
Jagdish K. Racha, Allan E. Rettie, and Kent L. Kunze, Biochemistry 1998, 37, 7407-7419

$$$$
furametpyr
  MOE2008           3D

 23 25  0  0  1  0  0  0  0  0999 V2000
    0.6810   -0.4110   -0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2190    0.6460   -0.7010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4870    1.8350   -0.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7530    1.4620   -1.3430 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8660    0.1520   -1.3080 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1020   -0.6560   -1.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5880    0.6320   -0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090    1.4080   -0.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9190   -0.1880    0.7290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0730   -0.6380    1.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9020   -1.2260    2.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9590   -1.7470    3.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2720   -1.6660    2.7860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4430   -1.1140    1.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3940   -0.6300    0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4360   -2.1060   -0.8130 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -6.7450   -0.9260    0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9900   -0.2140   -0.5990 C   0  0  3  0  0  0  0  0  0  0  0  0
   -7.4920    0.3150    1.2980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6380   -2.1800    0.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2690   -0.8360   -1.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3400   -0.7260   -0.5810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0420    3.2640   -0.8390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  5  1  0  0  0  0
  1 16  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  1  0  0  0  0
  3  4  2  0  0  0  0
  3 23  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 17 19  1  0  0  0  0
 17 20  1  0  0  0  0
 17 22  1  0  0  0  0
 18 21  1  0  0  0  0
 18 22  1  0  0  0  0
M  END
>  <ID>
furametpyr

> <PRIMARY_SOM>
6

>  <Citation>
H. Nagahori, H. Yoshino, Y. Tomigahara, N. Isobe, H. Kaneko, I. Nakatsuka, J. Agric. Food Chem. 2000, 48, 5754-5759.

$$$$
galangin
  MOE2008           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
   -0.0370    1.4010    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0570    0.0250    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060    2.1470   -0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.0100    0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430   -0.6590    0.1950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0860   -0.7350    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4610    1.3680   -0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060    3.3570   -0.4370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4420    1.2620    0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4580    3.3500   -0.1240 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4170    0.0450   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3230   -0.1060    0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6190    2.0610   -0.5180 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6110   -0.8160   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4400   -0.8460    0.7540 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8340   -0.3860    0.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5260   -2.1220   -0.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9450   -1.2270    0.5110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6330   -2.9690   -0.5110 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8440   -2.5190    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  2  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 11  2  0  0  0  0
  7 13  1  0  0  0  0
  9 12  1  0  0  0  0
 11 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
galangin

> <PRIMARY_SOM>
20

>  <Citation>
Y. Otake, T. Walle, Drug Metab. Dispos. 2002, 30, 103-105.

>  <DOI>
10.1124/dmd.30.2.103

$$$$
guanabenz
  MOE2008           2D

 14 14  0  0  0  0  0  0  0  0999 V2000
    1.0720   -0.4120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010   -0.4120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.2380    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.2380    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  5  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 12  2  0  0  0  0
  8  9  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
guanabenz

> <PRIMARY_SOM>
3 4

>  <Citation>
Bernd Clement and Mark Demesmaeker Formation of Guanoxabenz from Guanabenz in Human Liver A new metabolic marker for CYP1A2 Drug Metab. Dispos. 1997   vol. 25  no. 11  1266-1271 

$$$$
h259_31
  MOE2008           3D

 24 27  0  0  1  0  0  0  0  0999 V2000
    5.2040   -1.8460    0.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4720   -1.3300    0.6920 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7270    0.0070    0.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7170    0.8340   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4260    0.3250   -0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1750   -1.0290    0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9750    0.4990    0.5710 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.8330   -1.2300   -0.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3220   -0.0420   -0.5970 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2500    0.8690   -0.6000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6420    0.2270   -1.0570 S   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0520    0.7050    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2540   -1.1060   -1.3630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5230    0.9910    0.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4370   -0.0290    0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7940    0.2470    0.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1740    1.5510    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1990    2.5160   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9220    2.2160    0.1100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7240   -0.7300    0.5720 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0000   -0.1230    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0980   -1.1760    0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5470   -0.7210    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8700   -1.5890   -0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 10  1  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  2  0  0  0  0
 12 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 19  2  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 16 20  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 22 24  1  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
h259_31

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
2 21

>  <Citation>
Abelo, Angela; Andersson, Tommy B.; Bredberg, Ulf; Skanberg, Inger; Weidolf, Lars Stereoselective Metabolism by Human Liver CYP Enzymes of a Substituted Benzimidazole. Drug Metab. Dispos. 2000, 28, 58–64.

$$$$
halothane
  MOE2008           3D

  7  6  0  0  1  0  0  0  0  0999 V2000
    0.1040   -0.1670    0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4570   -0.1470    0.4390 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    0.7030    1.3300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3010   -1.4020    0.7590 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3980    0.2250   -0.9860 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1750    0.2560   -1.0660 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2770   -1.0090   -2.3420 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
M  END
>  <ID>
halothane

> <PRIMARY_SOM>
5

>  <Citation>
Spracklin et al.,J. Pharma. Exp. Thera.,281,400,1997

$$$$
harmaline
  MOE2008           3D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3870    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2880    1.8240    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1580    2.3720    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3700   -0.3970   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0230   -0.9650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1300    0.7400   -0.0040 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5850    3.2630    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6940    3.6360    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7260   -1.7430   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6450   -2.2810   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6280    4.0750    0.3400 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9490    3.7790   -0.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6910   -2.6690   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920   -3.9940   -0.0220 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4120   -4.0940   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5  7  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  2  0  0  0  0
  8 12  2  0  0  0  0
  8 13  1  0  0  0  0
  9 12  1  0  0  0  0
 10 14  2  0  0  0  0
 11 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
harmaline

> <PRIMARY_SOM>
16

>  <Citation>
Yu et al.,J. Pharm. Exp. Ther.,305,315,2003

>  <DOI>
10.1124/jpet.102.047050

$$$$
harmine
  MOE2008           3D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4670    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3240    1.8860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0230    2.4330    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3540   -0.3830   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9950   -0.9780    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1300    0.7630   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5920    3.2490    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6630    3.7640    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6850   -1.7340   -0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6530   -2.3110   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6080    4.1250    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0200    3.7300   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6860   -2.6900   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0140   -4.0090   -0.0300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2130   -4.7400   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5  7  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  2  0  0  0  0
  8 12  2  0  0  0  0
  8 13  1  0  0  0  0
  9 12  1  0  0  0  0
 10 14  2  0  0  0  0
 11 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
harmine

> <PRIMARY_SOM>
16

>  <Citation>
Yu et al.,J. Pharm. Exp. Ther.,305,315,2003

>  <DOI>
10.1124/jpet.102.047050

$$$$
iloperidone
  MOE2008           3D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -6.2880   -0.1390   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0790    0.2990    0.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5460   -1.1250   -1.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8150   -1.2960   -1.6310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8540   -0.4960   -1.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6190    0.4840   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3360    0.6680    0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1040   -0.6780   -1.6500 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8050    1.5190    1.1740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4190    1.2700    1.2920 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6940   -0.2720    0.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1990   -0.8170    1.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7520   -1.2900    1.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8980   -0.1610    1.1420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3160    0.2690   -0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7390    0.8280   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -0.6900    1.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4150    0.4420    0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8360   -0.1080    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7220    0.9490    0.0960 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9600    0.4030   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1440   -0.9520    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3970   -1.5110    0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4910   -0.7140   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3050    0.6530   -0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0440    1.2040   -0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8290   -1.3080   -0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8590    2.5290   -0.6180 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1370    3.0680   -0.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7750   -0.6150   -0.6580 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0270   -2.7780   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  7  2  0  0  0  0
  2 10  2  0  0  0  0
  2 11  1  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 26  2  0  0  0  0
 22 23  2  0  0  0  0
 23 24  1  0  0  0  0
 24 25  2  0  0  0  0
 24 27  1  0  0  0  0
 25 26  1  0  0  0  0
 26 28  1  0  0  0  0
 27 30  2  0  0  0  0
 27 31  1  0  0  0  0
 28 29  1  0  0  0  0
M  END
>  <ID>
iloperidone

> <PRIMARY_SOM>
27 30

>  <Citation>
Mutlib et al.,J. Pharm. Exp. Ther.,286,1285,1998

$$$$
imipramine
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.9390    0.1750   -1.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9290    0.2890   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4210    0.0410   -0.6980 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3550    0.3590   -0.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9520   -1.2380   -0.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1160    1.1950   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3050    0.4690    0.4980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2240   -1.6720    0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940   -2.0490   -1.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8440    1.3520    0.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0480    2.2400   -1.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2320   -0.7960    1.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6470    0.5320   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920   -0.7660    1.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7260   -2.9480    0.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7030   -3.3190   -1.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9750    0.3680    1.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5390    2.5500    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7230    3.4200   -1.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9640   -3.7660   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4810    3.5700    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6 10  2  0  0  0  0
  6 11  1  0  0  0  0
  7 12  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
  8 15  1  0  0  0  0
  9 16  2  0  0  0  0
 10 17  1  0  0  0  0
 10 18  1  0  0  0  0
 11 19  2  0  0  0  0
 14 17  1  0  0  0  0
 15 20  2  0  0  0  0
 16 20  1  0  0  0  0
 18 21  2  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
imipramine

> <PRIMARY_SOM>
12 13

> <SECONDARY_SOM>
20 21

>  <Citation>
E. Koyama, K. Chiba, M. Tani, T. Ishizaki, J. Pharmacol. Exp. Ther. 1997, 281, 1199-1210. 

$$$$
ipriflavone
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -3.1970    1.7830    5.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6970    1.8870    5.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0110    0.5220    5.8350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0410    2.8860    5.0720 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0120    2.6520    3.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0920    2.0140    3.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1520    1.8350    1.7800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8720    2.3140    0.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9610    2.9890    1.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0210    3.1700    2.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7850    2.1150   -0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6710    2.5240   -1.2300 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4250    1.4050   -0.9940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3200    1.0000   -0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2500    1.1830    1.2810 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6320    1.1220   -2.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8370    1.4610   -3.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0290    1.1850   -4.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0190    0.5700   -5.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1840    0.2340   -4.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3770    0.5090   -3.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 10  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 15  1  0  0  0  0
  8  9  2  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
 13 14  2  0  0  0  0
 13 16  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 21  2  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
ipriflavone

> <PRIMARY_SOM>
1 3

> <SECONDARY_SOM>
19

> <TERTIARY_SOM>
2

>  <Citation>
Moon et al., Xenobiotica, 2007, 37, 246-259

>  <DOI>
10.1080/00498250601146962

$$$$
jpc_2056
  MOE2008           3D

 27 27  0  0  0  0  0  0  0  0999 V2000
    3.5420   -0.7580   -0.3840 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2330    3.3690   -0.6060 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2930    7.9160    0.2330 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4440   12.3950   -1.9040 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8340    8.7060   -0.8220 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4120   10.4290   -2.2790 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0460   11.1310   -3.8460 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9620    9.6800   -0.6050 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7940    5.6330   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7280    4.5770   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2840    6.9300    0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4270   13.3660   -2.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3120    2.3570   -0.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7270   14.6880   -2.5730 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4830   13.5200   -1.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6660    1.1080   -1.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0420    2.5190    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1410    1.4570    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7620    0.0460   -1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4970    0.2150   -0.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3410   11.3590   -2.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7450    9.6570   -1.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2110    0.8170   -1.7720 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.8930   -2.0310   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8460   -2.8690   -0.7460 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.1660   -1.9530   -2.2290 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.9530   -2.5510   -0.2550 F   0  0  0  0  0  0  0  0  0  0  0  0
  1 20  1  0  0  0  0
  1 24  1  0  0  0  0
  2 10  1  0  0  0  0
  2 13  1  0  0  0  0
  3  5  1  0  0  0  0
  3 11  1  0  0  0  0
  4 12  1  0  0  0  0
  4 21  2  0  0  0  0
  5 22  1  0  0  0  0
  6 21  1  0  0  0  0
  6 22  2  0  0  0  0
  7 21  1  0  0  0  0
  8 22  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 14  1  0  0  0  0
 12 15  1  0  0  0  0
 13 16  2  0  0  0  0
 13 17  1  0  0  0  0
 16 19  1  0  0  0  0
 16 23  1  0  0  0  0
 17 18  2  0  0  0  0
 18 20  1  0  0  0  0
 19 20  2  0  0  0  0
 24 25  1  0  0  0  0
 24 26  1  0  0  0  0
 24 27  1  0  0  0  0
M  END
>  <ID>
jpc_2056

> <PRIMARY_SOM>
5 12

>  <Citation>
Diaz et al.,Drug Metab. Disp.,36,380,2008

>  <DOI>
10.1124/dmd.106.013920

$$$$
kaempferide
  MOE2008           3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.1190   -0.0630    0.0850 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0570    1.1610    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660    2.0010    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2430    1.8630    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    3.3850    0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5600    1.4730    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3720    1.0780    0.0920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2680    3.2050    0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1270    3.9950    0.0460 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2070    4.2330    0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7950    0.1300    0.0770 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6730    2.3080    0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5110    3.9970    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4820    3.6830    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5490    5.2360    0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6570    3.5760   -0.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5650    4.5080    0.0440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7010    6.0220    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8120    4.3570   -0.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8380    5.5830   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9210    6.4180    0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0240    5.8690   -0.6760 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  5  2  0  0  0  0
  3  6  1  0  0  0  0
  4  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  1  0  0  0  0
  6 12  2  0  0  0  0
  8  9  1  0  0  0  0
  8 13  1  0  0  0  0
 10 14  2  0  0  0  0
 12 14  1  0  0  0  0
 13 15  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 16 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
kaempferide

> <PRIMARY_SOM>
22

>  <Citation>
Y. Otake, T. Walle, Drug Metab. Dispos. 2002, 30, 103-105.

>  <DOI>
10.1124/dmd.30.2.103

$$$$
kr_60436
  MOE2008           3D

 31 34  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.4190    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1960    2.0720    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0840    2.3010    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2440   -0.6760   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1900   -0.7400    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3860    1.3400   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9380    3.5620    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4330    1.9270    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5960    3.6830    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2590   -2.0860   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870    0.0210   -0.0210 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1480   -2.1020    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5980    2.0170   -0.0220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1080    1.7470   -1.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0950    1.7300    1.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0690   -2.7780   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4410   -2.7580   -0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8560    1.2680   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4390    1.3780   -1.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3890    1.9550   -2.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4260    1.3620    1.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1240   -4.1510   -0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0330    2.2460   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1010    1.1880    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3660   -4.4530   -1.1770 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3060   -4.8980   -0.0570 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.3890   -4.4660    1.1070 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.0470    2.9820    1.1800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4120    0.8250    0.0390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8030    0.7080    1.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  2  0  0  0  0
  6 13  2  0  0  0  0
  7 12  1  0  0  0  0
  7 14  1  0  0  0  0
  8 10  1  0  0  0  0
  9 15  2  0  0  0  0
  9 16  1  0  0  0  0
 11 17  2  0  0  0  0
 11 18  1  0  0  0  0
 13 17  1  0  0  0  0
 14 19  1  0  0  0  0
 15 20  1  0  0  0  0
 15 21  1  0  0  0  0
 16 22  2  0  0  0  0
 18 23  1  0  0  0  0
 19 24  1  0  0  0  0
 20 25  2  0  0  0  0
 22 25  1  0  0  0  0
 23 26  1  0  0  0  0
 23 27  1  0  0  0  0
 23 28  1  0  0  0  0
 24 29  1  0  0  0  0
 25 30  1  0  0  0  0
 30 31  1  0  0  0  0
M  END
>  <ID>
kr_60436

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
8 10

> <TERTIARY_SOM>
31

>  <Citation>
Ji et al.,Toxicology Lett.,155,103,2005

>  <DOI>
10.1016/j.toxlet.2004.9.001

$$$$
lidocaine
  MOE2008           3D

 17 17  0  0  0  0  0  0  0  0999 V2000
    2.4900    1.1150    0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7430    1.2950   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3920    0.2360   -0.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890   -1.0080   -0.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360   -1.1950   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8840   -0.1340    0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6170   -0.3220    0.9770 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4860   -0.1880    0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8520   -0.2730    0.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8780   -0.0120   -0.1730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1560   -0.4690    0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9750    1.4480   -0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3790    0.0020   -0.9790 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7830    2.2700    1.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800   -2.5500   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2120   -1.9980    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0320    1.7920   -1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 17  1  0  0  0  0
M  END
>  <ID>
lidocaine

> <PRIMARY_SOM>
11 12

> <SECONDARY_SOM>
2 4

>  <Citation>
S. Imaoka, K. Enomoto, Y. Oda, A. Asada, M. Fujimori, T. Shimada, S. Fujita, F. P. Guengerich, Y. Funae, J. Pharmacol. Exp. Ther. 1990, 255, 1385-1391.

$$$$
linoleic_acid
  MOE2008           3D

 20 19  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5260    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4170    2.0550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4120   -0.5260    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3960    3.5850    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8100   -1.3580   -0.9170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8310    4.1150   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2240   -1.8800   -0.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8110    5.6450    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8760   -1.5900   -2.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2460    6.1740   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4080   -2.5650   -2.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260    7.6810    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0600   -2.2760   -4.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1710    8.2710    0.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3790    8.3680   -0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4290   -3.1560   -5.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0910   -2.8620   -6.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600   -3.7420   -7.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1220   -3.4490   -9.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  2  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
linoleic_acid

> <PRIMARY_SOM>
4 6 8 10 12 19 20

>  <Citation>
Bylund et al.,J. Pharm. Exp. Ther.,284,51,1998

$$$$
lisofylline
  MOE2008           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
    3.4700    0.4900   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5560   -0.8940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1770    1.0770    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7360    0.9680   -0.1800 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690   -1.6380    0.1810 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8560   -1.2610   -0.1520 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1270    0.2770    0.3240 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9900    2.3110    0.1000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5700   -0.1040   -0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2080    2.3590   -0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2830   -1.0580    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -3.1020    0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1630    0.9740    0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3380   -1.8410    0.6160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2880    0.5400   -0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5380    1.3040    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7960    0.5300   -0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0270    1.3560   -0.0030 C   0  0  3  0  0  0  0  0  0  0  0  0
   -6.2630    0.4680   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9390    1.7590    1.3680 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  2  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6  9  2  0  0  0  0
  7 11  1  0  0  0  0
  7 13  1  0  0  0  0
 11 14  2  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
lisofylline

> <PRIMARY_SOM>
18

>  <Citation>
Lee et al.,Drug Metab. Disp.,25,1354,1997

$$$$
loratadine
  MOE2008           3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -2.8000    3.7890    0.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2190    4.6740   -0.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1880    4.2350   -1.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7800    2.9900   -1.1570 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    2.0980   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3390    2.4680    0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0290    1.6270    1.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3540    0.3210    1.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090   -0.6610    0.7680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6510   -0.4610   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6980   -1.3510   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5190   -2.4600   -1.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2790   -2.6700   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2290   -1.7750    0.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7760    0.7250   -0.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5480    0.5510   -0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4860    1.7380   -0.5030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5430    1.5430    0.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070    0.1920    0.4680 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2100   -0.9690    0.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1440   -0.8380   -0.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4310    0.0200    0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9400   -1.2220    0.1780 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3670   -1.4070   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6790   -2.9020   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1670    0.9850    0.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3030   -4.0670   -0.0950 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  2  0  0  0  0
 10 15  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 13 27  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 16 21  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 22  1  0  0  0  0
 20 21  1  0  0  0  0
 22 23  1  0  0  0  0
 22 26  2  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
loratadine

> <PRIMARY_SOM>
24

>  <Citation>
Ghosal et al.,Drug Metab. Letters,3,162,2009

$$$$
lu25_109
  MOE2008           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.4660    0.0100 N   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4280   -0.4820   -1.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6940    0.2260   -1.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1160    1.3030   -1.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3810    1.9050   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    1.8740    1.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3680    1.9450   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1360    1.5530   -2.6180 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1250    2.3760   -2.7000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0080    3.2760   -1.7880 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9400    3.0440   -1.1040 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2120    2.2980   -3.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8300    3.0930   -4.9300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1  7  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  8  9  2  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 13  1  0  0  0  0
 11 12  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
lu25_109

> <PRIMARY_SOM>
2 3 6 7

> <SECONDARY_SOM>
1

>  <Citation>
K.G. Jensen and L. Dalgaard, Drug Metab. Dispos., 1999, 27, 125-132

$$$$
m-xylene
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.9430    5.2230    0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5810    5.2320    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1010    4.0550    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5840    2.8770    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1590    1.5910    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410    2.8730    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6290    4.0500    0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310    4.0590    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
m-xylene

> <PRIMARY_SOM>
1 3

>  <Citation>
Tassaneeyakul et al., J. Pharm. Exp. Ther., 1996, 276, 101-108

$$$$
malathion
  MOE2008           3D

 19 18  0  0  1  0  0  0  0  0999 V2000
   -0.0220    1.8100    0.0120 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.4130    2.3390    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7510    2.3090   -1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0710   -0.4020    0.2020 P   0  0  0  0  0  0  0  0  0  0  0  0
    2.1040    1.9430    1.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0570    2.6100   -1.1340 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1600    2.4380   -2.2550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6100    0.2380    1.5770 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8640    0.2490   -1.0390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3510   -2.2440    0.2210 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3800    2.3010    1.4920 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5100    1.3030    2.1150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7600    3.0910   -2.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1460   -0.6050    2.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1230   -0.0750   -2.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0460    1.9190    2.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2240    3.3580   -1.9570 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4820    2.4490    2.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  2  0  0  0  0
  6 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  9 15  1  0  0  0  0
 10 16  1  0  0  0  0
 12 17  1  0  0  0  0
 14 18  1  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
malathion

> <PRIMARY_SOM>
5 11

>  <Citation>
Buratti et al.,Drug Metab. Disp.,33,295,2005

>  <DOI>
10.1124/dmd.104.001693

$$$$
maprotiline
  MOE2008           3D

 21 24  0  0  0  0  0  0  0  0999 V2000
   -0.0120    1.5160    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2120    0.0180   -0.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4910    1.7050    0.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3770    2.1330   -1.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8010    2.1000    1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5370   -0.5510   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0430   -0.7490    0.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2400    1.1360   -0.8730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1020    2.3670    1.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4440    1.5090   -2.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6650    3.6240    1.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4130    0.4340   -1.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4570   -1.8890   -1.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1300   -2.1100    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6030    1.2280   -0.8780 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4880    2.4640    1.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3420    4.1980    2.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3860   -2.6750   -0.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2310    1.9000    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2110    5.6610    2.4320 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8790    6.1450    3.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  2  0  0  0  0
  3  9  1  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  1  0  0  0  0
  6 13  1  0  0  0  0
  7 14  2  0  0  0  0
  8 12  1  0  0  0  0
  8 15  1  0  0  0  0
  9 16  2  0  0  0  0
 10 12  1  0  0  0  0
 11 17  1  0  0  0  0
 13 18  2  0  0  0  0
 14 18  1  0  0  0  0
 15 19  2  0  0  0  0
 16 19  1  0  0  0  0
 17 20  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
maprotiline

> <PRIMARY_SOM>
21

>  <Citation>
Brachtenorf et al.,Pharmacol. Toxicol.,90,144,2002

>  <DOI>
10.1034/j.1600-0773.2002.900306.x

$$$$
mde
  MOE2008           3D

 15 16  0  0  1  0  0  0  0  0999 V2000
    0.1140    1.1540    0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0540    0.2290   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3460    1.7130    0.5510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0450    1.4320    0.9270 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9970   -0.1900   -1.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3410   -0.1920   -0.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4360    1.3050   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9590    0.5630    0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2530    0.3620   -1.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8080    1.8600   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1060    2.3590    1.3840 C   0  0  3  0  0  0  0  0  0  0  0  0
    4.3720    1.2300    2.2660 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3190    3.2620    1.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4710    1.7100    3.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7430    0.5280    4.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
mde

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
14

>  <Citation>
Kreth et al.,Biochem. Pharm.,59,1563,2000

>  <DOI>
10.1016/S0006-2952(00)00284-7

$$$$
melatonin
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    1.8270   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2360    2.0840    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -0.3920   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -0.7060    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1330    0.7120   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8920    3.2460    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    1.3690    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3950   -0.0240    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9580    3.7610    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6070    2.0270    0.0620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4510    5.1410    1.4430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300    1.0300    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5920    5.8030    2.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0990    7.2220    2.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3120    5.2570    3.6540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5  7  1  0  0  0  0
  6 10  2  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  2  0  0  0  0
M  END
>  <ID>
melatonin

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
14

>  <Citation>
X. C. Ma, J. R. Idle, K. W. Krausz, F. J. Gonzalez, Drug Metab. Dispos. 2005, 33, 489-494.

>  <DOI>
10.1124/dmd.104.002410

$$$$
meperidine
  MOE2008           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.1070    0.0550    0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2390    1.4800    0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6290   -0.6280   -0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1520   -0.6270    0.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3240   -1.9440   -1.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4620   -1.9430    0.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7230   -2.6010   -0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0520    2.1670   -0.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110    3.6580   -0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0420    4.3700   -0.1790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8040    4.3170   -1.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8220    3.7580    0.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0540    2.2690    0.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0260    1.4670    1.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5370    1.6810    2.9250 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3350    1.1480    1.6040 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0860    1.0670    2.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0450   -0.3560    3.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  8  1  0  0  0  0
  2 13  1  0  0  0  0
  2 14  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  2  0  0  0  0
  5  7  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 12 13  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
meperidine

> <PRIMARY_SOM>
11

>  <Citation>
Ramirez et al.,Drug Metab. Disp.,32,930,2004

$$$$
mephenytoin
  MOE2008           3D

 16 17  0  0  1  0  0  0  0  0999 V2000
    1.2500    0.9420   -0.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4250    1.8040    0.2060 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.1390    2.5910    1.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2920    3.4310    1.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1030    0.8450    0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9730    0.0470    0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9150   -0.6720   -0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2180   -0.5920   -1.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2900    0.2090   -1.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6290    1.0060    0.3460 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6220    1.4140   -0.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1290    2.4580   -1.2770 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8670    3.1440   -2.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8500    2.7660   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1550    3.6540   -1.3840 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7350    0.9180   -0.6460 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  1  0  0  0  0
  1  9  2  0  0  0  0
  2  3  1  0  0  0  0
  2 10  1  0  0  0  0
  2 14  1  0  0  0  0
  3  4  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 16  2  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  2  0  0  0  0
M  END
>  <ID>
mephenytoin

> <PRIMARY_SOM>
7

>  <Citation>
J. K. Coller, A. A. Somogyi, F. Bochner, Br. J. Clin. Pharmacol. 1999, 48, 158-167.

>  <DOI>
10.1046/j.1365-2125.1999.00005.x

$$$$
mesoridazine
  MOE2008           3D

 26 29  0  0  1  0  0  0  0  0999 V2000
   -0.8940    0.8200    0.4900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0400   -0.5430    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5790   -1.0300    1.0710 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2330    1.4390    1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0060   -1.4680    0.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3970    0.7160    1.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0310    1.6810    0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0500    3.5390   -2.9490 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.2400   -1.0280   -0.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9440    2.1960   -1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1200    3.0890   -1.5630 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.1870   -2.8180    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4240   -2.3710   -0.6890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9660   -2.9330   -1.4070 S   0  0  3  0  0  0  0  0  0  0  0  0
   -4.8920   -1.7530   -1.3570 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3870   -3.2700   -0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0910    2.3780   -3.8270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2470    4.3090   -3.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2280    2.8140    1.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.3640    1.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1730    4.2640   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4260   -4.0370   -0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3680    5.5470   -2.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3260    3.4560    1.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690    2.7260    2.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2800    5.2430   -0.9170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  7  1  0  0  0  0
  2  5  2  0  0  0  0
  2  9  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  6  2  0  0  0  0
  4 19  1  0  0  0  0
  5 12  1  0  0  0  0
  6 20  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  8 17  1  0  0  0  0
  8 18  1  0  0  0  0
  9 13  2  0  0  0  0
 10 11  1  0  0  0  0
 11 21  1  0  0  0  0
 12 16  2  0  0  0  0
 13 14  1  0  0  0  0
 13 16  1  0  0  0  0
 14 15  2  0  0  0  0
 14 22  1  0  0  0  0
 18 23  1  0  0  0  0
 19 24  2  0  0  0  0
 20 25  2  0  0  0  0
 21 26  1  0  0  0  0
 23 26  1  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
mesoridazine

> <PRIMARY_SOM>
14

>  <Citation>
Wojcikowski et al.,Drug Metab. Disp.,34,471,2006

>  <DOI>
10.1124/dmd.105.006445

$$$$
methiocarb
  MOE2008           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.0250    1.3690    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200   -0.0110   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1730    2.0590    0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0460    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1770   -0.6990   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    1.3730    0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0270    1.9390    1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -0.0090   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1820   -2.1980   -0.3190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6710    2.1230    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2460    2.5130    1.0470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6710    1.3240    2.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9050   -0.8860   -0.0730 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1420    2.3960    2.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2500   -0.8580   -1.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 12  2  0  0  0  0
  8 13  1  0  0  0  0
 11 14  1  0  0  0  0
 13 15  1  0  0  0  0
M  END
>  <ID>
methiocarb

> <PRIMARY_SOM>
13

>  <Citation>
Usmani et al.,Drug Metab. Disp.,32,333,2004

>  <DOI>
10.1124/dmd.32.3.333

$$$$
methoxychlor
  MOE2008           3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1680    0.0620   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.0860    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.2920   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.2880   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.9090    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300    3.0220   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    1.6890    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540    1.7310   -1.5320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    4.0480   -0.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    2.0270   -2.6200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.6090   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -2.2300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480    3.5580   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180    2.2230    1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5840   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    3.1570    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780   -3.8830   -1.4830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9440    3.6830    1.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -4.6320   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2930    3.0800    2.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
 12 16  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
methoxychlor

> <PRIMARY_SOM>
20 21

> <SECONDARY_SOM>
12 13 14 15

>  <Citation>
D. M. Stresser, D. Kupfer, Biochemistry 1997, 36, 2203-2210
Hu et al.,Drug Metab. Disp.,30,1035,2002

>  <DOI>
10.1021/bi962129k
10.1124/dmd.30.9.1035

$$$$
methoxychlor_catechol
  MOE2008           3D

 21 22  0  0  1  0  0  0  0  0999 V2000
    0.1720    1.5500   -0.2310 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.2500    0.1020   -0.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4640    2.1140    0.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7950    2.4720   -0.9970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7510   -0.3120   -1.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1840   -0.8590    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4770    2.5410   -0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6600    2.2010    1.6640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4210    1.7110   -1.1330 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0340    4.0160   -0.1010 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.2130    2.8600   -2.6450 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8120   -1.6660   -2.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1240   -2.2140   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6700    3.0560   -0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8510    2.7150    2.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0180    2.7920    3.5120 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3720   -2.6210   -1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8480    3.1400    1.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -3.9250   -1.6510 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0180    3.6460    1.7770 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0230   -4.8100   -0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
 12 17  2  0  0  0  0
 13 17  1  0  0  0  0
 14 18  2  0  0  0  0
 15 16  1  0  0  0  0
 15 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
methoxychlor_catechol

> <PRIMARY_SOM>
21

>  <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

>  <DOI>
10.1124/dmd.30.9.1035

$$$$
methoxychlor_mono_OH
  MOE2008           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.1680    0.0620   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.0860    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.2920   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.2880   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.9090    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300    3.0220   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    1.6890    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540    1.7310   -1.5320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    4.0480   -0.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    2.0270   -2.6200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.6090   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -2.2300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480    3.5580   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180    2.2230    1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5840   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    3.1570    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780   -3.8830   -1.4830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9440    3.6830    1.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -4.6320   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
 12 16  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
methoxychlor_mono_OH

> <PRIMARY_SOM>
20

> <SECONDARY_SOM>
14 15

>  <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

>  <DOI>
10.1124/dmd.30.9.1035

$$$$
methyleugenol
  MOE2008           3D

 13 13  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3880    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750    2.0940    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030    2.0530    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1650   -0.7020    0.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4150   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1460    3.4810    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3990    0.0340   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690   -2.1270    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6760    2.1850   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1210    2.4340    1.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3150    2.0570    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7  9  1  0  0  0  0
  7 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
M  END
>  <ID>
methyleugenol

> <PRIMARY_SOM>
11

>  <Citation>
S.M.F. Jeurissen et al., Chem. Res. Toxicol., 2006, 19, 111-116

>  <DOI>
10.1021/tx050267h

$$$$
metoclopramide
  MOE2008           3D

 20 20  0  0  0  0  0  0  0  0999 V2000
   -1.0070    0.8290   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0640   -0.4240   -0.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2200    1.3260    0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2110    1.6620   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1170   -1.1590   -1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2670   -0.8680   -1.3720 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3870    0.5830    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9750    3.0160   -0.1520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3030    1.1640    0.1850 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3460   -0.6730   -0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1730   -2.1630   -1.9530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8550    1.2690    0.6020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -3.0550    3.9480    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970   -1.4630   -0.7670 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5460    5.3640   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6090    6.3450    0.0380 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0120    6.3480    1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0750    7.6600   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1990    7.2570    1.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7480    7.7650   -1.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  2  0  0  0  0
  6 11  1  0  0  0  0
  7 10  1  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
metoclopramide

> <PRIMARY_SOM>
18 17

>  <Citation>
Desta et al.,Drug Metab. Disp.,30,336,2002

>  <DOI>
10.1124/dmd.30.3.336

$$$$
mianserin
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
    3.3030   -1.0630    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2800   -0.2430   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9240    0.9530   -0.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9620   -0.7050    0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6010    0.4860   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5980    1.3170   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9670   -1.6660    0.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3420   -2.0690    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2630   -1.0720    0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4910   -1.3960   -0.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6330   -3.3840    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8610   -3.7090   -0.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7890   -2.7180   -0.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2900    0.9410   -0.3140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8740    0.3610    0.3550 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.4070    2.3720    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8950    3.1080   -0.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9510    2.5710    0.5740 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1500    1.1830    0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1830    3.2980    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
  3  6  2  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 15  1  0  0  0  0
 10 13  2  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 15 19  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
mianserin

> <PRIMARY_SOM>
20

> <SECONDARY_SOM>
18

> <TERTIARY_SOM>
2

>  <Citation>
Koyama et al.,J. Pharm. Exp. Ther.,278,21,1996

$$$$
mirtazapine
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.4290    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.2670    1.9380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5320   -0.6890    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0700    1.9100    1.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2050   -0.1140    2.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6130    1.9220   -1.2430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5300    1.3450    2.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9050   -0.1170   -1.5580 N   0  0  3  0  0  0  0  0  0  0  0  0
   -1.3920   -0.5880   -0.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7290    2.4660   -1.1340 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0130    1.3440   -1.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2860   -2.0670    1.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3600    2.4060    1.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2750   -0.6330   -1.6810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6390   -0.9090    3.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9490    2.9560   -1.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8050    2.9420   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7080   -2.8460    2.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3960   -2.2620    3.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  7  1  0  0  0  0
  2  4  1  0  0  0  0
  2 10  1  0  0  0  0
  3  5  2  0  0  0  0
  3 11  1  0  0  0  0
  4  6  2  0  0  0  0
  4 13  1  0  0  0  0
  5  8  1  0  0  0  0
  5 14  1  0  0  0  0
  6  8  1  0  0  0  0
  6 16  1  0  0  0  0
  7 12  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
  9 15  1  0  0  0  0
 11 17  2  0  0  0  0
 13 19  2  0  0  0  0
 14 18  2  0  0  0  0
 16 20  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
mirtazapine

> <PRIMARY_SOM>
15 18

> <SECONDARY_SOM>
9

>  <Citation>
Stormer, E.; von Moltke, L.L.; Shader, R.I.; Greenblatt, D.J. Metabolism of the Antidepressant Mirtazapine In Vitro: Contribution of Cytochromes P-450 1A2, 2D6, and 3A4. Drug Metab. Dispos. 2000, 28, 1168–1175. 

$$$$
ml_3403
  MOE2008           3D

 29 32  0  0  1  0  0  0  0  0999 V2000
    4.9490    5.6840    1.3110 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.0260    2.2230   -0.9340 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.1950   -1.7210   -0.5560 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2050    4.3490    0.7430 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4570    3.0210    1.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2810   -1.9440    0.6450 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2080   -3.1710   -0.4950 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.8260   -3.6910   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5830    2.2770    0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5150    0.8370    0.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7010    3.0800    0.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3300   -1.1640    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8040   -3.7250   -1.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4200    0.2250    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0910    2.8450    0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8600   -3.7280   -1.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4900   -4.1380    1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4870    0.0470    1.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8760    4.2620    1.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3260   -1.3250    1.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4530    1.7310   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0880    3.7520    0.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5800   -4.2110   -1.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110   -4.6210    1.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2570   -4.6580    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7780    1.5150   -0.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4170    3.5470    0.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7500    2.4260   -0.5810 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3330    4.9290    1.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 19  1  0  0  0  0
  1 29  1  0  0  0  0
  2 28  1  0  0  0  0
  3  7  1  0  0  0  0
  3 12  1  0  0  0  0
  4 11  1  0  0  0  0
  4 19  1  0  0  0  0
  5  9  1  0  0  0  0
  5 19  2  0  0  0  0
  6 12  1  0  0  0  0
  6 20  2  0  0  0  0
  7  8  1  0  0  0  0
  7 13  1  0  0  0  0
  8 16  2  0  0  0  0
  8 17  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  2  0  0  0  0
 10 14  1  0  0  0  0
 10 18  2  0  0  0  0
 11 15  1  0  0  0  0
 12 14  2  0  0  0  0
 15 21  2  0  0  0  0
 15 22  1  0  0  0  0
 16 23  1  0  0  0  0
 17 24  2  0  0  0  0
 18 20  1  0  0  0  0
 21 26  1  0  0  0  0
 22 27  2  0  0  0  0
 23 25  2  0  0  0  0
 24 25  1  0  0  0  0
 26 28  2  0  0  0  0
 27 28  1  0  0  0  0
M  END
>  <ID>
ml_3403

> <PRIMARY_SOM>
1

>  <Citation>
Kammerer et al.,Drug Metab. Disp.,35,875,2007

>  <DOI>
10.1124/dmd.106.013409

$$$$
ml_3603
  MOE2008           3D

 30 33  0  0  1  0  0  0  0  0999 V2000
    4.9430    5.6450    1.7340 S   0  0  3  0  0  0  0  0  0  0  0  0
    5.8740    6.6900    2.2720 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8480    2.1460   -1.1400 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.2370   -1.7400   -0.4780 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1970    4.3340    0.9800 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4500    3.0270    1.3640 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2600   -1.9570    0.8250 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2730   -3.1930   -0.4520 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.8870   -3.7410   -0.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5400    2.2700    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4620    0.8290    0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6540    3.0600    0.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3290   -1.1760    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9620   -3.7030   -1.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4020    0.2170    0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0100    2.8090    0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9930   -3.7710   -1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750   -4.2250    0.9220 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4120    0.0370    1.5630 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8940    4.2610    1.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2670   -1.3360    1.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3150    1.6630   -0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0320    3.7320    0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7080   -4.2810   -1.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -4.7360    1.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3070   -4.7640    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6070    1.4330   -0.9650 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3280    3.5140    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6040    2.3620   -0.6930 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0030    4.9040    3.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1 20  1  0  0  0  0
  1 30  1  0  0  0  0
  3 29  1  0  0  0  0
  4  8  1  0  0  0  0
  4 13  1  0  0  0  0
  5 12  1  0  0  0  0
  5 20  1  0  0  0  0
  6 10  1  0  0  0  0
  6 20  2  0  0  0  0
  7 13  1  0  0  0  0
  7 21  2  0  0  0  0
  8  9  1  0  0  0  0
  8 14  1  0  0  0  0
  9 17  2  0  0  0  0
  9 18  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  2  0  0  0  0
 11 15  1  0  0  0  0
 11 19  2  0  0  0  0
 12 16  1  0  0  0  0
 13 15  2  0  0  0  0
 16 22  2  0  0  0  0
 16 23  1  0  0  0  0
 17 24  1  0  0  0  0
 18 25  2  0  0  0  0
 19 21  1  0  0  0  0
 22 27  1  0  0  0  0
 23 28  2  0  0  0  0
 24 26  2  0  0  0  0
 25 26  1  0  0  0  0
 27 29  2  0  0  0  0
 28 29  1  0  0  0  0
M  END
>  <ID>
ml_3603

> <PRIMARY_SOM>
1

>  <Citation>
Kammerer et al.,Drug Metab. Disp.,35,875,2007

>  <DOI>
10.1124/dmd.106.013409

$$$$
montelukast
  MOE2008           3D

 41 45  0  0  1  0  0  0  0  0999 V2000
    1.3780    2.7390    0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700    1.4960    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9000    2.8890    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6330    3.0390   -1.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6360    3.1100    1.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2280    4.6290   -1.0920 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4010    2.0600    1.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0000    4.7240   -2.7310 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2090    2.2020    2.7120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5050    1.0900    0.9370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0100    3.6150   -2.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    6.0750   -2.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8640    2.6770   -3.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0790    3.5360   -2.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6580    7.1950   -2.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8010    1.6490   -4.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0110    2.5210   -2.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3360    8.5170   -3.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6520    0.6430   -5.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8810    1.5800   -3.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0140    9.1550   -2.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2740    9.0930   -4.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -0.3440   -5.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360   10.3680   -2.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0770    8.5300   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8950   10.3040   -4.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4060   -1.3480   -6.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5780   10.9410   -3.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660    9.3760    0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5340    8.4640   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5340    7.2100   -0.7850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3770   -1.2660   -7.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3570   -2.3790   -6.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040   -2.1570   -8.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2290   -3.3140   -7.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1320   -3.2150   -8.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -2.0640   -8.9470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9430   -4.1460   -9.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9550   -2.9850   -9.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8710   -4.0240  -10.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4000   -2.8630  -11.0170 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  3  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  2  0  0  0  0
  8 11  1  0  0  0  0
  8 12  1  0  0  0  0
 11 13  2  0  0  0  0
 11 14  1  0  0  0  0
 12 15  1  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  1  0  0  0  0
 16 20  2  0  0  0  0
 17 20  1  0  0  0  0
 18 21  2  0  0  0  0
 18 22  1  0  0  0  0
 19 23  2  0  0  0  0
 21 24  1  0  0  0  0
 21 25  1  0  0  0  0
 22 26  2  0  0  0  0
 23 27  1  0  0  0  0
 24 28  2  0  0  0  0
 25 29  1  0  0  0  0
 25 30  1  0  0  0  0
 25 31  1  0  0  0  0
 26 28  1  0  0  0  0
 27 32  2  0  0  0  0
 27 33  1  0  0  0  0
 32 34  1  0  0  0  0
 33 35  2  0  0  0  0
 34 36  2  0  0  0  0
 34 37  1  0  0  0  0
 35 36  1  0  0  0  0
 36 38  1  0  0  0  0
 37 39  2  0  0  0  0
 38 40  2  0  0  0  0
 39 40  1  0  0  0  0
 39 41  1  0  0  0  0
M  END
>  <ID>
montelukast

> <PRIMARY_SOM>
6

>  <Citation>
Chiba et al.,Drug Metab. Dispos.,25,1022,1997

$$$$
nabumetone
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1850    1.3840   -0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1530   -0.0250   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9950    2.0910   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950    2.0560    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330   -0.7320    0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0580   -0.6960   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2070    1.4170   -0.5230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680    1.3390    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5420   -0.0540    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2300    0.0220   -0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4360    2.2240   -0.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6420   -0.8360    0.5450 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7370    1.5970   -0.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170   -0.0470    0.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8810    1.5910    1.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5260    2.8500    1.8970 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3360    0.6150    1.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  2  0  0  0  0
M  END
>  <ID>
nabumetone

> <PRIMARY_SOM>
16

>  <Citation>
Turpeinen et al.,Drug Metab. Disp.,37,1017,2009

>  <DOI>
10.1124/dmd.108.025700

$$$$
naproxen
  MOE2008           3D

 17 18  0  0  1  0  0  0  0  0999 V2000
    0.0340    1.3810    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0060    0.0250   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2640    2.0330    0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550    2.0580    0.3080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2350   -0.6250   -0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1830   -0.6510   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4550    1.3550   -0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3780    1.3980    0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4220    0.0570   -0.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    0.0110   -0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    2.0970    0.0030 C   0  0  3  0  0  0  0  0  0  0  0  0
   -3.5740   -0.6670   -0.3280 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4440    1.8830    1.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7080    1.8100   -1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7230    0.1210   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8150    3.0820    1.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6840    0.8070    1.8430 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 12 15  1  0  0  0  0
 13 16  1  0  0  0  0
 13 17  2  0  0  0  0
M  END
>  <ID>
naproxen

> <PRIMARY_SOM>
15

>  <Citation>
T. S. Tracy, C. Marra, S. A. Wrighton, F. J. Gonzalez, K. R. Korzekwa, Eur. J. Clin. Pharmacol. 1997, 52, 293-298.

>  <DOI>
10.1007/s002280050293

$$$$
ne_100
  MOE2008           3D

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.6600    1.6260   -1.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5880    0.3370   -1.7750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8100    2.0140   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6680   -0.5360   -1.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8880    1.1430   -0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2460    3.1960    1.7790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4160    2.4590   -1.4100 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8090   -0.1370   -0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0070    2.8400    1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310    1.5320    0.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5560   -0.0100   -2.4460 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1880    3.7330   -0.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    5.9700   -0.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4070    4.5950   -1.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0780    4.5160    2.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4800    2.2380    2.8500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4880   -1.3400   -2.9450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3860    6.8320   -0.6290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1620    6.4220    0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9290    5.5790    1.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8150    2.4810    3.5160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7520    6.9270    1.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0200    1.4720    4.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3390    8.1270   -0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1110    7.7150    0.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2010    8.5680    0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  7  1  0  0  0  0
  2  4  1  0  0  0  0
  2 11  1  0  0  0  0
  3  5  2  0  0  0  0
  4  8  2  0  0  0  0
  5  8  1  0  0  0  0
  5 10  1  0  0  0  0
  6  9  1  0  0  0  0
  6 15  1  0  0  0  0
  6 16  1  0  0  0  0
  7 12  1  0  0  0  0
  9 10  1  0  0  0  0
 11 17  1  0  0  0  0
 12 14  1  0  0  0  0
 13 14  1  0  0  0  0
 13 18  2  0  0  0  0
 13 19  1  0  0  0  0
 15 20  1  0  0  0  0
 16 21  1  0  0  0  0
 18 24  1  0  0  0  0
 19 25  2  0  0  0  0
 20 22  1  0  0  0  0
 21 23  1  0  0  0  0
 24 26  2  0  0  0  0
 25 26  1  0  0  0  0
M  END
>  <ID>
ne_100

> <PRIMARY_SOM>
16 15

>  <Citation>
Yamamoto et al.,Drug Metab. Pharmacokin.,18,173,2003

>  <DOI>
10.2133/dmpk.18.173

$$$$
nicardipine
  MOE2008           3D

 35 37  0  0  1  0  0  0  0  0999 V2000
    0.4840    1.2560   -0.4290 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0690   -0.1930   -0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9780    1.4680   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0750    1.9000   -1.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7920   -0.5650    0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5350   -1.1680   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7140    1.9570   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5500    1.1140    1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    2.3970   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5410    1.9810   -1.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1640   -1.9000    0.8490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510   -2.5010   -1.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    2.3860   -2.4610 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2000    2.1000   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5450    1.9680    1.4020 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    0.2070    1.7610 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2840    3.0490   -3.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880    1.7490   -3.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2430    2.1700   -0.7680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7020   -2.8750   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0500   -2.2870    1.9280 N   0  3  0  0  0  0  0  0  0  0  0  0
    4.1550    1.6340    2.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4110    1.7770   -3.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6020   -1.3850    2.5740 O   0  5  0  0  0  0  0  0  0  0  0  0
   -2.2120   -3.4990    2.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1330    0.4760    2.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2770    0.7730    1.6420 N   0  0  3  0  0  0  0  0  0  0  0  0
    7.0530    1.8480    2.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1050   -0.4220    1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9580    2.5380    1.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4510    3.5100    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3160    2.2210    1.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2960    4.1560   -0.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1610    2.8670    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6500    3.8340   -0.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 13  1  0  0  0  0
  9 17  1  0  0  0  0
 10 18  1  0  0  0  0
 10 19  2  0  0  0  0
 11 20  2  0  0  0  0
 11 21  1  0  0  0  0
 12 20  1  0  0  0  0
 15 22  1  0  0  0  0
 18 23  1  0  0  0  0
 21 24  1  0  0  0  0
 21 25  2  0  0  0  0
 22 26  1  0  0  0  0
 26 27  1  0  0  0  0
 27 28  1  0  0  0  0
 27 29  1  0  0  0  0
 28 30  1  0  0  0  0
 30 31  2  0  0  0  0
 30 32  1  0  0  0  0
 31 33  1  0  0  0  0
 32 34  2  0  0  0  0
 33 35  2  0  0  0  0
 34 35  1  0  0  0  0
M  CHG  1  21   1
M  CHG  1  24  -1
M  END
>  <ID>
nicardipine

> <PRIMARY_SOM>
28

>  <Citation>
Nakamura et al.,Biol. Pharm. Bull.,28,882,2005

>  <DOI>
10.1248/bpb.28.882

$$$$
nicotine
  MOE2008           3D

 12 13  0  0  1  0  0  0  0  0999 V2000
    1.1240    0.6150   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1580    1.2470    0.6500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0140    0.5900    0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5920   -1.2980    0.4680 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2680   -0.6650    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2420   -1.2800   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9790   -0.6390   -0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7190   -0.9130   -0.3960 N   0  0  3  0  0  0  0  0  0  0  0  0
   -3.2950   -0.5140   -1.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5110   -2.1420   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1360   -2.9830    0.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360   -2.8070    0.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  4 12  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
nicotine

> <PRIMARY_SOM>
10

>  <Citation>
Yamazaki et al.,Arch. Toxicol.,73,65,1999

>  <DOI>
10.1007/s002040050588

$$$$
nordexfenfluramine
  MOE2008           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
    8.6810    0.1720    0.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1710    0.4720   -0.8420 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.7650    0.0810    1.2130 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.0030    1.2800    0.8040 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.6680   -2.1340    0.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1830   -2.0830    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5230   -0.8080    0.5480 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.4930   -0.7530    2.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1470   -0.8120    0.0830 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820   -3.3820    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4560   -0.9820    0.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6650   -3.4780    0.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8420   -1.0660    0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4420   -2.3230    0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1 13  1  0  0  0  0
  5  6  1  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7  9  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
nordexfenfluramine

> <PRIMARY_SOM>
4

>  <Citation>
Haritos, V.S.; Ching, M.S.; Ghabrial, H.; Gross, A.S.; Taavitsainen, P.; Pelkonen, O.; Battaglia, S.E.; Smallwood, R.A.; Ahokas, J.T. Metabolism of Dexfenfluramine in Human Liver Microsomes and by Recombinant Enzymes: Role of CYP2D6 and 1A2. Pharmacogenetics 1998, 8, 423–432.

$$$$
nordiazepam
  MOE2008           3D

 19 21  0  0  0  0  0  0  0  0999 V2000
    1.6670   -2.6700    0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3360   -1.4640    0.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7350   -0.2460    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4160   -0.2350   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2440   -1.4520   -0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3850   -2.6560   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4480   -4.1320   -0.4700 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3790    1.0180   -0.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5400    0.8850    0.3670 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0440    3.1120    0.1140 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3980    2.1200   -0.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4720    2.1300   -1.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0930    2.1200   -0.9530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8100    1.0380   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2660    0.2310    0.9930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6890    1.9220   -0.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5990    0.2920    1.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0220    1.9820   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4760    1.1660    0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  2  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 11  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  2  0  0  0  0
 17 19  2  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
nordiazepam

> <PRIMARY_SOM>
12

>  <Citation>
T. J. Yang, M. Shou, K. R. Korzekwa, F. J. Gonzalez, H. V. Gelboin, S. K. Yang, Biochem. Pharmacol. 1998, 55, 889-896.

$$$$
nortriptyline
  MOE2008           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4760    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2340    2.2630    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1160    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5720   -0.6200   -1.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5370   -0.7430    1.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3250    1.9670   -0.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2750    3.3660    0.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4790    1.3290    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    0.1960   -2.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6060   -2.0040   -1.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4980   -2.1240    0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    0.8690   -1.8150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4650    2.7680   -0.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4000    4.1510    0.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3400    1.7630    1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0700   -2.7480   -0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5050    3.8420    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5930    0.9960    1.2110 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3690    1.4580    2.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 16  1  0  0  0  0
 10 13  1  0  0  0  0
 11 17  2  0  0  0  0
 12 17  1  0  0  0  0
 14 18  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
nortriptyline

> <PRIMARY_SOM>
20

>  <Citation>
Breyer-Pfaff, Drug Metab. Rev.,36,723,2004

>  <DOI>
10.1081/DMR-200033482

$$$$
o-Aminoazotoluene
  MOE2008           2D

 17 18  0  0  0  0  0  0  0  0999 V2000
    2.1430    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.2060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    0.2060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  2 17  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  2  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
o-Aminoazotoluene

> <PRIMARY_SOM>
7 13

> <SECONDARY_SOM>
16

>  <Citation>
Masakuni Degawa, Chie Kanazawa and Yoshiyuki Hashimoto, Carcinogenesis , 3, 1113-1117, 1982

>  <DOI>
10.1093/carcin/3.10.1113

$$$$
o-phenylphenol
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.9830    2.1830    0.7750 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7520   -0.1310    0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250   -0.1760    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5380    0.9910    0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4560   -1.2880   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5010    0.9030    0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4190   -1.3300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9330    0.9640    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8480   -1.3320   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8950    0.8450    0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -1.4060   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5890   -0.2000   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -0.3140    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  2  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  2  0  0  0  0
  8 12  2  0  0  0  0
  9 12  1  0  0  0  0
 10 13  2  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
o-phenylphenol

> <PRIMARY_SOM>
9

>  <Citation>
S. Ozawa, K. Ohta, A. Miyajima, H. Kurebayashi, M. Sunouchi, M. Shimizu, N. Murayama, Y. Matsumoto, M. Fukuoka, Y. Ohno, Xenobiotica 2000, 30, 1005-1017.

>  <DOI>
10.1080/00498250050200159

$$$$
ochratoxin_a
  MOE2008           3D

 28 30  0  0  1  0  0  0  0  0999 V2000
   -0.0870    0.1040   -0.1560 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0160    1.8180   -0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2440    2.4810   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1710    2.5380    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780    3.8840    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5290    1.7240   -0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1580    3.9310    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0720    4.6010    0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5900    4.5710    0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4920    2.5920   -0.8970 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.4590    4.6420    0.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0980    5.9640    0.2140 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7060    5.7220    0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790    3.8340   -0.2080 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8320    1.9070   -0.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5680    3.8410    0.0220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5360    5.8510    0.3930 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8960    4.4140    0.0530 C   0  0  3  0  0  0  0  0  0  0  0  0
   -5.9160    3.4280   -0.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2750    4.6660    1.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8810    3.2250   -1.9650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1380    3.8890    2.4240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8540    5.8890    1.5980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3310    2.0090   -2.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4340    4.2150   -2.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3260    1.7800   -3.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4290    3.9880   -4.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8740    2.7700   -4.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  7  2  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6 10  1  0  0  0  0
  7  8  1  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  2  0  0  0  0
  9 14  1  0  0  0  0
 10 14  1  0  0  0  0
 10 15  1  0  0  0  0
 11 16  1  0  0  0  0
 11 17  2  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 22  2  0  0  0  0
 20 23  1  0  0  0  0
 21 24  2  0  0  0  0
 21 25  1  0  0  0  0
 24 26  1  0  0  0  0
 25 27  2  0  0  0  0
 26 28  2  0  0  0  0
 27 28  1  0  0  0  0
M  END
>  <ID>
ochratoxin_a

> <PRIMARY_SOM>
6

>  <Citation>
Herbert Zepnik, Axel Pähler, Ute Schauer and Wolfgang Dekant, Toxicological Sciences 59, 59-67 (2001)

>  <DOI>
10.1093/toxsci/59.1.59

$$$$
olanzapine
  MOE2008           3D

 22 25  0  0  0  0  0  0  0  0999 V2000
    1.4120    0.8030    0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1880    1.4060    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9400    0.5870    0.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8780   -0.8000    0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3350   -1.4030    0.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4540   -0.6030    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6520    1.3960   -0.1370 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0310    2.6370   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3810    2.8820   -0.4080 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1620    3.8090   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8070    3.7960    0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0590    2.7800    0.4410 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5790    5.1710   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6160    6.1180   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7310    7.5870   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1410    5.3910    0.3640 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.2810    1.7630   -0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4080    1.7440    0.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1570    3.0020    0.3900 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0580    2.9340    1.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2210    4.0980    0.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0890    4.1500   -0.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  2 12  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 17  1  0  0  0  0
  9 22  1  0  0  0  0
 10 11  2  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
olanzapine

> <PRIMARY_SOM>
20

> <SECONDARY_SOM>
15

> <TERTIARY_SOM>
5 19

>  <Citation>
Ring et al.,J. Pharmacol. Exp. Ther.,276,658,1996

$$$$
ondansetron
  MOE2008           3D

 22 25  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.4490    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3110    1.8620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960    2.3670    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3720   -0.3680   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0040   -0.9690    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1140    0.7850   -0.0070 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6940    3.3220   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7660    3.8430    0.0730 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.2480    1.9830   -0.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7500   -1.7080   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6020   -2.2940   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5780    0.8350   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5480    4.1110   -0.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8870    4.6380   -0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7360   -2.6500   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1220    4.4890    0.1750 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4890    5.2200    1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1240    3.5850   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6500    4.7970    1.6680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6890    6.3400    1.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0640    3.7920    0.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  2  0  0  0  0
  5  7  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
  9 14  1  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 15 17  1  0  0  0  0
 17 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  2  0  0  0  0
 18 21  1  0  0  0  0
 19 22  2  0  0  0  0
 20 22  1  0  0  0  0
M  END
>  <ID>
ondansetron

> <PRIMARY_SOM>
11 16

>  <Citation>
Dixon et al., Drug Metab. Dispos., 1995, 23, 1225-1230

$$$$
ortho_dichlorobenzene
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
   -0.0130    1.0760    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750    1.7830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1580    3.1650    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0480    3.8410    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2380    3.1330    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2190    1.7500    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0710    5.5770    0.0320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7540    3.9810    0.0490 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
M  END
>  <ID>
ortho_dichlorobenzene

> <PRIMARY_SOM>
1 2

> <SECONDARY_SOM>
6 3

>  <Citation>
Bogaards, J.J.P.; Omen, B.V.; Wolf, C.R.; Van Bladeren, P.J. Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes. Toxicol. Appl. Pharamcol. 1995, 132, 44–52.

$$$$
osu_6162
  MOE2008           3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -0.6950    2.5740   -1.2090 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4320    0.8420   -1.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0170   -4.3590   -2.9970 N   0  0  3  0  0  0  0  0  0  0  0  0
   -1.4600   -0.0220   -1.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2640   -1.4010   -1.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3170    3.2360   -0.4080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8700    2.8800   -2.6140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3780   -2.3210   -1.7570 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.9200   -3.4650   -2.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2470    2.8120   -0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5680   -4.9350   -1.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4560   -5.4230   -3.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7890    0.3650   -0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0360   -1.8870   -0.9090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1200   -3.8790   -0.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9850   -1.0090   -0.5440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1050   -2.8070   -0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5370   -6.3500   -4.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9160   -7.4380   -5.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  2  0  0  0  0
  1 10  1  0  0  0  0
  2  4  2  0  0  0  0
  2 13  1  0  0  0  0
  3  9  1  0  0  0  0
  3 11  1  0  0  0  0
  3 12  1  0  0  0  0
  4  5  1  0  0  0  0
  5  8  1  0  0  0  0
  5 14  2  0  0  0  0
  8  9  1  0  0  0  0
  8 17  1  0  0  0  0
 11 15  1  0  0  0  0
 12 18  1  0  0  0  0
 13 16  2  0  0  0  0
 14 16  1  0  0  0  0
 15 17  1  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
osu_6162

> <PRIMARY_SOM>
12

>  <Citation>
Wienkers and Wynalda,Drug Metab. Disp.,30,1372,2002

>  <DOI>
10.1124/dmd.30.12.1372

$$$$
oxycodone
  MOE2008           3D

 23 27  0  0  1  0  0  0  0  0999 V2000
   -0.2940    1.5470   -0.1680 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5160    0.0620   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090    1.7270   -0.0160 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.1640    1.8480    1.0420 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.7710    2.2670   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6920   -0.2610    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400   -0.8350   -0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8700    1.1380   -1.2620 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.7020    1.0060    1.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5160    3.1200    0.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2070    0.8330    0.9350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4410    1.6050    2.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0070    1.6840   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1160   -1.5940    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.3550   -1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0940   -2.1490   -0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4340    1.8770   -2.4490 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.0510    1.6530    2.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    1.3580    3.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2960   -2.5020   -0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2750   -1.9870    0.8920 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0870    1.2470   -3.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980   -3.3930    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  3 10  1  0  0  0  0
  4 11  1  0  0  0  0
  4 12  1  0  0  0  0
  5 13  1  0  0  0  0
  6 11  1  0  0  0  0
  6 14  1  0  0  0  0
  7 15  1  0  0  0  0
  7 16  2  0  0  0  0
  8 15  1  0  0  0  0
  8 17  1  0  0  0  0
  9 18  1  0  0  0  0
 12 18  1  0  0  0  0
 12 19  2  0  0  0  0
 13 17  1  0  0  0  0
 14 20  2  0  0  0  0
 14 21  1  0  0  0  0
 16 20  1  0  0  0  0
 17 22  1  0  0  0  0
 21 23  1  0  0  0  0
M  END
>  <ID>
oxycodone

> <PRIMARY_SOM>
22

>  <Citation>
Lalovic et al.,Drug Metab. Disp.,32,447,2004

>  <DOI>
10.1124/dmd.32.4.447

$$$$
p-isopropyloxyacetanilide
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    2.3050    1.2650    0.0280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2470    1.5220   -0.0140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0120   -0.4690    0.0070 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6780   -0.0070    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6640   -0.9720    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3170    1.3380    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0500    0.7410    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6890   -0.6010    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0350    1.7030    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1660    0.2980    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4060   -0.5600    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5040    0.4870   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7470   -0.3230    1.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6950   -0.2920   -1.3050 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0  0  0  0
  1 12  1  0  0  0  0
  2 10  2  0  0  0  0
  3  4  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  2  0  0  0  0
  4  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  9  2  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
 10 11  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
p-isopropyloxyacetanilide

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
12

>  <Citation>
F. P. Guengerich, A. Parikh, C. H. Yun, D. Kim, K. Nakamura, L. M. Notley, E. M. J. Gillam, Drug Metab. Rev. 2000, 32, 267-281.

>  <DOI>
10.1081/DMR-100102334 

$$$$
p-methoxyacetanilide
  MOE2008           3D

 12 12  0  0  0  0  0  0  0  0999 V2000
    3.3330   -0.5080   -0.0170 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4560   -0.7060    0.1150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2420   -0.9630    0.0550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8540   -0.7230    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0330   -1.8580   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2400    0.5260    0.1140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9660   -0.4890    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3600   -1.7410   -0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    0.6440    0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3480   -0.1680    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2530    1.3160   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9940    0.7490    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0  0  0  0
  1 12  1  0  0  0  0
  2 10  2  0  0  0  0
  3  4  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  2  0  0  0  0
  4  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  9  2  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
 10 11  1  0  0  0  0
M  END
>  <ID>
p-methoxyacetanilide

> <PRIMARY_SOM>
12

> <SECONDARY_SOM>
11

>  <Citation>
F. P. Guengerich, A. Parikh, C. H. Yun, D. Kim, K. Nakamura, L. M. Notley, E. M. J. Gillam, Drug Metab. Rev. 2000, 32, 267-281.

>  <DOI>
10.1081/DMR-100102334 

$$$$
para_cresol
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    0.0670    0.0110   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9460   -0.7310    0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3200   -0.6150    0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7980    0.2450   -0.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9350    0.9910   -1.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5620    0.8710   -1.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4020   -0.1140    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1430    0.3600   -0.5970 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
para_cresol

> <PRIMARY_SOM>
7

>  <Citation>
Yan et al.,Drug Metab. Disp.,33,1867,2005

>  <DOI>
10.1124/dmd.105.006387

$$$$
parathion
  MOE2008           3D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0810    1.9290    0.1620 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6050    0.5790    0.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5230    1.4100   -0.3740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350    2.1230   -1.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1080    3.4820    1.3270 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1520   -0.1220    1.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5210    0.2970   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2870    3.1600   -2.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9370   -1.1930    2.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0330    0.1850    2.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9540   -0.0440   -1.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540    3.1510   -3.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5440   -1.9580    3.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360   -0.5730    3.5940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6400   -1.6380    4.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0550   -2.4310    5.1580 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.3190   -3.3640    5.5080 O   0  5  0  0  0  0  0  0  0  0  0  0
    2.1190   -2.1260    5.7130 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
 10 14  2  0  0  0  0
 13 15  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  2  0  0  0  0
M  CHG  1  16   1
M  CHG  1  17  -1
M  END
>  <ID>
parathion

> <PRIMARY_SOM>
1 5

>  <Citation>
Mutch et al.,Toxicology,224,22,2006

>  <DOI>
10.1016/j.tox.2006.04.024

$$$$
pefloxacin
  MOE2008           2D

 24 26  0  0  1  0  0  0  0  0999 V2000
    8.6650    1.2910    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350    2.2670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5370    0.7670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4030    2.2670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6650   -0.7570    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3930   -1.7640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350   -0.7330    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6610   -1.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5330   -0.2600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5250   -2.2600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3970   -0.7640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8010   -0.2540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0010   -0.2330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8950   -0.7680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2570   -2.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8010    0.7880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0010    0.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8950    1.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350   -1.7330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350    1.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2690   -0.2330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2690    0.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2690   -2.2330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4030    1.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 16  1  0  0  0  0
  2 20  2  0  0  0  0
  3 24  1  0  0  0  0
  4 24  2  0  0  0  0
  5  8  1  0  0  0  0
  5  9  1  0  0  0  0
  5 12  1  0  0  0  0
  6 10  1  0  0  0  0
  6 11  1  0  0  0  0
  6 15  1  0  0  0  0
  7 13  1  0  0  0  0
  7 19  1  0  0  0  0
  7 21  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 14  2  0  0  0  0
 12 16  1  0  0  0  0
 13 14  1  0  0  0  0
 13 17  2  0  0  0  0
 16 18  2  0  0  0  0
 17 18  1  0  0  0  0
 17 20  1  0  0  0  0
 19 23  1  0  0  0  0
 20 22  1  0  0  0  0
 21 22  2  0  0  0  0
 22 24  1  0  0  0  0
M  END
>  <ID>
pefloxacin

> <PRIMARY_SOM>
15

>  <Citation>
M. Kinzig-Schippers, U. Fuhr, M. Zaigler, J. Dammeyer, G. Rusing, A. Labedzki, J. Bulitta, F. Sorgel, Clin. Pharmacol. Ther. 1999, 65, 262-274.

>  <DOI>
10.1016/S0009-9236(99)70105-0

$$$$
perazine
  MOE2008           3D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3900    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420    2.1590    0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    0.0000   -0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3130    2.0730    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3540    1.7290   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0680    3.3850    0.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890   -0.6710   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960   -0.7200    0.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8160    2.1910    1.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5050    0.1890   -1.2380 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4820    2.5340   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1940    4.1760    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0610   -2.0600   -0.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1140   -2.0990    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1700    2.9040    1.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4010    3.7500    0.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0350   -2.7680   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6530    3.0180    2.8520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170    3.9120    2.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1460    1.6890    3.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4500    3.9810    4.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7790    1.7590    4.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9440    2.6530    4.5960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4270    2.7670    5.9780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
perazine

> <PRIMARY_SOM>
24

> <SECONDARY_SOM>
10

>  <Citation>
Wojcikowski et al.,Europ. Neuropsychopharm.,14,199,2004

>  <DOI>
10.1016/S0924-977X(03)00105-6

$$$$
perphenazine
  MOE2008           3D

 27 30  0  0  1  0  0  0  0  0999 V2000
   -0.1710    2.2120   -0.4920 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9550    3.0250   -0.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0940    0.8390   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4950    2.8260   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1590    2.7010   -0.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8580    4.1860    0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9930    0.2710   -1.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1360    0.0290   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9340    2.7900    1.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390    1.2460   -1.9510 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2550    3.5450   -0.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9520    5.0180    0.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0230   -1.1040   -1.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960   -1.3360   -0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3160    3.4310    1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1500    4.6970   -0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8210    6.4650    1.4870 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0170   -1.9020   -1.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7370    3.3960    2.6430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9410    4.2310    2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6860    4.0700    3.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3680    4.3420    4.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1130    4.1810    4.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3160    5.0160    4.9800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7380    4.9810    6.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6380    5.5850    7.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4580    6.9610    6.9200 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 12 17  1  0  0  0  0
 13 18  2  0  0  0  0
 14 18  1  0  0  0  0
 15 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 24  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
M  END
>  <ID>
perphenazine

> <PRIMARY_SOM>
25

>  <Citation>
Olesen and Linnet,Br. J. Clin. Pharm.,50,563,2000

$$$$
phenacetin
  MOE2008           2D

 13 13  0  0  0  0  0  0  0  0999 V2000
    2.8660   -2.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980    2.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    2.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1 10  1  0  0  0  0
  2 12  2  0  0  0  0
  3  4  1  0  0  0  0
  3 12  1  0  0  0  0
  4  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  2  0  0  0  0
 10 11  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
phenacetin

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
13

>  <Citation>
F. P. Guengerich, A. Parikh, C. H. Yun, D. Kim, K. Nakamura, L. M. Notley, E. M. J. Gillam, Drug Metab. Rev. 2000, 32, 267-281.

>  <DOI>
10.1081/DMR-100102334 

$$$$
phenanthrene
  MOE2008           2D

 14 16  0  0  0  0  0  0  0  0999 V2000
    1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    3.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    2.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  1  0  0  0  0
  2 11  2  0  0  0  0
  3  4  1  0  0  0  0
  3 14  2  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
phenanthrene

> <PRIMARY_SOM>
7 8 13 14

> <SECONDARY_SOM>
9 10 11 12

> <TERTIARY_SOM>
4 5

>  <Citation>
Shou et al., Canc. Lett. 1994, 83, 305-313

>  <DOI>
10.1016/0304-3835(94)90334-4

$$$$
phenytoin
  MOE2008           3D

 19 21  0  0  0  0  0  0  0  0999 V2000
   -0.0570    1.5580    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2250    0.2250    0.2410 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4370    1.7730   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9440   -0.4240    0.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9900    0.4090    0.0580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9220    2.4070    0.1260 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0490   -1.6320    0.2820 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7660    2.4210   -1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9550    2.6060    1.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7410    1.8750   -2.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0900    3.5590   -1.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0640    2.1880    1.8550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250    3.7900    1.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3920    4.1530   -2.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5380    2.9510    2.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8000    4.5530    2.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0430    2.4700   -3.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    3.6110   -3.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9050    4.1330    3.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  2  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  1  0  0  0  0
  4  7  2  0  0  0  0
  8 10  2  0  0  0  0
  8 11  1  0  0  0  0
  9 12  2  0  0  0  0
  9 13  1  0  0  0  0
 10 17  1  0  0  0  0
 11 14  2  0  0  0  0
 12 15  1  0  0  0  0
 13 16  2  0  0  0  0
 14 18  1  0  0  0  0
 15 19  2  0  0  0  0
 16 19  1  0  0  0  0
 17 18  2  0  0  0  0
M  END
>  <ID>
phenytoin

> <PRIMARY_SOM>
14 15 16 17 18 19

>  <Citation>
Komatsu et al.,Drug Metab. Disp.,28,1361,2000

$$$$
phorate
  MOE2008           3D

 13 12  0  0  0  0  0  0  0  0999 V2000
    0.0600    1.8750   -0.0690 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2770   -0.1900   -0.4090 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.6440    2.1570   -0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5900    2.7300   -1.2680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7240    2.3750    1.5460 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.4140   -0.3510   -2.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1000    1.6730    1.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0060    2.6970   -1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2260   -0.3430   -1.9850 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.6060    1.9120    1.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6950    3.3750   -2.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5160   -2.0150   -1.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0200   -2.2440   -1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
phorate

> <PRIMARY_SOM>
9

>  <Citation>
Usmani et al.,Drug Metab. Disp.,32,333,2004

>  <DOI>
10.1124/dmd.32.3.333

$$$$
pimobendan
  MOE2008           3D

 25 28  0  0  1  0  0  0  0  0999 V2000
   -5.2650   -1.6470    0.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9210   -1.3460    0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5090   -0.0550    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4610    0.9260   -0.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8030    0.6170   -0.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2090   -0.6700    0.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5320   -0.9720    0.2090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2400    0.2210   -0.1310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0690    0.2730    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5520    1.5000   -0.3040 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0950   -0.5670    0.2670 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1760    1.3930   -0.2430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0980    0.0630    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230   -0.3520    0.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    0.5560    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1610    1.8770   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8660    2.2870   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8560    0.1280    0.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7100    0.9330    0.7420 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0560    0.5840    0.8850 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5690   -0.4570    0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7170   -0.8020    0.3870 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7080   -1.1910   -0.7970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2680   -1.2410   -0.2740 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.3340   -1.6920   -1.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  2  0  0  0  0
 10 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 18  1  0  0  0  0
 16 17  1  0  0  0  0
 18 19  2  0  0  0  0
 18 24  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  2  0  0  0  0
 21 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
pimobendan

> <PRIMARY_SOM>
8

>  <Citation>
Kuriya, S.-I.; Ohmori, S.; Hino, M.; Ishii, I.; Nakamura, H.; Senda, C.; Igarashi, T.; Kiuchi, M.; Kitada, M. Identification of Cytochrome P450 Isoenzyme(s) Responsible for the Metabolism of Pimobendan in Human Liver Microsomes. Drug Metab. Dispos. 2000, 28, 73–78.

$$$$
pimozide
  MOE2008           3D

 34 38  0  0  0  0  0  0  0  0999 V2000
    5.0500   -0.4370   -0.1960 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1440   -0.0100    0.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2080    0.1430   -0.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4440    0.5650    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6160    0.8310    1.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5610    0.6790    2.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3270    0.2590    1.9010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7280   -0.1950   -1.6000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4330   -0.5440   -1.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7170   -0.8990   -2.4000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7130   -0.7270    0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3520   -2.1870    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9130   -2.4490    0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9950   -1.5870   -0.2730 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2820   -0.2010    0.1140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6880    0.1870   -0.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3590   -1.8870    0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3730   -1.0170   -0.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7830   -1.3310   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7970   -0.4610   -0.7760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1850   -0.7690   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4870    0.9940   -0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3480    1.8600   -1.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0640    3.1940   -1.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9200    3.6630   -0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0600    2.7950    0.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3480    1.4620    0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6420    4.9670    0.1370 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1870   -1.0820   -1.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4610   -1.3650   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7340   -1.3370    0.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7300   -1.0230    1.5330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4550   -0.7450    1.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9790   -1.6130    1.0780 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  1  0  0  0  0
  1 11  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  2  0  0  0  0
  3  4  2  0  0  0  0
  3  8  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 20 22  1  0  0  0  0
 21 29  1  0  0  0  0
 21 33  2  0  0  0  0
 22 23  1  0  0  0  0
 22 27  2  0  0  0  0
 23 24  2  0  0  0  0
 24 25  1  0  0  0  0
 25 26  2  0  0  0  0
 25 28  1  0  0  0  0
 26 27  1  0  0  0  0
 29 30  2  0  0  0  0
 30 31  1  0  0  0  0
 31 32  2  0  0  0  0
 31 34  1  0  0  0  0
 32 33  1  0  0  0  0
M  END
>  <ID>
pimozide

> <PRIMARY_SOM>
17

>  <Citation>
Z. Desta, T. Kerbusch, N. Soukhova, E. Richard, J. W. Ko, D. A. Flockhart, J. Pharmacol. Exp. Ther. 1998, 285, 428-437.

$$$$
progesterone
  MOE2008           3D

 23 26  0  0  1  0  0  0  0  0999 V2000
   -4.1190   -0.9300    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8210   -0.8520    0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8730    0.2870   -0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2900    1.5940    0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9070    0.2500   -0.9180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8180    1.6240   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0530    0.4340    0.3550 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.0940   -2.1420    0.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6850    0.7350    1.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7430    0.2750   -0.4260 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0320   -0.9350    0.1160 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.8030   -2.2060   -0.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730    1.5580   -0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4530    1.4210   -0.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1510    0.2480   -0.3020 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.3440   -1.0170   -0.6420 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.3080   -2.1190   -0.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5540   -0.0800   -0.8020 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.6870   -1.6000   -0.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1750    0.4470    1.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5880    0.5950    0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240    2.0040   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0660    0.0060    1.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  2  7  1  0  0  0  0
  2  8  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  2  0  0  0  0
  4  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 12  1  0  0  0  0
 10 11  1  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 18  1  0  0  0  0
 15 20  1  0  0  0  0
 16 17  1  0  0  0  0
 17 19  1  0  0  0  0
 18 19  1  0  0  0  0
 18 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 23  2  0  0  0  0
M  END
>  <ID>
progesterone

> <PRIMARY_SOM>
8

>  <Citation>
T. Niwa, Y. Yabusaki, K. Honma, N. Matsuo, K. Tatsuta, F. Ishibashi, M. Katagiri, Xenobiotica 1998, 28, 539-547. Links  

>  <DOI>
10.1080/004982598239290

$$$$
promazine
  MOE2008           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0430    1.5840    0.0510 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    2.4400    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0690    0.1900   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2720    2.2060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690    1.9520    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9770    3.8260    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2760   -0.5260   -0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1230   -0.5360   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7560    2.2410    1.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8770    0.2290   -0.0190 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500    2.8320    0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0540    4.7000    0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660   -1.9130   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1310   -1.9160   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1070    2.9140    1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3470    4.2000    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0700   -2.6070   -0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6150    2.9690    2.9600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7940    3.8840    3.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9430    3.5530    2.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
promazine

> <PRIMARY_SOM>
20 19

> <SECONDARY_SOM>
10

>  <Citation>
Wojcikowski et al.,Br. J. Pharm.,138,1465,2003

>  <DOI>
10.1038/sj.bjp.0705195

$$$$
propafenone
  MOE2008           3D

 25 26  0  0  1  0  0  0  0  0999 V2000
    5.1520   -1.2950   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6450   -1.2510   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8360   -1.3430    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2180   -1.3830    1.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9150   -1.3750   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2300   -1.3280   -1.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8490   -1.2940   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1780    0.2050   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6710    0.2490   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9750    1.5410   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7050    2.7350    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0440    3.9430    0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3410    3.9840    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0750    2.8150    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4290    1.5880   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490    0.4390   -0.0560 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0340   -0.7830   -0.0610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    0.8160   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3990   -0.4410   -0.0990 C   0  0  3  0  0  0  0  0  0  0  0  0
   -4.8750   -0.0380   -0.1030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7120   -1.2450   -0.1420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1280   -1.2450    1.0500 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1090   -0.7900   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0410   -2.0030   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4950   -1.5290   -0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  7  2  0  0  0  0
  2  8  1  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 17  2  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 22  1  0  0  0  0
 20 21  1  0  0  0  0
 21 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
propafenone

> <PRIMARY_SOM>
23

>  <Citation>
S. Botsch, J. C. Gautier, P. Beaune, M. Eichelbaum, H. K. Kroemer, Mol. Pharmacol. 1993, 43, 120-126.

$$$$
propofol
  MOE2008           3D

 13 13  0  0  0  0  0  0  0  0999 V2000
    1.2200    0.7140    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5030    1.4740    0.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970    1.1810    1.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4290    1.1690   -0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020    2.7620    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    0.7100   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4950    1.4650   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1880    1.1570   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4210    1.1700    0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1930   -0.6880   -0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0070   -1.3830    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060   -0.6840    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  1  0  0  0  0
  1 13  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
propofol

> <PRIMARY_SOM>
12

>  <Citation>
Court et al.,Anesthesiology,94,110,2001
J. Guitton, T. Buronfosse, M. Desage, J. P. Flinois, J. P. Perdrix, J. L. Brazier, P. Beaune, Br. J. Anaesth. 1998, 80, 788-795.

$$$$
propranolol
  MOE2008           3D

 19 20  0  0  1  0  0  0  0  0999 V2000
    0.0180    1.3640   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1300   -0.0370   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0330   -0.7640   -0.1380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9540   -5.2220   -0.3830 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1950    2.1450    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0770   -2.9390   -0.1940 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.7780   -2.1630   -0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7540   -4.4180   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8110   -2.6060    0.9760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5960   -6.6300   -0.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5470    0.1450   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3940   -0.6330   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2200    2.0240    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450    1.5300    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1120    3.5350    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0780   -7.0300    1.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8340   -7.4330   -0.6670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2950    3.4130    0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1280    4.1680    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  5  1  0  0  0  0
  1 13  1  0  0  0  0
  2  3  1  0  0  0  0
  2 12  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  4 10  1  0  0  0  0
  5 14  2  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6  9  1  0  0  0  0
 10 16  1  0  0  0  0
 10 17  1  0  0  0  0
 11 12  2  0  0  0  0
 11 14  1  0  0  0  0
 13 18  2  0  0  0  0
 15 19  2  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
propranolol

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
14

> <TERTIARY_SOM>
15

>  <Citation>
M. S. Ching, N. Bichara, C. L. Blake, H. Ghabrial, R. H. Tukey, R. A. Smallwood, Drug Metab. Dispos. 1996, 24, 692-694. 

$$$$
prostaglandin_H2
  MOE2008           3D

 25 26  0  0  1  0  0  0  0  0999 V2000
    5.0520    0.6840   -0.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7430    1.3840   -0.4900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9400   -1.7380    0.2410 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4330   -3.9810   -4.7540 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740   -5.1030   -3.0890 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9610   -1.4620   -0.2230 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.6060   -0.7110   -0.3310 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.8540   -0.4000    0.4440 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.9330    0.6020    0.4090 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.9410    0.2260    1.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4800   -1.9450   -1.5700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4770   -1.4640    0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8250   -2.6170   -1.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3580   -1.8080   -0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7760   -2.5650    0.2690 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.0830   -3.9180   -1.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1160   -3.8630   -0.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0210   -4.9420   -1.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1220   -4.9950   -0.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4130   -6.2670   -1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9700   -6.0740   -2.1330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5340   -7.4230   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7110   -5.5960   -3.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2090   -8.6550   -1.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3870   -4.8840   -3.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  1  0  0  0  0
  2  9  1  0  0  0  0
  3 15  1  0  0  0  0
  4 25  1  0  0  0  0
  5 25  2  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6 11  1  0  0  0  0
  7  9  1  0  0  0  0
  7 12  1  0  0  0  0
  8 10  1  0  0  0  0
  9 10  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  2  0  0  0  0
 13 16  2  0  0  0  0
 14 15  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 21  1  0  0  0  0
 19 20  1  0  0  0  0
 20 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 24  1  0  0  0  0
 23 25  1  0  0  0  0
M  END
>  <ID>
prostaglandin_H2

> <PRIMARY_SOM>
8 9

>  <Citation>
Plastaras, J.P.; Guengerich, F.P.; Nebert, D.W.; Marnett, L.J. Xenobiotic Metabolizing Cytochromes P450 Convert Prostaglandin Endoperoxide to Hydroxyheptadecatrienoic Acid and Mutagen, Malondialdehyde. J. Biol. Chem. 2000, 275, 11784–11790.

>  <DOI>
10.1074/jbc.275.16.11784

$$$$
ps_15
  MOE2008           3D

 24 24  0  0  0  0  0  0  0  0999 V2000
    0.4860   -3.9100    0.1690 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.9940   -6.7500   -0.4960 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.1900   -8.4310   -0.5410 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.1460   -2.5830    0.1800 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4070    1.5590    0.5800 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5340    5.9670   -0.7380 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6930    2.0890    0.4990 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9110    4.0740    0.4200 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3000    6.1360    1.5240 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5150    4.1210    0.5780 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2520   -0.4980    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4340   -1.9790    0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6030    0.1670    0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5540    7.4250   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2160   -3.9390    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1560    7.9190   -1.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4800    7.8890   -1.8330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0220   -4.6680   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4250   -4.6220   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4510   -6.0060   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0440   -6.0510   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2550   -6.7230   -0.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9030    5.4480    0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7440    3.4810    0.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0  0  0  0
  2 20  1  0  0  0  0
  3 22  1  0  0  0  0
  4 12  1  0  0  0  0
  4 15  1  0  0  0  0
  5  7  1  0  0  0  0
  5 13  1  0  0  0  0
  6 14  1  0  0  0  0
  6 23  2  0  0  0  0
  7 24  1  0  0  0  0
  8 23  1  0  0  0  0
  8 24  2  0  0  0  0
  9 23  1  0  0  0  0
 10 24  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 14 16  1  0  0  0  0
 14 17  1  0  0  0  0
 15 18  2  0  0  0  0
 15 19  1  0  0  0  0
 18 21  1  0  0  0  0
 19 20  2  0  0  0  0
 20 22  1  0  0  0  0
 21 22  2  0  0  0  0
M  END
>  <ID>
ps_15

> <PRIMARY_SOM>
7 14

>  <Citation>
Diaz et al.,Drug Metab. Disp.,36,380,2008

>  <DOI>
10.1124/dmd.106.013920

$$$$
pyrazoloacridine
  MOE2008           3D

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.3400    0.3540    0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5590    1.4200    0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0640   -1.0030    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5760    0.8790    0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9390    1.0970   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0520    2.5920    0.3670 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1660   -1.8320    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660   -1.3360   -0.1650 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3430    2.2300    0.6050 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6910    0.0570    0.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2600   -0.2920   -0.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9160    2.0740   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450   -1.3230    0.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0370   -3.2650    0.2090 N   0  3  0  0  0  0  0  0  0  0  0  0
    2.3270    3.2590    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5710   -0.6520   -0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2220    1.6910   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0660   -3.8010    0.7580 O   0  5  0  0  0  0  0  0  0  0  0  0
    1.9230   -3.8620   -0.4180 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0720    3.5820   -0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5420    0.3380   -0.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1250    2.7110   -0.7320 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1140    4.6360   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4260    2.2210   -1.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8520    4.9550   -1.3370 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7290    6.0670   -1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7100    3.8320   -1.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  2  0  0  0  0
  5 11  2  0  0  0  0
  5 12  1  0  0  0  0
  6  9  1  0  0  0  0
  7 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 11  1  0  0  0  0
  9 15  1  0  0  0  0
 10 13  1  0  0  0  0
 11 16  1  0  0  0  0
 12 17  2  0  0  0  0
 14 18  1  0  0  0  0
 14 19  2  0  0  0  0
 15 20  1  0  0  0  0
 16 21  2  0  0  0  0
 17 21  1  0  0  0  0
 17 22  1  0  0  0  0
 20 23  1  0  0  0  0
 22 24  1  0  0  0  0
 23 25  1  0  0  0  0
 25 26  1  0  0  0  0
 25 27  1  0  0  0  0
M  CHG  1  14   1
M  CHG  1  18  -1
M  END
>  <ID>
pyrazoloacridine

> <PRIMARY_SOM>
24

>  <Citation>
Reid et al.,Clin. Cancer Res.,10,1471,2004

>  <DOI>
10.1158/1078-0432.CCR-0557-03

$$$$
quinoline
  MOE2008           3D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0210    0.6400   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.7540   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    1.3900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470    1.3740    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440   -1.4600   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090   -1.4360   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3660    0.6780   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440    0.6720   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440   -0.7300    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3580   -0.7260    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
quinoline

> <PRIMARY_SOM>
4 8

> <SECONDARY_SOM>
7

> <TERTIARY_SOM>
6

>  <Citation>
Reigh et al., Carcinogenesis, 1996, 17, 1989-1996

$$$$
rabeprazole_thioether
  MOE2008           3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.0830    1.2680    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1220   -0.0140   -0.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1930    1.7400    0.1980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4260    2.3220    0.3360 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1100    1.6960    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7460    1.0830    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7120    1.9050   -1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -0.3900   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0430    0.6940   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7080    2.0160    1.3870 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9840    2.4790   -1.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9380    2.5700    1.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6120    2.8200    0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5470    2.6750   -2.2920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3580    3.4700   -3.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0170    1.5260   -2.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7590   -1.6470   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1890    4.2790   -4.8740 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4350    0.6110   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8340    3.2750   -2.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7230    4.1080   -3.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4720    4.8780   -4.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9680   -0.6510   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1520   -1.7570   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  6  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  2  0  0  0  0
  5 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 16  1  0  0  0  0
  8  9  2  0  0  0  0
  8 17  1  0  0  0  0
  9 19  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  2  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 14 20  1  0  0  0  0
 15 20  1  0  0  0  0
 15 21  1  0  0  0  0
 17 24  2  0  0  0  0
 18 21  1  0  0  0  0
 18 22  1  0  0  0  0
 19 23  2  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
rabeprazole_thioether

> <PRIMARY_SOM>
4

> <SECONDARY_SOM>
22

>  <Citation>
Miura et al.,Eur. J. Clin. Pharmacol.,62,113,2006

>  <DOI>
10.1007/s00228-005-0077-8

$$$$
ranitidine
  MOE2008           3D

 21 21  0  0  0  0  0  0  0  0999 V2000
   -0.6480    0.0600    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0270   -1.0010    0.8980 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0480    0.4530   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8630    0.5610    0.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0710   -1.2840    0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1540   -0.4210   -0.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0490    0.5580    0.1350 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9010   -2.4150    0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1950    0.6540    1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0440    1.7750   -0.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3810   -1.8510    1.4710 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.1430   -3.4690    1.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2890   -4.2830    2.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8590   -5.6120    2.7930 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2810   -6.5830    3.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9530   -7.7540    3.5840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1600   -6.2280    4.3640 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4950   -8.9010    4.3090 N   0  3  0  0  0  0  0  0  0  0  0  0
    1.4840   -7.0120    5.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3360   -9.2940    4.1290 O   0  5  0  0  0  0  0  0  0  0  0  0
    4.3390   -9.4570    5.0210 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  7  1  0  0  0  0
  5  6  2  0  0  0  0
  5  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
 18 21  2  0  0  0  0
M  CHG  1  18   1
M  CHG  1  20  -1
M  END
>  <ID>
ranitidine

> <PRIMARY_SOM>
9 10

>  <Citation>
W. G. Chung, C. S. Park, H. K. Roh, W. K. Lee, Y. N. Cha, Jpn. J. Pharmacol. 2000, 84, 213-220.

>  <DOI>
10.1254/jjp.84.213

$$$$
reduced_diclofenac
  MOE2008           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -1.4130   -0.1220    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4410   -1.0750   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7470   -0.8260    0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0560    0.3690    1.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0520    1.3040    1.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7440    1.0640    0.7860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1600   -2.5950   -0.8330 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.5810    2.2420    1.2830 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.1210   -0.4460   -0.3720 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8310    0.3560   -1.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1560   -0.0970   -1.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0970    0.6590   -1.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7340    1.8640   -2.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4240    2.3160   -2.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4830    1.5620   -1.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6050   -1.3940   -0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7720   -1.2620    0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2020   -2.5130    1.4450 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  2  7  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  8  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  2  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
reduced_diclofenac

> <PRIMARY_SOM>
13

>  <Citation>
Mancy, A.; Antignac, M.; Minoletti, C.; Dijols, S.; Mouries, V.; Ha Duong, N.T.; Battioni, P.; Dansette, P.M.; Mansuy, D. Diclofenac and Its Derivatives as Tools for Studying Human Cytochromes P450 Active Sites: Particular Efficiency and Regioselectivity of P450 2Cs. Biochemistry 1999, 38, 14264–14270.

>  <DOI>
10.1021/bi991195u

$$$$
riluzole
  MOE2008           3D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -1.1610   -3.1780   -3.6390 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5410    1.4470   -0.8960 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690    1.9040    1.1890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2970    0.1550    0.7300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0630    0.1220    0.2400 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1120   -2.3900   -4.5690 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0160   -3.9860   -5.8940 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2880   -2.0110   -2.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9090   -1.7110   -3.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6360   -1.4060   -1.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2500   -0.4800   -0.9420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.7720   -2.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4460   -0.1660   -1.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0920   -3.1830   -4.8030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2530    0.8980    0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  8  1  0  0  0  0
  1 14  1  0  0  0  0
  2 15  1  0  0  0  0
  3 15  1  0  0  0  0
  4 15  1  0  0  0  0
  5 11  1  0  0  0  0
  5 15  1  0  0  0  0
  6  9  1  0  0  0  0
  6 14  2  0  0  0  0
  7 14  1  0  0  0  0
  8  9  2  0  0  0  0
  8 10  1  0  0  0  0
  9 12  1  0  0  0  0
 10 11  2  0  0  0  0
 11 13  1  0  0  0  0
 12 13  2  0  0  0  0
M  END
>  <ID>
riluzole

> <PRIMARY_SOM>
7

>  <Citation>
Sanderink, G.J.; Bournique, B.; Stevens, J.; Petry, M.; Martinet, M. Involvement of Human CYP1A Isoenzymes in the Metabolism and Drug Interactions of Riluzole In Vitro. J. Pharmacol. Exp. Ther. 1997, 282, 1465–1472.

$$$$
ropinirole
  MOE2008           3D

 19 20  0  0  0  0  0  0  0  0999 V2000
    1.0890    0.8930    0.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1910    0.4080    0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1680    0.0460    0.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    0.4770   -0.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4420    1.7850   -0.8390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3590    2.6330   -0.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1800    2.1900   -0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3890   -1.3940    0.6120 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2970   -0.5550   -0.3640 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0920   -0.1970   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3400   -0.6700    0.4810 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0280    0.5160    1.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1750   -1.1920   -0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2290    1.5320   -0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8870    2.7940    0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4470   -1.8100   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3170   -2.3530   -1.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8150   -1.6800    0.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4100   -2.7280    0.3260 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  7  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  2  0  0  0  0
  3  8  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8 18  1  0  0  0  0
  9 18  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 16  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 18 19  2  0  0  0  0
M  END
>  <ID>
ropinirole

> <PRIMARY_SOM>
13 12

> <SECONDARY_SOM>
5

>  <Citation>
J. C. Bloomer, S. E. Clarke, R. J. Chenery, Drug Metab. Dispos. 1997, 25, 840-844.

$$$$
ropivacaine
  MOE2008           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
    0.9280   -0.5320    0.8250 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2230   -0.2590    0.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9870    0.7210    0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2640    0.9880    0.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    0.2810   -0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0250   -0.6950   -1.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7490   -0.9710   -0.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4220    1.4920    2.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9260   -2.0400   -1.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1230   -0.3870   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5170   -0.6870    0.4830 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0530   -0.0150   -1.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4800    0.1390   -0.2530 N   0  0  3  0  0  0  0  0  0  0  0  0
   -1.8270   -2.1680    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2310   -2.4750    0.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7980   -0.0850    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2340   -1.5320    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1260    1.5400    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8200    2.4450   -1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4510    3.9040   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  2  0  0  0  0
  3  4  2  0  0  0  0
  3  8  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  9  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 13 16  1  0  0  0  0
 13 18  1  0  0  0  0
 14 15  1  0  0  0  0
 15 17  1  0  0  0  0
 16 17  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
ropivacaine

> <PRIMARY_SOM>
4 6

>  <Citation>
Ekstrom, G.; Gunnarsson, U.B. Ropivacaine, a New Amide-Type Local Anesthetic Agent, Is Metabolized by Cytochromes P450 1A and 3A in Human Liver Microsomes. Drug Metab. Dispos. 1996, 24, 955–961.
Oda, Y.; Furuichi, K.; Tanaka, K.; Hiroi, T.; Imaoka, S.; Asada, A.; Fujimori, M.; Funae, Y. Metabolism of a New Local-Anesthetic, Ropivacaine, by Human Hepatic Cytochrome-P450. Anaestesiology 1995, 82, 214–220. 

$$$$
rosiglitazone
  MOE2008           3D

 25 27  0  0  1  0  0  0  0  0999 V2000
   -0.0160    1.3420    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0790    2.0830    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7420   -0.4080   -0.0170 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.3900    1.3110   -0.0140 C   0  0  3  0  0  0  0  0  0  0  0  0
    9.3200   -4.4040    0.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5780   -4.5610    1.8480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9450   -0.7670    0.0070 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7360   -3.2470   -0.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0400    3.2950    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1930    1.6050   -1.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5320    0.9190   -1.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9900   -0.3420   -1.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6790   -0.3680   -1.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6130    1.5790   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8420    0.9520   -0.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9050   -1.0000   -1.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1980   -0.9610   -0.9740 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0300   -2.2620   -1.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3600   -3.0160   -1.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6430   -5.3890   -0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2020   -5.6440    2.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5490   -2.2590    0.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2360   -6.5350    0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5210   -6.6590    1.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  8  2  0  0  0  0
  3  5  1  0  0  0  0
  3 10  2  0  0  0  0
  4  5  1  0  0  0  0
  5 11  1  0  0  0  0
  6  7  2  0  0  0  0
  6  9  1  0  0  0  0
  6 21  1  0  0  0  0
  7 22  1  0  0  0  0
  9 20  1  0  0  0  0
  9 23  1  0  0  0  0
 11 12  1  0  0  0  0
 12 14  1  0  0  0  0
 12 15  2  0  0  0  0
 13 16  2  0  0  0  0
 13 17  1  0  0  0  0
 13 18  1  0  0  0  0
 14 17  2  0  0  0  0
 15 16  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 21 24  2  0  0  0  0
 22 25  2  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
rosiglitazone

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
25

> <TERTIARY_SOM>
21

>  <Citation>
Baldwin et al.,Brit. J. Clin. Pharm.,48,424,1999

$$$$
rutaecarpine
  MOE2008           3D

 22 26  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4700    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1640    2.1770    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700    2.3480    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1880   -0.6140    0.3600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680   -0.6770   -0.3360 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8490    3.5310    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4890    1.4510   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5710    3.6220    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3010   -1.9600    0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3200    0.1830    0.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0760   -2.0230   -0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6410    4.6910    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070    4.8610    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1090   -2.7310   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3560   -2.5150    0.5450 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2270   -2.7330   -0.7450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9850    5.8950    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3980    5.9840    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1260   -4.1230   -0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1890   -4.1080   -0.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0200   -4.8000   -0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  1  0  0  0  0
  7  9  2  0  0  0  0
  7 13  1  0  0  0  0
  8 11  1  0  0  0  0
  9 14  1  0  0  0  0
 10 15  1  0  0  0  0
 10 16  2  0  0  0  0
 12 15  2  0  0  0  0
 12 17  1  0  0  0  0
 13 18  2  0  0  0  0
 14 19  2  0  0  0  0
 15 20  1  0  0  0  0
 17 21  2  0  0  0  0
 18 19  1  0  0  0  0
 20 22  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
rutaecarpine

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
14

> <TERTIARY_SOM>
22 13

>  <Citation>
Ueng et al.,Drug Metab. Disp.,34,821,2006
Lee et al.,J. Pharm. Bio. Anal.,41,304,2006

>  <DOI>
10.1124/dmd.105.007849
10.1016/j.jpba.2005.10.039

$$$$
selegiline
  MOE2008           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
    3.7100    1.4800    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9440    0.2810   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9200   -0.6550   -0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.4050   -0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4320    0.8000    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    1.7400    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6060   -1.4520   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7660   -1.2830    0.2630 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.5700   -0.1870   -0.2590 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.6710   -1.2840    1.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7140   -0.3550   -1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6520    0.9880    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2720    2.0080    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9040   -0.2580    0.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
 12 13  3  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
selegiline

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
11

>  <Citation>
Benetton et al., Drug Metab. Pharma.,2,78,2007

>  <DOI>
10.2133/dmpk.22.78

$$$$
sertraline
  MOE2008           3D

 20 22  0  0  1  0  0  0  0  0999 V2000
   -2.6400    8.7890    2.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3890    7.7420    1.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3700    8.5450    3.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8700    6.4500    1.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6020    6.1870    2.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8450    7.2490    3.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0550    4.7890    2.4670 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.5370    7.0210    3.5880 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.2020    5.9260    2.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4210    4.6270    2.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8650    3.7630    3.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5970    2.8260    2.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650    1.8690    3.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9120    3.7320    4.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6790    2.7760    5.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4080    1.8420    4.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5260    6.6110    4.9900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3830    0.6260    5.2570 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.6750    2.8170    6.9810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2510    7.7690    5.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  6  2  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 17  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  2  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 13 16  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 15 19  1  0  0  0  0
 16 18  1  0  0  0  0
 17 20  1  0  0  0  0
M  END
>  <ID>
sertraline

> <PRIMARY_SOM>
20

>  <Citation>
Obach et al.,Drug Metab. Disp.,33,262,2005

>  <DOI>
10.1124/dmd.104.002428

$$$$
styrene
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.1560    0.6760   -0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0180    1.4440   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500    2.8720   -0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9550    3.5830   -0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1130    0.8270    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -0.5390    0.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0300   -1.2970    0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1630   -0.6900   -0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  2  0  0  0  0
  3  4  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
styrene

> <PRIMARY_SOM>
3 4

>  <Citation>
Nakajima et al.,Chem. Res. Toxicol.,7,891,1994

>  <DOI>
10.1021/tx00042a026

$$$$
tacrine
  MOE2008           2D

 15 17  0  0  0  0  0  0  0  0999 V2000
    4.6660   -1.6380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6660    1.3620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3320   -0.1170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4260    0.3970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3320   -1.1580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5320   -0.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4260   -1.6720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5320   -1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6660    0.3620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000   -0.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000   -1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9060    0.3970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9060   -1.6720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.1170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -1.1580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  8  2  0  0  0  0
  1 11  1  0  0  0  0
  2  9  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6  9  2  0  0  0  0
  7  8  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  2  0  0  0  0
 13 15  2  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
tacrine

> <PRIMARY_SOM>
4 14

> <SECONDARY_SOM>
3 7

>  <Citation>
V. Spaldin, S. Madden, D. A. Adams, R. J. Edwards, D. S. Davies, B. K. Park, Drug Metab. Dispos. 1995, 23, 929-934.

$$$$
tamarixetin
  MOE2008           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0030   -0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660    2.1210    0.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    2.0900    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1820   -0.6580   -0.0630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1960   -0.6990   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    1.3420    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080    3.3400    0.1040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4210    1.3780   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570    3.4460    0.0800 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3610   -0.0160   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3990   -0.0110   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6700    1.9480    0.0790 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6040   -0.8100   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5680   -0.7000   -0.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7410   -1.9130    0.8140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6440   -0.4670   -0.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9070   -2.6530    0.7960 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8050   -1.2110   -0.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9430   -2.3010   -0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0440   -3.7260    1.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0890   -3.0310   -0.0830 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9470   -2.4310   -1.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  2  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 11  2  0  0  0  0
  7 13  1  0  0  0  0
  9 12  1  0  0  0  0
 11 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 18 21  1  0  0  0  0
 19 20  1  0  0  0  0
 20 22  1  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
tamarixetin

> <PRIMARY_SOM>
23

>  <Citation>
Breinholt et al.,Food and Chem. Tox.,40,609,2002

$$$$
tamoxifen
  MOE2008           3D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -0.0590    1.3520   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0030    0.0160    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1860    2.1280   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3710    2.0320   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -0.6820    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2520   -0.7520    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4490    2.7380   -1.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0980    2.2570    0.7530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7380    2.9370    0.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2460    1.7760   -1.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8400   -1.2710    1.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9820   -0.7670   -1.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4100   -0.8560    1.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6100    3.4600   -1.6980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2570    2.9810    0.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9630    3.5680    0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4680    2.4140   -1.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0520   -1.9240    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1930   -1.4250   -1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5180    3.5820   -0.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8280    3.3050   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7290   -1.9990   -0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6610    4.2940   -0.8300 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3780    4.2360    0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6840    5.0230    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3790    6.4450    0.0670 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9790    6.9850    1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6450    7.1000   -0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  2  0  0  0  0
  5 12  1  0  0  0  0
  6 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 16  1  0  0  0  0
 10 17  2  0  0  0  0
 11 18  1  0  0  0  0
 12 19  2  0  0  0  0
 14 20  2  0  0  0  0
 15 20  1  0  0  0  0
 16 21  2  0  0  0  0
 17 21  1  0  0  0  0
 18 22  2  0  0  0  0
 19 22  1  0  0  0  0
 20 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
 26 28  1  0  0  0  0
M  END
>  <ID>
tamoxifen

> <PRIMARY_SOM>
27 28

>  <Citation>
Desta, Z., Ward, B. A., Soukhova, N. V., Flockhart, D. A. (2004). Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: Prominent roles for CYP3A and CYP2D6. J. Pharmacol. Exp. Ther. 310:1062–1075.

$$$$
tangeretin
  MOE2008           3D

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.3760    1.2710   -0.4950 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3530   -0.0540    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6380    1.7860   -0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2730    2.2950   -1.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2580    1.8910    0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5400    2.8780   -1.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900    2.1770   -2.6620 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900    1.4070    2.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5560    2.4200    1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1810    2.9480   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1420    3.4090   -2.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1860    2.6280   -3.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5180    2.4360    3.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1740    2.4520    2.2330 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4420    3.4720   -0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2160    3.9980   -2.6630 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3830    3.2180   -3.8690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3980    2.4190   -5.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3310    1.6240    2.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2910    4.7890    0.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1470    1.7940   -4.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8640    2.8270   -6.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6160    1.5820   -6.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1050    2.6170   -7.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1390    1.9940   -7.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9530    1.7440   -8.4360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3670    2.2060   -9.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  3  4  2  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  4  7  1  0  0  0  0
  5  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  6 11  1  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  1  0  0  0  0
 10 15  1  0  0  0  0
 11 16  2  0  0  0  0
 11 17  1  0  0  0  0
 12 17  2  0  0  0  0
 12 18  1  0  0  0  0
 14 19  1  0  0  0  0
 15 20  1  0  0  0  0
 18 21  2  0  0  0  0
 18 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 24  2  0  0  0  0
 23 25  2  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
M  END
>  <ID>
tangeretin

> <PRIMARY_SOM>
27

>  <Citation>
Brienholt et al.,Pharmacol. Toxicol.,93,14,2003

>  <DOI>
10.1034/j.1600-0773.2003.930102.x

$$$$
tangeretin_T27
  MOE2008           3D

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.3860    1.2550   -0.4890 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3440   -0.0420    0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6460    1.7780   -0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2750    2.2840   -1.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2720    1.8960    0.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5410    2.8720   -1.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5880    2.1600   -2.6660 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6110    1.4230    2.0250 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5680    2.4290    0.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1870    2.9510   -0.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1370    3.3990   -2.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1760    2.6150   -3.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5300    2.4680    2.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1900    2.4720    2.2190 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4470    3.4800   -0.0610 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2110    3.9880   -2.6870 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3710    3.2080   -3.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3840    2.4100   -5.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3500    1.6470    2.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2940    4.7990    0.4550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1310    1.7890   -4.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8530    2.8230   -6.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350    1.5840   -6.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0970    2.6240   -7.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1400    2.0050   -7.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8840    1.8070   -8.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  3  4  2  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  4  7  1  0  0  0  0
  5  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  6 11  1  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  1  0  0  0  0
 10 15  1  0  0  0  0
 11 16  2  0  0  0  0
 11 17  1  0  0  0  0
 12 17  2  0  0  0  0
 12 18  1  0  0  0  0
 14 19  1  0  0  0  0
 15 20  1  0  0  0  0
 18 21  2  0  0  0  0
 18 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 24  2  0  0  0  0
 23 25  2  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
M  END
>  <ID>
tangeretin_T27

> <PRIMARY_SOM>
23 24

>  <Citation>
Brienholt et al.,Pharmacol. Toxicol.,93,14,2003

>  <DOI>
10.1034/j.1600-0773.2003.930102.x

$$$$
tauromustine
  MOE2008           3D

 17 16  0  0  0  0  0  0  0  0999 V2000
   -0.0660    1.3460   -0.0440 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0360   -0.0460   -0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1320    2.1590   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470    1.8930    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1620   -0.7360   -0.0280 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1240   -0.6260   -0.0910 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9830    1.8750   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2720    3.1240    0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1680   -2.1740   -0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4050    2.9320   -1.2570 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.5850   -2.6780   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5420   -4.4520   -0.0260 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1920   -4.8070    0.0770 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0620   -4.8660   -1.3280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8990   -4.8900    1.1940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0150   -4.4450   -1.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8590   -4.4640    1.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  7 10  1  0  0  0  0
  9 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  2  0  0  0  0
 12 15  2  0  0  0  0
 13 16  1  0  0  0  0
 13 17  1  0  0  0  0
M  END
>  <ID>
tauromustine

> <PRIMARY_SOM>
4 8

> <SECONDARY_SOM>
16 17

>  <Citation>
Tuvesson, H.; Gunnarsson, P.O.; Seidegard, J. Metabolism of Tauromustine in Liver and Lung Microsomes from Various Species. Xenobiotica 1999, 29, 783–792.

>  <DOI>
10.1080/004982599238236

$$$$
tegafur
  MOE2008           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
    6.6960   -0.3830    0.8750 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1880   -0.4070    2.4460 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1800   -4.3660    1.8820 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4870   -2.9820    0.9680 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5860   -2.0840    1.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3240   -3.6770    1.4260 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2240   -1.6940    1.8100 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4360   -1.5700    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4310   -0.5020    0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530    0.4220    1.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9590   -3.4380    1.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5070   -1.0880    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7950   -1.3500    1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3030   -2.7300    1.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0  0  0  0
  2  7  1  0  0  0  0
  2 10  1  0  0  0  0
  3 11  2  0  0  0  0
  4 14  2  0  0  0  0
  5  7  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 11  1  0  0  0  0
  6 14  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
tegafur

> <PRIMARY_SOM>
7

>  <Citation>
Komatsu, T.; Yamazaki, H.; Shimada, N.; Nakajima, M.; Yokoi, T. Roles of Cytochromes P450 1A2 2A6, and 2C8 in 5-Fluorouracil Formation from Tegafur, an Anticancer Prodrug, in Human Liver Microsomes. Drug Metab. Dispos. 2000, 28, 1457–1463. 

$$$$
tegaserod
  MOE2008           3D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -0.0530    1.3970    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1910    0.0220    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    2.0560   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3900    1.8390    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5500   -0.1390   -0.0200 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8280   -0.9340    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1800    1.0690   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5340    3.4620   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4280    0.9040    0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1420   -0.4590    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5770    4.3280   -0.0050 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6940    1.4250    0.0750 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0880    5.5870   -0.0150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6770    0.3970    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2860    6.7210   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0310    7.8870   -0.0150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0180    6.7110    0.0210 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3490    9.1630   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3810   10.2630   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6920   11.6040   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7240   12.7040   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0340   14.0450   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5  7  1  0  0  0  0
  6 10  2  0  0  0  0
  8 11  2  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  2  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
tegaserod

> <PRIMARY_SOM>
14

>  <Citation>
Vickers et al.,Drug Metab. Disp.,29,1269,2001

$$$$
terbinafine
  MOE2008           3D

 22 23  0  0  1  0  0  0  0  0999 V2000
   -6.4320    0.3690    0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6890    1.4420    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3470    1.2600   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7860   -0.0420   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5840   -1.1250    0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8790   -0.9090    0.7450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5480    2.3420   -0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2520    2.1280   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7010    0.8480   -0.7810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4430   -0.2240   -0.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8280   -1.6000   -0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3890   -1.4990   -0.6380 N   0  0  3  0  0  0  0  0  0  0  0  0
    0.0720   -2.8540   -0.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2590   -1.1310    0.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7460   -1.0100    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3600    0.1440    0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7730    0.2590    0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9310    0.3530    0.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3840    0.4700    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8350    1.8920    0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1110   -0.5270    0.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7150    0.1680   -1.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  2  0  0  0  0
  4  5  1  0  0  0  0
  4 10  2  0  0  0  0
  5  6  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  3  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 19 22  1  0  0  0  0
M  END
>  <ID>
terbinafine

> <PRIMARY_SOM>
1 2 7 8

> <SECONDARY_SOM>
13

> <TERTIARY_SOM>
11 20 21 22

>  <Citation>
A. E. M. Vickers, J. R. Sinclair, M. Zollinger, F. Heitz, U. Glanzel, L. Johanson, V. Fischer, Drug Metab. Dispos. 1999, 27, 1029-1038.

$$$$
terbuthylazine
  MOE2008           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.4880   -1.3640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6790   -0.7290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7110    0.6020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4170    1.2920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5810    0.6630    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6200   -0.6670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8340   -1.3230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0820   -0.5550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2720   -1.5150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8570   -1.4480    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1430   -0.7470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2460    0.1310    1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2810   -1.7700    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3710    3.0280    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.2460    0.1300   -1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 15  1  0  0  0  0
M  END
>  <ID>
terbuthylazine

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
12 13 15

>  <Citation>
Lang et al.,Chem. Res. Tox.,10,1037,1997

$$$$
terbutryne
  MOE2008           3D

 16 16  0  0  0  0  0  0  0  0999 V2000
   -0.1960   -1.5640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9010   -0.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000    0.5120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3990    1.0880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4970    0.3370    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950   -0.9880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5340   -1.7680    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8550   -1.1340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9390   -2.2140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1450   -1.4110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3550   -0.5840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3690    0.3000    1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5900   -1.4870    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5330    2.8450    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3690    0.2990   -1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3340    3.0220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 15  1  0  0  0  0
 14 16  1  0  0  0  0
M  END
>  <ID>
terbutryne

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
14

> <TERTIARY_SOM>
12 13 15

>  <Citation>
Lang et al.,Chem. Res. Tox.,10,1037,1997

$$$$
theobromine
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -5.9060    0.0420   -1.1980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5800   -2.3050    0.9880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6740    1.5130   -2.6250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8900   -0.6890   -0.5560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2100   -1.1150   -0.1220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5200    1.0760   -2.2370 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6470    0.5240   -1.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3170    0.2750   -1.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7090   -0.1610   -1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -1.4310    0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3690    1.8120   -2.9250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4690   -0.9290   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8360    2.1400   -3.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  2  0  0  0  0
  2 10  2  0  0  0  0
  3  7  1  0  0  0  0
  3 11  1  0  0  0  0
  3 13  1  0  0  0  0
  4  8  1  0  0  0  0
  4 10  1  0  0  0  0
  4 12  1  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6  8  1  0  0  0  0
  6 11  2  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
M  END
>  <ID>
theobromine

> <PRIMARY_SOM>
12

>  <Citation>
Gates, S.; Miners, J.O. Cytochrome P450 Isoform Selectivity in Human Hepatic Theobromine Metabolism. Br. J. Clin. Pharmacol. 1999, 47, 299–305.

>  <DOI>
10.1046/j.1365-2125.1999.00890.x

$$$$
theophylline
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
    1.2130    0.5920    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0370    1.3820    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0200    2.5990    0.2840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0930    0.6030   -0.1330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450    1.3030   -0.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1340   -0.7960   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1870   -1.3920   -0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0870   -1.4650   -0.1920 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1180   -2.8950   -0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -0.7620    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4890   -1.2730    0.2160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2420   -0.2170    0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5020    0.9400    0.4830 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  2  0  0  0  0
  1 13  1  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
theophylline

> <PRIMARY_SOM>
12

> <SECONDARY_SOM>
9

> <TERTIARY_SOM>
5

>  <Citation>
H. R. Ha, J. Z. Chen, A. U. Freiburghaus, F. Follath, Br. J. Clin. Pharmacol. 1995, 39, 321-326.

$$$$
thiabendazole
  MOE2008           3D

 14 16  0  0  0  0  0  0  0  0999 V2000
   -4.8270    0.6410    0.0130 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1260    1.0400   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2280   -1.1760    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930   -1.2700   -0.0180 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1780    0.6140   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0850   -0.7740    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9380   -0.0660    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -0.0790    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3940    1.3000   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2610   -1.5410    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5560    0.5190   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4940   -0.8770    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1610    1.0650    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3820   -1.0150   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0  0  0  0
  1 14  1  0  0  0  0
  2  5  1  0  0  0  0
  2  7  1  0  0  0  0
  3  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  1  0  0  0  0
  4 14  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 10  1  0  0  0  0
  7  8  1  0  0  0  0
  8 13  2  0  0  0  0
  9 11  2  0  0  0  0
 10 12  2  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
thiabendazole

> <PRIMARY_SOM>
12

>  <Citation>
M. Coulet, M. Dacasto, C. Eeckhoutte, G. Larrieu, J. F. Sutra, M. Alvinerie, K. Mace, A. M. A. Pfeifer, P. Galtier, Fundam. Clin. Pharmacol. 1998, 12, 225-235.

>  <DOI>
10.1111/j.1472-8206.1998.tb00946.x

$$$$
thioridazine
  MOE2008           3D

 25 28  0  0  1  0  0  0  0  0999 V2000
   -0.9640    0.8750    0.5140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -0.4900    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9660   -0.9560    1.9930 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2420    1.4560    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -1.4430    0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    0.7390    1.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1130    1.7600    0.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4150    3.5460   -2.7700 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1700   -0.9020   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.2420   -1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3120    3.1940   -1.3480 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5680   -2.7940    0.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -2.2540   -0.7700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6850   -2.7690   -1.8460 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5840   -3.2010   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4880    2.3410   -3.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5630    4.4280   -3.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4720    2.7920    0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    1.3590    1.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930    4.4630   -0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -4.5780   -1.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3800    5.7340   -2.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560    3.4020    0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6200    2.6890    1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2650    5.4220   -0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  7  1  0  0  0  0
  2  5  2  0  0  0  0
  2  9  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  6  2  0  0  0  0
  4 18  1  0  0  0  0
  5 12  1  0  0  0  0
  6 19  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  8 16  1  0  0  0  0
  8 17  1  0  0  0  0
  9 13  2  0  0  0  0
 10 11  1  0  0  0  0
 11 20  1  0  0  0  0
 12 15  2  0  0  0  0
 13 14  1  0  0  0  0
 13 15  1  0  0  0  0
 14 21  1  0  0  0  0
 17 22  1  0  0  0  0
 18 23  2  0  0  0  0
 19 24  2  0  0  0  0
 20 25  1  0  0  0  0
 22 25  1  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
thioridazine

> <PRIMARY_SOM>
3

> <SECONDARY_SOM>
16

> <TERTIARY_SOM>
14

>  <Citation>
Wojcikowski et al.,Drug Metab. Disp.,34,471,2006

>  <DOI>
10.1124/dmd.105.006445

$$$$
ticlopidine
  MOE2008           3D

 17 19  0  0  1  0  0  0  0  0999 V2000
    1.1180    0.5290    0.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1340    1.0490    1.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1330    0.1180    0.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5840   -1.3720    0.2610 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.9940   -0.7750    0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1610   -1.5240   -0.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0090   -0.5230   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140    0.7710   -0.5030 N   0  0  3  0  0  0  0  0  0  0  0  0
    3.2430    1.7610   -1.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0900    2.9680   -1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450    1.1930    0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4280    3.0340   -1.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1970    1.7290   -2.5410 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.1840    4.1790   -1.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6070    5.2690   -0.8250 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2740    5.2150   -0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5200    4.0700   -0.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
 10 12  1  0  0  0  0
 10 17  2  0  0  0  0
 12 13  1  0  0  0  0
 12 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
ticlopidine

> <PRIMARY_SOM>
4

>  <Citation>
Dansette et al.,Chem. Res. Toxicol.,22,369,2009

>  <DOI>
10.1021/tx8004828

$$$$
tolperisone
  MOE2008           3D

 18 19  0  0  1  0  0  0  0  0999 V2000
   -0.0460    1.4750    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0040    0.0040   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1400    2.2130   -0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2730    2.1410    0.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2850   -0.7880    0.0410 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.0620   -0.5710   -0.0870 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0930    3.5910   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3040    3.5190    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680   -2.1560   -0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7040   -0.9770    1.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1260    4.2430    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3300   -2.9080   -0.6010 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1690    5.7490    0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0760   -4.1650   -1.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2850   -2.1370   -1.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3540   -5.0050   -1.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300   -2.8640   -1.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4400   -4.2340   -2.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  7 11  2  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
tolperisone

> <PRIMARY_SOM>
13

>  <Citation>
Dalmadi et al.,Drug Metab. Disp.,31,631,2003

>  <DOI>
10.1124/dmd.31.5.631

$$$$
toluene
  MOE2008           3D

  7  7  0  0  0  0  0  0  0  0999 V2000
    1.2070    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.3980   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.8860   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060   -0.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.3880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060   -0.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
toluene

> <PRIMARY_SOM>
3

> <SECONDARY_SOM>
6

> <TERTIARY_SOM>
1 4

>  <Citation>
Tamie Nakajima , Rui-Sheng Wang, Eivor Elovaara, Frank J. Gonzalez, Harry V. Gelboin, Hannu Raunio, Olavi Pelkonen, Harri Vainio and Toshifumi Aoyama. Toluene Metabolism by cDNA-Expressed Human Hepatic Cytochrome P450, Biochemical Pharmacology, Vol. 53, pp. 271-277, 1997

>  <DOI>
10.1016/S0006-2952(96)00652-1 

$$$$
toremifene
  MOE2008           3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -4.0680    0.1800   -1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6290    0.9280    0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1260    0.9030    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720   -0.2820    0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2340   -1.5510    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0090   -2.4920   -0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7230   -3.6720   -0.6880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6600   -3.9240    0.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8880   -2.9940    1.2980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1760   -1.8130    1.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040   -0.3070    0.4390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6210   -0.8920    1.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9970   -0.9140    1.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7680   -0.3540    0.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1240   -0.3770    0.7160 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6280    0.2650   -0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1570    0.2730   -0.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6540   -1.1100   -0.4220 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5190   -1.6020   -1.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0940   -1.0420   -0.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1580    0.2290   -0.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7840    0.2490   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3680    2.1630    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4530    3.0470   -0.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7400    4.2260   -0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0590    4.5370    0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1480    3.6690    1.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5640    2.4880    1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8670    0.2100   -1.2220 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 29  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  2  0  0  0  0
  3 23  1  0  0  0  0
  4  5  1  0  0  0  0
  4 11  1  0  0  0  0
  5  6  1  0  0  0  0
  5 10  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 11 22  2  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 21  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 21 22  1  0  0  0  0
 23 24  1  0  0  0  0
 23 28  2  0  0  0  0
 24 25  2  0  0  0  0
 25 26  1  0  0  0  0
 26 27  2  0  0  0  0
 27 28  1  0  0  0  0
M  END
>  <ID>
toremifene

> <PRIMARY_SOM>
20 19

> <SECONDARY_SOM>
17

>  <Citation>
F. Berthou, Y. Dreano, C. Belloc, L. Kangas, J. C. Gautier, P. Beaune, Biochem. Pharmacol. 1994, 47, 1883-1895.

$$$$
trans_retinoic_acid
  MOE2008           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.4780    1.9650   -0.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100    0.5660   -0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1430    2.7470   -1.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3040    2.4730    0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7010   -0.0880   -0.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3530   -6.2680   -1.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4030   -7.6710   -1.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9560   -3.5470   -0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1930   -5.6010   -0.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7300   -1.4880   -0.8940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1430   -4.2050   -1.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9250   -2.1440   -0.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4110   -8.2870   -0.7420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5520   -8.3320   -1.3430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1870    4.2430   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5770    3.9710    0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9000    2.1010   -2.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4950    2.2360    1.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6340    1.7220    0.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7420    4.6740    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9640   -6.3630   -0.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4400   -2.2640   -0.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  3 15  1  0  0  0  0
  3 17  1  0  0  0  0
  4 16  1  0  0  0  0
  4 18  1  0  0  0  0
  4 19  1  0  0  0  0
  5 10  1  0  0  0  0
  6  7  1  0  0  0  0
  6  9  2  0  0  0  0
  7 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 11  2  0  0  0  0
  8 12  1  0  0  0  0
  9 11  1  0  0  0  0
  9 21  1  0  0  0  0
 10 12  2  0  0  0  0
 10 22  1  0  0  0  0
 15 20  1  0  0  0  0
 16 20  1  0  0  0  0
M  END
>  <ID>
trans_retinoic_acid

> <PRIMARY_SOM>
15

>  <Citation>
Marill et al.,Current Drug. Metab.,4,1,2003

$$$$
triamterene
  MOE2008           3D

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.8460   -0.6200   -6.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2670    0.1450   -5.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5320    0.4460   -4.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3070   -0.0210   -3.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4340   -0.7790   -3.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6990   -1.0800   -5.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150    0.2990   -2.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1030    1.6220   -1.9210 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3470    1.9720   -0.6290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4790    1.0300    0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3730   -0.2710    0.0950 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1380   -0.6520   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0870   -2.0130   -1.3930 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7130    1.3680    1.6540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8260    2.6630    1.9510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7190    3.6470    1.0590 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4810    3.2910   -0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3700    4.3250   -1.1300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680    3.0030    3.2540 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7 12  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 17  2  0  0  0  0
 10 11  1  0  0  0  0
 10 14  2  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 19  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
triamterene

> <PRIMARY_SOM>
1

>  <Citation>
Fuhr et al., Int. J. Clin. Pharmacol. Ther., 2005, 43, 327-334

$$$$
troglitazone
  MOE2008           3D

 31 34  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3770    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0970    2.1490    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    2.0410    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -0.7840    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1860   -0.7170   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1960    1.4460    0.5620 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.4270    1.3320    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2800    3.5470    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4540    0.1810   -0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4020   -0.0550   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550   -2.2240   -0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4400    2.3370    0.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8750    1.0570    2.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7440    2.0630    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5650   -0.7590   -0.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2380    3.4620    1.3920 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3690    4.2130    1.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4680    5.3850    2.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4280    3.8060    0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6180    6.1460    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5770    4.5710    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6710    5.7420    1.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9250    6.5740    1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9050    6.1150    2.2080 C   0  0  3  0  0  0  0  0  0  0  0  0
   10.2350    6.8460    2.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3740    6.6800    3.8740 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.5620    7.5900    3.1390 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9460    6.7510    1.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7890    7.7100    4.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0040    8.3660    5.2350 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  2  0  0  0  0
  6 12  1  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 11  1  0  0  0  0
  8 15  1  0  0  0  0
 11 16  1  0  0  0  0
 13 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 22  2  0  0  0  0
 21 23  2  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 25 27  1  0  0  0  0
 26 28  1  0  0  0  0
 26 29  2  0  0  0  0
 27 30  1  0  0  0  0
 28 30  1  0  0  0  0
 30 31  2  0  0  0  0
M  END
>  <ID>
troglitazone

> <PRIMARY_SOM>
16

> <SECONDARY_SOM>
25 27

>  <Citation>
Yamazaki et al., Drug Metab. Dispos.,27,1260,1999; He et al., Drug Metab. Dispos., 2004, 32, 442-446; He et al., Drug Metab. Dispos., 2004, 32, 639-646

$$$$
urporphyrinogen
  MOE2008           2D

 60 64  0  0  0  0  0  0  0  0999 V2000
   13.6810   -0.5980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5900   -4.6900    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3220    6.1980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5720    2.0080    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0040    0.9970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2380   -4.1590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7510    5.4690    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2410    0.4100    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5010    4.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0080   -5.6980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4170    5.0440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3540   -2.8180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.5500    3.0340    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4030   -4.6710    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8120    6.0710    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4880   -1.3180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6260    0.6830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1240   -0.6870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0910    2.0520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6210    0.6830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1940    1.4850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9260   -1.2880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2890    2.6870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0540   -0.0860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2270   -0.0520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3230   -1.3210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9260    2.7200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0540    1.4510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8940    2.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9280   -1.0200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3210    2.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3550   -1.0200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1630    1.2170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6250   -2.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5900    3.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0860    0.1820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1630    0.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6240   -2.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5920    3.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0860    1.1840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9590    1.8230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2180   -3.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9980    4.4600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2200   -0.3180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9620   -0.3860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9530   -2.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1670    4.4720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2900    1.7890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8320    2.8150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8170   -3.9770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0040    4.3490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2200   -1.3180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8820    0.0040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2600   -3.9490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7470    5.3800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3680    1.4020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6280    3.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4100   -4.7820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4110    5.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3540   -1.8180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 53  1  0  0  0  0
  2 54  1  0  0  0  0
  3 55  1  0  0  0  0
  4 56  1  0  0  0  0
  5 53  2  0  0  0  0
  6 54  2  0  0  0  0
  7 55  2  0  0  0  0
  8 56  2  0  0  0  0
  9 57  1  0  0  0  0
 10 58  1  0  0  0  0
 11 59  1  0  0  0  0
 12 60  1  0  0  0  0
 13 57  2  0  0  0  0
 14 58  2  0  0  0  0
 15 59  2  0  0  0  0
 16 60  2  0  0  0  0
 17 21  1  0  0  0  0
 17 25  1  0  0  0  0
 18 22  1  0  0  0  0
 18 26  1  0  0  0  0
 19 23  1  0  0  0  0
 19 27  1  0  0  0  0
 20 24  1  0  0  0  0
 20 28  1  0  0  0  0
 21 29  1  0  0  0  0
 21 33  2  0  0  0  0
 22 30  1  0  0  0  0
 22 34  2  0  0  0  0
 23 31  1  0  0  0  0
 23 35  2  0  0  0  0
 24 32  1  0  0  0  0
 24 36  2  0  0  0  0
 25 30  1  0  0  0  0
 25 37  2  0  0  0  0
 26 32  1  0  0  0  0
 26 38  2  0  0  0  0
 27 29  1  0  0  0  0
 27 39  2  0  0  0  0
 28 31  1  0  0  0  0
 28 40  2  0  0  0  0
 33 37  1  0  0  0  0
 33 41  1  0  0  0  0
 34 38  1  0  0  0  0
 34 42  1  0  0  0  0
 35 39  1  0  0  0  0
 35 43  1  0  0  0  0
 36 40  1  0  0  0  0
 36 44  1  0  0  0  0
 37 45  1  0  0  0  0
 38 46  1  0  0  0  0
 39 47  1  0  0  0  0
 40 48  1  0  0  0  0
 41 49  1  0  0  0  0
 42 50  1  0  0  0  0
 43 51  1  0  0  0  0
 44 52  1  0  0  0  0
 45 53  1  0  0  0  0
 46 54  1  0  0  0  0
 47 55  1  0  0  0  0
 48 56  1  0  0  0  0
 49 57  1  0  0  0  0
 50 58  1  0  0  0  0
 51 59  1  0  0  0  0
 52 60  1  0  0  0  0
M  END
>  <ID>
urporphyrinogen

> <PRIMARY_SOM>
29 30 31 32

>  <Citation>
Sinclair et al., Drug Metab. Dispos., 1998, 26, 1019-1025

$$$$
verapamil
  MOE2008           3D

 33 34  0  0  1  0  0  0  0  0999 V2000
   -6.8870    1.3830    1.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5490    1.1060   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0780    0.1010   -1.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9480   -0.6180   -0.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9600    2.9830    0.5170 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7220    1.9370   -1.3240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7250   -0.1740   -2.1780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6590    1.8150   -0.5170 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3080   -1.1800    1.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4200   -2.5320   -0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6420   -3.5010    0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8340   -2.5570   -1.5730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5010   -1.0980    2.1820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7680    1.7300    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6580    1.2010   -0.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4580   -0.0770   -1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3760   -0.8230   -0.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4920   -0.2980   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6890    0.9740    0.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140   -1.1160    0.4120 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.0180   -0.4660   -0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8190   -1.2140    0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4700   -0.4690    0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6210   -1.1880    0.7210 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.8190   -0.4240    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0620   -1.1210    0.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2910   -0.3370    0.5230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7560    0.6650    1.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8990    3.2320    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4370    1.1310   -2.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0080   -1.2390   -2.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8860    2.7590    0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3030   -1.2290    3.0170 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 28  2  0  0  0  0
  2  3  2  0  0  0  0
  2  8  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4 27  2  0  0  0  0
  5 14  1  0  0  0  0
  5 29  1  0  0  0  0
  6 15  1  0  0  0  0
  6 30  1  0  0  0  0
  7 31  1  0  0  0  0
  8 32  1  0  0  0  0
  9 20  1  0  0  0  0
  9 33  3  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 10 20  1  0  0  0  0
 13 24  1  0  0  0  0
 14 15  1  0  0  0  0
 14 19  2  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
 27 28  1  0  0  0  0
M  END
>  <ID>
verapamil

> <PRIMARY_SOM>
25

> <SECONDARY_SOM>
13

>  <Citation>
Kroemer, K.; Gautier, J.C.; Beaune, P.; Henderson, C.; Wolf, C.R.; Eichelbaum, M. Identification of P450 Enzymes Involved in Metabolism of Verapamil in Humans. Naunyn Schmiedebergs Arch. Pharmacol. 1993, 348, 332–337. 

$$$$
voreloxin
  MOE2008           3D

 28 31  0  0  1  0  0  0  0  0999 V2000
   -4.3720    0.7010   -0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4050   -0.6870   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2200   -1.4060   -0.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0100   -0.7370   -0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0080    0.6400   -0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1740    1.3290   -0.0560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6160    1.4160   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7800    0.6630   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9240   -0.6540   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6800   -1.4280   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6760   -2.6410   -0.4900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7480    2.7890    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9180    3.3650    0.3730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8100    4.7350    0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5540    5.2280    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4680    3.9650   -0.0600 S   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2990   -1.1710   -0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3300   -2.5190   -0.2500 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3030   -0.4770   -0.0880 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6190    3.1040   -0.3560 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.3420    1.9490    0.3450 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5020    0.7880   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8410    1.3340   -0.0970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8090    2.7760    0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9800    4.4200    0.1480 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1180    4.8960   -0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6820    1.8050   -0.1020 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5290    2.3970    0.8730 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 23  1  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
  9 17  1  0  0  0  0
 10 11  2  0  0  0  0
 12 13  2  0  0  0  0
 12 16  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 17 19  2  0  0  0  0
 20 21  1  0  0  0  0
 20 24  1  0  0  0  0
 20 25  1  0  0  0  0
 21 22  1  0  0  0  0
 21 27  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 25 26  1  0  0  0  0
 27 28  1  0  0  0  0
M  END
>  <ID>
voreloxin

> <PRIMARY_SOM>
8 9 26 28

>  <Citation>
Evanchik et al.,Drug Metab. Disp.,37,594,2009

>  <DOI>
10.1124/dmd.108.023432

$$$$
warfarin-r
  MOE2008           3D

 23 25  0  0  1  0  0  0  0  0999 V2000
    2.0440    0.2690    8.9340 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6550    0.0320    6.6760 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0530    4.3120    8.5670 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5430    4.0440    4.0570 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7210    2.9250    6.2650 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.4060    2.2080    7.5430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9540    2.4100    5.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1840    3.1390    6.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    3.0920    8.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3610    0.8770    7.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7550    2.4430    9.9510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6550    3.5230    4.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7610    4.3560    6.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9880    2.1500    5.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7580    1.0570   10.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4540    3.2070   11.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1200    4.5830    6.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3470    2.3760    5.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7660    3.9650    3.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4580    0.4180   11.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9120    3.5930    5.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1540    2.5670   12.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1570    1.1740   12.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0  0  0  0
  1 15  1  0  0  0  0
  2 10  1  0  0  0  0
  3  9  2  0  0  0  0
  4 12  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  5  8  1  0  0  0  0
  6  9  1  0  0  0  0
  6 10  2  0  0  0  0
  7 12  1  0  0  0  0
  8 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 11  1  0  0  0  0
 11 15  2  0  0  0  0
 11 16  1  0  0  0  0
 12 19  1  0  0  0  0
 13 17  1  0  0  0  0
 14 18  2  0  0  0  0
 15 20  1  0  0  0  0
 16 22  2  0  0  0  0
 17 21  2  0  0  0  0
 18 21  1  0  0  0  0
 20 23  2  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
warfarin-r

> <PRIMARY_SOM>
22

> <SECONDARY_SOM>
20

>  <Citation>
Zhang, Z., Fasco, M. J., Huang, Z., Guengerich, F. P. and Kaminsky, L. S. ( 1995) Human cytochromes P450 1A1 and 1A2: R-warfarin as a probe Drug Metab. Dispos. 23, 1339– 1345

$$$$
zileuton
  MOE2008           3D

 16 17  0  0  1  0  0  0  0  0999 V2000
   -0.0240    1.6300    0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    0.1680    0.1310 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.0030    2.4640    0.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4580    2.6620    0.7340 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0280   -0.5500    0.8580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2000    0.0110   -1.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7330    3.8520    1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6370    4.1860    1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200   -0.2120    0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6850   -1.6000    1.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6530    4.8930    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670    5.4580    1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2740   -0.7700    1.4550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6270    0.5960   -0.1730 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    6.1430    1.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1380    6.4450    1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  7  8  2  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
  9 14  2  0  0  0  0
 11 15  2  0  0  0  0
 12 16  2  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
zileuton

> <PRIMARY_SOM>
11 12 15 16

>  <Citation>
J. M. Machinist, M. D. Mayer, M. S. Shet, J. L. Ferrero, A. D. Rodrigues, Drug Metab. Dispos. 1995, 23, 1163-1174.

$$$$
zolmitriptan
  MOE2008           3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    5.7540   -1.3780   -0.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1120   -3.0900    1.3610 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1940   -2.9790    0.0480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7920   -6.2690   -2.7130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4090   -6.3590    3.1080 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7550   -2.1720   -1.0460 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2680   -1.8800   -1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4570   -3.0230   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2480   -5.0840   -1.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3510   -6.2290   -0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6210   -0.9380   -0.8880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0440   -5.1330   -2.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0130   -4.0080   -0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3060   -6.6010    0.8910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1500   -3.0970   -2.8890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4800   -6.0090    1.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9830   -6.9370   -1.5330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3930   -4.1550   -3.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4130   -2.5430    0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5130   -5.7440    3.8470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1250   -5.9470    3.6760 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0  0  0  0
  1 19  1  0  0  0  0
  2 19  2  0  0  0  0
  3  6  1  0  0  0  0
  3 19  1  0  0  0  0
  4 12  1  0  0  0  0
  4 17  1  0  0  0  0
  5 16  1  0  0  0  0
  5 20  1  0  0  0  0
  5 21  1  0  0  0  0
  6  7  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  8 13  1  0  0  0  0
  8 15  2  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
  9 13  2  0  0  0  0
 10 14  1  0  0  0  0
 10 17  2  0  0  0  0
 12 18  2  0  0  0  0
 14 16  1  0  0  0  0
 15 18  1  0  0  0  0
M  END
>  <ID>
zolmitriptan

> <PRIMARY_SOM>
20 21

> <SECONDARY_SOM>
5

>  <Citation>
Wild, M.J.; McKillop, D.; Butters, C.J. Determination of the Human Cytochrome P450 Isoforms Involved in the Metabolism of Zolmitriptan. Xenobiotica 1999, 29, 847–857.

>  <DOI>
10.1080/004982599238290 

$$$$
zolpidem
  MOE2008           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.0010    1.3780   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0130    0.0160    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    1.7680   -0.0360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2050    2.2820   -0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2230   -0.8430    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2580   -0.4150    0.0460 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    0.6300    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    2.9970   -0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4920    2.6320   -1.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2910   -0.5520   -0.8370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920   -1.9460    0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4770    0.7350    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2470    3.1120   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5300    3.4360   -1.8560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7880    2.1910   -2.4370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4140   -1.3540   -0.8270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4200   -2.7420    0.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0550    1.9650    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8830    4.4780   -0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8090    3.7770   -3.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3800    3.9680   -0.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4800   -2.4460    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7090   -3.3180    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6  7  2  0  0  0  0
  7 12  1  0  0  0  0
  8 13  2  0  0  0  0
  9 14  1  0  0  0  0
  9 15  2  0  0  0  0
 10 16  1  0  0  0  0
 11 17  2  0  0  0  0
 12 18  2  0  0  0  0
 13 18  1  0  0  0  0
 13 19  1  0  0  0  0
 14 20  1  0  0  0  0
 14 21  1  0  0  0  0
 16 22  2  0  0  0  0
 17 22  1  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
zolpidem

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
19

>  <Citation>
von Moltke et al.,Br. J. Clin. Pharm.,48,89,1999

>  <DOI>
10.1046/j.1365-2125.1999.00953.x 

$$$$
zotepine
  MOE2008           3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.3360    1.9550   -0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4180    0.5680   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4970    2.8440   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350    2.5460   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9420   -0.3530   -0.6610 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7550   -0.1860   -0.7370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6110    2.8100   -0.9440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3280    3.8820    0.6920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900    1.7860   -0.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    0.5030   -1.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0080    0.4160   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0330    1.8850   -1.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    3.3140    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250    2.5460   -0.4110 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.3080   -0.2880   -3.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7900    2.4390   -3.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7350    4.2160    3.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0410    0.2780   -4.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2850    1.6450   -4.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7180    4.1450    2.9580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1410    2.8340    3.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2230    5.1130    3.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  1  0  0  0  0
  6 11  2  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
 10 12  2  0  0  0  0
 10 15  1  0  0  0  0
 12 16  1  0  0  0  0
 13 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 19  2  0  0  0  0
 17 20  1  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
 20 22  1  0  0  0  0
M  END
>  <ID>
zotepine

> <PRIMARY_SOM>
22 21

> <SECONDARY_SOM>
19

> <TERTIARY_SOM>
5 18

>  <Citation>
Shiraga, T.; Kaneko, H.; Iwasaki, K.; Tozuka, Z.; Suzuki, A.; Hata, T. Identification of Cytochrome P450 Enzymes Involved in the Metabolism of Zotepine, an Antipsychotic Drug, in Human Liver Microsomes. Xenobiotica 1999, 29, 217–229.

>  <DOI>
10.1080/004982599238623

$$$$
